NZ582942A - Use of kncq potassium channel openers for treating attention deficit hyperactivity disorder (adhd) or aggression - Google Patents

Info

Publication number

NZ582942A

NZ582942A NZ582942A NZ58294208A NZ582942A NZ 582942 A NZ582942 A NZ 582942A NZ 582942 A NZ582942 A NZ 582942A NZ 58294208 A NZ58294208 A NZ 58294208A NZ 582942 A NZ582942 A NZ 582942A

Authority

NZ

New Zealand

Prior art keywords

alk

phenyl

cycloalk

dimethyl

methyl

Prior art date

2007-08-01

Links

• Espacenet
• Global Dossier
• Discuss

• 230000016571 aggressive behavior Effects 0.000 title claims abstract description 42
• 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 title claims abstract description 6
• 229940127315 Potassium Channel Openers Drugs 0.000 title description 3
• 150000001875 compounds Chemical class 0.000 claims abstract description 338
• 238000011282 treatment Methods 0.000 claims abstract description 58
• 150000003839 salts Chemical class 0.000 claims abstract description 51
• IAAITAGXZWCRTQ-UHFFFAOYSA-N 2-cyclopentyl-n-(2,6-dimethyl-4-morpholin-4-ylphenyl)acetamide Chemical compound CC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CC1CCCC1 IAAITAGXZWCRTQ-UHFFFAOYSA-N 0.000 claims abstract description 23
• OVEJXWFUXCATFY-UHFFFAOYSA-N n-(2,6-dimethyl-4-morpholin-4-ylphenyl)-3,3-dimethylbutanamide Chemical compound CC1=C(NC(=O)CC(C)(C)C)C(C)=CC(N2CCOCC2)=C1 OVEJXWFUXCATFY-UHFFFAOYSA-N 0.000 claims abstract description 22
• 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 13
• JNWPEEJRMRBMPA-UHFFFAOYSA-N 2-cyclopentyl-n-(2-methoxy-6-methyl-4-morpholin-4-ylphenyl)acetamide Chemical compound COC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CC1CCCC1 JNWPEEJRMRBMPA-UHFFFAOYSA-N 0.000 claims abstract description 8
• IMOFGKWQMCCNKF-UHFFFAOYSA-N 2-cyclopentyl-n-(4,6-dimethyl-2-morpholin-4-ylpyrimidin-5-yl)acetamide Chemical compound CC1=NC(N2CCOCC2)=NC(C)=C1NC(=O)CC1CCCC1 IMOFGKWQMCCNKF-UHFFFAOYSA-N 0.000 claims abstract description 6
• BPFWCATXXHFMHU-UHFFFAOYSA-N n-(2,6-difluoro-4-morpholin-4-ylphenyl)hexanamide Chemical compound C1=C(F)C(NC(=O)CCCCC)=C(F)C=C1N1CCOCC1 BPFWCATXXHFMHU-UHFFFAOYSA-N 0.000 claims abstract description 6
• DKKUESYXEUWVTR-UHFFFAOYSA-N n-(4,6-dimethyl-2-morpholin-4-ylpyrimidin-5-yl)-2-(4-fluorophenyl)acetamide Chemical compound CC1=NC(N2CCOCC2)=NC(C)=C1NC(=O)CC1=CC=C(F)C=C1 DKKUESYXEUWVTR-UHFFFAOYSA-N 0.000 claims abstract description 6
• WOVDEFIGDUUBDM-UHFFFAOYSA-N n-[2-bromo-4-morpholin-4-yl-6-(trifluoromethyl)phenyl]propanamide Chemical compound C1=C(C(F)(F)F)C(NC(=O)CC)=C(Br)C=C1N1CCOCC1 WOVDEFIGDUUBDM-UHFFFAOYSA-N 0.000 claims abstract description 6
• SCOOTUMXCXKEAD-UHFFFAOYSA-N ethyl n-[2-amino-4-[(2,4,6-trimethylphenyl)methylamino]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1NCC1=C(C)C=C(C)C=C1C SCOOTUMXCXKEAD-UHFFFAOYSA-N 0.000 claims abstract description 5
• 238000004519 manufacturing process Methods 0.000 claims abstract description 3
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 125
• 230000000694 effects Effects 0.000 claims description 98
• 102000012359 KCNQ Potassium Channels Human genes 0.000 claims description 60
• 108010022282 KCNQ Potassium Channels Proteins 0.000 claims description 60
• 241001465754 Metazoa Species 0.000 claims description 47
• 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims description 42
• 208000015802 attention deficit-hyperactivity disease Diseases 0.000 claims description 42
• 201000010099 disease Diseases 0.000 claims description 15
• 230000001787 epileptiform Effects 0.000 claims description 8
• 230000001773 anti-convulsant effect Effects 0.000 claims description 6
• BKFDFCVASNKPOA-UHFFFAOYSA-N n-(2,4-dimethyl-6-morpholin-4-ylpyridin-3-yl)-3,3-dimethylbutanamide Chemical compound CC1=C(NC(=O)CC(C)(C)C)C(C)=CC(N2CCOCC2)=N1 BKFDFCVASNKPOA-UHFFFAOYSA-N 0.000 claims description 6
• 230000001594 aberrant effect Effects 0.000 claims description 4
• 210000001320 hippocampus Anatomy 0.000 claims description 3
• 230000003389 potentiating effect Effects 0.000 claims description 2
• 210000001353 entorhinal cortex Anatomy 0.000 claims 1
• 208000024891 symptom Diseases 0.000 description 127
• -1 alcohol Chemical compound 0.000 description 116
• 208000035475 disorder Diseases 0.000 description 110
• 238000000034 method Methods 0.000 description 95
• 125000004432 carbon atom Chemical group C* 0.000 description 89
• 208000028017 Psychotic disease Diseases 0.000 description 82
• 201000000980 schizophrenia Diseases 0.000 description 82
• 125000005842 heteroatom Chemical group 0.000 description 71
• 125000001424 substituent group Chemical group 0.000 description 69
• 239000003814 drug Substances 0.000 description 66
• VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 65
• 229910052736 halogen Inorganic materials 0.000 description 65
• 229940079593 drug Drugs 0.000 description 64
• 229910052757 nitrogen Inorganic materials 0.000 description 56
• 238000012360 testing method Methods 0.000 description 55
• 230000000561 anti-psychotic effect Effects 0.000 description 54
• 125000003118 aryl group Chemical group 0.000 description 54
• 150000002500 ions Chemical class 0.000 description 54
• 239000001257 hydrogen Substances 0.000 description 53
• 229910052739 hydrogen Inorganic materials 0.000 description 53
• 239000000164 antipsychotic agent Substances 0.000 description 47
• 241000700159 Rattus Species 0.000 description 45
• 208000011117 substance-related disease Diseases 0.000 description 45
• 229940005529 antipsychotics Drugs 0.000 description 43
• 125000005843 halogen group Chemical group 0.000 description 43
• KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 42
• 150000002367 halogens Chemical class 0.000 description 42
• 239000000126 substance Substances 0.000 description 41
• 229940025084 amphetamine Drugs 0.000 description 38
• PCOBBVZJEWWZFR-UHFFFAOYSA-N ezogabine Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1NCC1=CC=C(F)C=C1 PCOBBVZJEWWZFR-UHFFFAOYSA-N 0.000 description 38
• 201000009032 substance abuse Diseases 0.000 description 38
• 125000004093 cyano group Chemical group *C#N 0.000 description 36
• 230000003291 dopaminomimetic effect Effects 0.000 description 35
• 150000002431 hydrogen Chemical group 0.000 description 34
• 229960003638 dopamine Drugs 0.000 description 33
• 230000014509 gene expression Effects 0.000 description 33
• 125000002950 monocyclic group Chemical group 0.000 description 33
• 229910052717 sulfur Inorganic materials 0.000 description 33
• 125000002252 acyl group Chemical group 0.000 description 32
• 208000019022 Mood disease Diseases 0.000 description 31
• 229910052760 oxygen Inorganic materials 0.000 description 30
• 208000020401 Depressive disease Diseases 0.000 description 29
• 238000001228 spectrum Methods 0.000 description 29
• 206010026749 Mania Diseases 0.000 description 28
• 230000006399 behavior Effects 0.000 description 27
• 208000024714 major depressive disease Diseases 0.000 description 27
• 230000004044 response Effects 0.000 description 27
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 26
• 208000016285 Movement disease Diseases 0.000 description 26
• 125000004429 atom Chemical group 0.000 description 25
• 125000004433 nitrogen atom Chemical group N* 0.000 description 25
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
• ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 24
• 239000003981 vehicle Substances 0.000 description 24
• 238000002474 experimental method Methods 0.000 description 22
• 229920006395 saturated elastomer Polymers 0.000 description 22
• 125000002619 bicyclic group Chemical group 0.000 description 21
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 21
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 21
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 21
• 229960003312 retigabine Drugs 0.000 description 21
• 208000024827 Alzheimer disease Diseases 0.000 description 20
• 241000699670 Mus sp. Species 0.000 description 20
• BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 20
• 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 19
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 19
• 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 18
• RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 18
• 102000005962 receptors Human genes 0.000 description 18
• 108020003175 receptors Proteins 0.000 description 18
• 125000000217 alkyl group Chemical group 0.000 description 17
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 16
• 210000004556 brain Anatomy 0.000 description 16
• 230000005764 inhibitory process Effects 0.000 description 16
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 16
• 230000008092 positive effect Effects 0.000 description 16
• 238000007920 subcutaneous administration Methods 0.000 description 16
• 239000002253 acid Substances 0.000 description 15
• HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 15
• 210000004027 cell Anatomy 0.000 description 15
• 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 15
• 238000010304 firing Methods 0.000 description 15
• 230000004899 motility Effects 0.000 description 15
• 239000003368 psychostimulant agent Substances 0.000 description 15
• 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 15
• 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 description 14
• 108091006146 Channels Proteins 0.000 description 14
• 102000027484 GABAA receptors Human genes 0.000 description 14
• 108091008681 GABAA receptors Proteins 0.000 description 14
• 208000018737 Parkinson disease Diseases 0.000 description 14
• 239000000935 antidepressant agent Substances 0.000 description 14
• 230000001684 chronic effect Effects 0.000 description 14
• 125000001072 heteroaryl group Chemical group 0.000 description 14
• 208000013403 hyperactivity Diseases 0.000 description 14
• 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 14
• 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 14
• 230000001225 therapeutic effect Effects 0.000 description 14
• YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 13
• YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 13
• KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 13
• 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 13
• 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 13
• 125000004435 hydrogen atom Chemical group [H]* 0.000 description 13
• 230000002474 noradrenergic effect Effects 0.000 description 13
• 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 13
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 13
• NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 12
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 12
• 229940005513 antidepressants Drugs 0.000 description 12
• 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 12
• 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 12
• 229910052799 carbon Inorganic materials 0.000 description 12
• 229960003920 cocaine Drugs 0.000 description 12
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 12
• 210000004515 ventral tegmental area Anatomy 0.000 description 12
• 206010054089 Depressive symptom Diseases 0.000 description 11
• YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 11
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 11
• 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 11
• 239000001301 oxygen Substances 0.000 description 11
• 125000004430 oxygen atom Chemical group O* 0.000 description 11
• 239000000243 solution Substances 0.000 description 11
• SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 10
• GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 10
• SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 10
• GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 10
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
• 230000001430 anti-depressive effect Effects 0.000 description 10
• 230000003561 anti-manic effect Effects 0.000 description 10
• 125000004122 cyclic group Chemical group 0.000 description 10
• 229960002069 diamorphine Drugs 0.000 description 10
• 230000036651 mood Effects 0.000 description 10
• 229960005181 morphine Drugs 0.000 description 10
• 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 10
• 229960002715 nicotine Drugs 0.000 description 10
• SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 10
• 230000000306 recurrent effect Effects 0.000 description 10
• 230000002829 reductive effect Effects 0.000 description 10
• 241000218236 Cannabis Species 0.000 description 9
• 108010006746 KCNQ2 Potassium Channel Proteins 0.000 description 9
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
• 208000000323 Tourette Syndrome Diseases 0.000 description 9
• 208000016620 Tourette disease Diseases 0.000 description 9
• 150000001721 carbon Chemical group 0.000 description 9
• 239000003874 central nervous system depressant Substances 0.000 description 9
• 125000000392 cycloalkenyl group Chemical group 0.000 description 9
• 230000006735 deficit Effects 0.000 description 9
• 239000012458 free base Substances 0.000 description 9
• 230000002401 inhibitory effect Effects 0.000 description 9
• 230000010534 mechanism of action Effects 0.000 description 9
• 230000001537 neural effect Effects 0.000 description 9
• 229940005483 opioid analgesics Drugs 0.000 description 9
• 208000020925 Bipolar disease Diseases 0.000 description 8
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 8
• 230000001154 acute effect Effects 0.000 description 8
• 238000000540 analysis of variance Methods 0.000 description 8
• 230000003542 behavioural effect Effects 0.000 description 8
• 125000001246 bromo group Chemical group Br* 0.000 description 8
• 125000001309 chloro group Chemical group Cl* 0.000 description 8
• 230000001143 conditioned effect Effects 0.000 description 8
• 208000024732 dysthymic disease Diseases 0.000 description 8
• 150000002148 esters Chemical class 0.000 description 8
• 125000001153 fluoro group Chemical group F* 0.000 description 8
• 235000013305 food Nutrition 0.000 description 8
• 238000012048 forced swim test Methods 0.000 description 8
• 238000001727 in vivo Methods 0.000 description 8
• 239000007924 injection Substances 0.000 description 8
• 238000002347 injection Methods 0.000 description 8
• 125000002346 iodo group Chemical group I* 0.000 description 8
• 239000007788 liquid Substances 0.000 description 8
• 229910052744 lithium Inorganic materials 0.000 description 8
• 230000006742 locomotor activity Effects 0.000 description 8
• 239000000203 mixture Substances 0.000 description 8
• 125000001624 naphthyl group Chemical group 0.000 description 8
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 8
• 210000001009 nucleus accumben Anatomy 0.000 description 8
• 229960005017 olanzapine Drugs 0.000 description 8
• KVWDHTXUZHCGIO-UHFFFAOYSA-N olanzapine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C=C(C)S2 KVWDHTXUZHCGIO-UHFFFAOYSA-N 0.000 description 8
• 108020001213 potassium channel Proteins 0.000 description 8
• DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 8
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 8
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
• 206010010904 Convulsion Diseases 0.000 description 7
• 102000004980 Dopamine D2 Receptors Human genes 0.000 description 7
• 108090001111 Dopamine D2 Receptors Proteins 0.000 description 7
• 102000004257 Potassium Channel Human genes 0.000 description 7
• 230000009471 action Effects 0.000 description 7
• 210000005064 dopaminergic neuron Anatomy 0.000 description 7
• 125000004356 hydroxy functional group Chemical group O* 0.000 description 7
• 210000002569 neuron Anatomy 0.000 description 7
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
• 230000000698 schizophrenic effect Effects 0.000 description 7
• 239000011780 sodium chloride Substances 0.000 description 7
• 235000020679 tap water Nutrition 0.000 description 7
• 239000008399 tap water Substances 0.000 description 7
• 229930192474 thiophene Natural products 0.000 description 7
• 125000006592 (C2-C3) alkenyl group Chemical group 0.000 description 6
• 125000006593 (C2-C3) alkynyl group Chemical group 0.000 description 6
• 206010012374 Depressed mood Diseases 0.000 description 6
• 101000994648 Homo sapiens Potassium voltage-gated channel subfamily KQT member 4 Proteins 0.000 description 6
• 208000009668 Neurobehavioral Manifestations Diseases 0.000 description 6
• 239000004480 active ingredient Substances 0.000 description 6
• 239000002269 analeptic agent Substances 0.000 description 6
• 238000004458 analytical method Methods 0.000 description 6
• 239000001961 anticonvulsive agent Substances 0.000 description 6
• 208000022257 bipolar II disease Diseases 0.000 description 6
• 229940125904 compound 1 Drugs 0.000 description 6
• 239000003085 diluting agent Substances 0.000 description 6
• LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 6
• 230000001965 increasing effect Effects 0.000 description 6
• 230000033001 locomotion Effects 0.000 description 6
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
• 238000001543 one-way ANOVA Methods 0.000 description 6
• 230000003287 optical effect Effects 0.000 description 6
• 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 6
• 238000010149 post-hoc-test Methods 0.000 description 6
• 108090000623 proteins and genes Proteins 0.000 description 6
• 208000020016 psychiatric disease Diseases 0.000 description 6
• 239000000523 sample Substances 0.000 description 6
• 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 6
• 230000001568 sexual effect Effects 0.000 description 6
• 230000002269 spontaneous effect Effects 0.000 description 6
• 238000012549 training Methods 0.000 description 6
• 238000005303 weighing Methods 0.000 description 6
• 208000026331 Disruptive, Impulse Control, and Conduct disease Diseases 0.000 description 5
• JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 5
• 241000700157 Rattus norvegicus Species 0.000 description 5
• 201000001880 Sexual dysfunction Diseases 0.000 description 5
• 208000008234 Tics Diseases 0.000 description 5
• 230000036982 action potential Effects 0.000 description 5
• 125000003342 alkenyl group Chemical group 0.000 description 5
• SMWDFEZZVXVKRB-UHFFFAOYSA-N anhydrous quinoline Natural products N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 5
• 230000008485 antagonism Effects 0.000 description 5
• 229960003965 antiepileptics Drugs 0.000 description 5
• 230000008901 benefit Effects 0.000 description 5
• DNSISZSEWVHGLH-UHFFFAOYSA-N butanamide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 description 5
• 229940125782 compound 2 Drugs 0.000 description 5
• 229940126214 compound 3 Drugs 0.000 description 5
• 208000026725 cyclothymic disease Diseases 0.000 description 5
• 206010015037 epilepsy Diseases 0.000 description 5
• 238000009472 formulation Methods 0.000 description 5
• 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 5
• 125000000623 heterocyclic group Chemical group 0.000 description 5
• 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 5
• PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 5
• RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 5
• 238000007912 intraperitoneal administration Methods 0.000 description 5
• KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 5
• 230000015654 memory Effects 0.000 description 5
• 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 5
• 239000008188 pellet Substances 0.000 description 5
• 230000035479 physiological effects, processes and functions Effects 0.000 description 5
• 238000011160 research Methods 0.000 description 5
• 230000001624 sedative effect Effects 0.000 description 5
• 231100000872 sexual dysfunction Toxicity 0.000 description 5
• 231100000736 substance abuse Toxicity 0.000 description 5
• 239000003826 tablet Substances 0.000 description 5
• 150000003536 tetrazoles Chemical class 0.000 description 5
• PYHRZPFZZDCOPH-QXGOIDDHSA-N (S)-amphetamine sulfate Chemical compound [H+].[H+].[O-]S([O-])(=O)=O.C[C@H](N)CC1=CC=CC=C1.C[C@H](N)CC1=CC=CC=C1 PYHRZPFZZDCOPH-QXGOIDDHSA-N 0.000 description 4
• RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 4
• 206010001497 Agitation Diseases 0.000 description 4
• 206010001541 Akinesia Diseases 0.000 description 4
• 208000007415 Anhedonia Diseases 0.000 description 4
• 208000009132 Catalepsy Diseases 0.000 description 4
• 101150049660 DRD2 gene Proteins 0.000 description 4
• 206010012289 Dementia Diseases 0.000 description 4
• 206010012335 Dependence Diseases 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• 208000023105 Huntington disease Diseases 0.000 description 4
• 108010038888 KCNQ3 Potassium Channel Proteins 0.000 description 4
• 208000002740 Muscle Rigidity Diseases 0.000 description 4
• 208000012902 Nervous system disease Diseases 0.000 description 4
• ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 4
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
• 102100034354 Potassium voltage-gated channel subfamily KQT member 2 Human genes 0.000 description 4
• QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 4
• WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 4
• 206010039897 Sedation Diseases 0.000 description 4
• 206010044565 Tremor Diseases 0.000 description 4
• 206010047853 Waxy flexibility Diseases 0.000 description 4
• 238000011360 adjunctive therapy Methods 0.000 description 4
• 230000001270 agonistic effect Effects 0.000 description 4
• 125000000304 alkynyl group Chemical group 0.000 description 4
• 201000007201 aphasia Diseases 0.000 description 4
• HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 4
• 208000028683 bipolar I disease Diseases 0.000 description 4
• 239000002775 capsule Substances 0.000 description 4
• 206010007776 catatonia Diseases 0.000 description 4
• 239000003795 chemical substances by application Substances 0.000 description 4
• 230000001149 cognitive effect Effects 0.000 description 4
• NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 4
• JBDSSBMEKXHSJF-UHFFFAOYSA-N cyclopentanecarboxylic acid Chemical compound OC(=O)C1CCCC1 JBDSSBMEKXHSJF-UHFFFAOYSA-N 0.000 description 4
• 229960000632 dexamfetamine Drugs 0.000 description 4
• 239000002552 dosage form Substances 0.000 description 4
• 239000000839 emulsion Substances 0.000 description 4
• 238000011156 evaluation Methods 0.000 description 4
• 150000002240 furans Chemical class 0.000 description 4
• 238000000338 in vitro Methods 0.000 description 4
• 239000012528 membrane Substances 0.000 description 4
• 230000000897 modulatory effect Effects 0.000 description 4
• 230000037023 motor activity Effects 0.000 description 4
• QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 4
• 230000000144 pharmacologic effect Effects 0.000 description 4
• 238000011458 pharmacological treatment Methods 0.000 description 4
• 229910052700 potassium Inorganic materials 0.000 description 4
• 239000011591 potassium Substances 0.000 description 4
• 239000000843 powder Substances 0.000 description 4
• 238000002360 preparation method Methods 0.000 description 4
• 229940080818 propionamide Drugs 0.000 description 4
• 150000003222 pyridines Chemical class 0.000 description 4
• 125000004076 pyridyl group Chemical group 0.000 description 4
• 150000003230 pyrimidines Chemical class 0.000 description 4
• 238000012552 review Methods 0.000 description 4
• 238000012216 screening Methods 0.000 description 4
• 230000036280 sedation Effects 0.000 description 4
• 230000003997 social interaction Effects 0.000 description 4
• 239000007787 solid Substances 0.000 description 4
• 125000003107 substituted aryl group Chemical group 0.000 description 4
• 239000000725 suspension Substances 0.000 description 4
• 239000006188 syrup Substances 0.000 description 4
• 235000020357 syrup Nutrition 0.000 description 4
• 238000002560 therapeutic procedure Methods 0.000 description 4
• 150000003557 thiazoles Chemical class 0.000 description 4
• 150000003577 thiophenes Chemical class 0.000 description 4
• 150000003852 triazoles Chemical class 0.000 description 4
• 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 3
• OGYGFUAIIOPWQD-UHFFFAOYSA-N 1,3-thiazolidine Chemical compound C1CSCN1 OGYGFUAIIOPWQD-UHFFFAOYSA-N 0.000 description 3
• FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 3
• LINZZISWCNKFEM-UHFFFAOYSA-N 3,3-dimethylbutanamide Chemical compound CC(C)(C)CC(N)=O LINZZISWCNKFEM-UHFFFAOYSA-N 0.000 description 3
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
• 208000021465 Brief psychotic disease Diseases 0.000 description 3
• 125000003320 C2-C6 alkenyloxy group Chemical group 0.000 description 3
• 229920002261 Corn starch Polymers 0.000 description 3
• 229920000858 Cyclodextrin Polymers 0.000 description 3
• 206010011878 Deafness Diseases 0.000 description 3
• 206010012239 Delusion Diseases 0.000 description 3
• 208000024254 Delusional disease Diseases 0.000 description 3
• 239000001828 Gelatine Substances 0.000 description 3
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• 208000004547 Hallucinations Diseases 0.000 description 3
• WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 description 3
• 208000030990 Impulse-control disease Diseases 0.000 description 3
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
• DUGOZIWVEXMGBE-UHFFFAOYSA-N Methylphenidate Chemical compound C=1C=CC=CC=1C(C(=O)OC)C1CCCCN1 DUGOZIWVEXMGBE-UHFFFAOYSA-N 0.000 description 3
• 241000699666 Mus <mouse, genus> Species 0.000 description 3
• WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical compound C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 description 3
• 102100034360 Potassium voltage-gated channel subfamily KQT member 3 Human genes 0.000 description 3
• 102100034363 Potassium voltage-gated channel subfamily KQT member 4 Human genes 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• 208000001431 Psychomotor Agitation Diseases 0.000 description 3
• 206010037211 Psychomotor hyperactivity Diseases 0.000 description 3
• 206010037213 Psychomotor retardation Diseases 0.000 description 3
• 241000283984 Rodentia Species 0.000 description 3
• 241000124015 Salix viminalis Species 0.000 description 3
• 208000020186 Schizophreniform disease Diseases 0.000 description 3
• 206010070834 Sensitisation Diseases 0.000 description 3
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
• 238000003639 Student–Newman–Keuls (SNK) method Methods 0.000 description 3
• 206010042458 Suicidal ideation Diseases 0.000 description 3
• 230000004913 activation Effects 0.000 description 3
• 239000000654 additive Substances 0.000 description 3
• 239000002671 adjuvant Substances 0.000 description 3
• 125000001931 aliphatic group Chemical group 0.000 description 3
• 125000003277 amino group Chemical group 0.000 description 3
• 238000010171 animal model Methods 0.000 description 3
• 239000007864 aqueous solution Substances 0.000 description 3
• 230000037007 arousal Effects 0.000 description 3
• 229960002430 atomoxetine Drugs 0.000 description 3
• VHGCDTVCOLNTBX-QGZVFWFLSA-N atomoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=CC=C1C VHGCDTVCOLNTBX-QGZVFWFLSA-N 0.000 description 3
• 230000037396 body weight Effects 0.000 description 3
• 239000004202 carbamide Substances 0.000 description 3
• 239000000969 carrier Substances 0.000 description 3
• 238000006243 chemical reaction Methods 0.000 description 3
• 208000010877 cognitive disease Diseases 0.000 description 3
• 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 3
• ARUKYTASOALXFG-UHFFFAOYSA-N cycloheptylcycloheptane Chemical group C1CCCCCC1C1CCCCCC1 ARUKYTASOALXFG-UHFFFAOYSA-N 0.000 description 3
• 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 3
• 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 3
• 231100000895 deafness Toxicity 0.000 description 3
• 230000007423 decrease Effects 0.000 description 3
• 230000003111 delayed effect Effects 0.000 description 3
• 231100000868 delusion Toxicity 0.000 description 3
• 238000001647 drug administration Methods 0.000 description 3
• 239000003937 drug carrier Substances 0.000 description 3
• 230000000857 drug effect Effects 0.000 description 3
• 125000004494 ethyl ester group Chemical group 0.000 description 3
• 230000000763 evoking effect Effects 0.000 description 3
• 230000006870 function Effects 0.000 description 3
• 229920000159 gelatin Polymers 0.000 description 3
• 235000019322 gelatine Nutrition 0.000 description 3
• 239000008103 glucose Substances 0.000 description 3
• 229960003878 haloperidol Drugs 0.000 description 3
• 208000016354 hearing loss disease Diseases 0.000 description 3
• BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 description 3
• 229960004801 imipramine Drugs 0.000 description 3
• 230000001976 improved effect Effects 0.000 description 3
• 230000000977 initiatory effect Effects 0.000 description 3
• 238000007918 intramuscular administration Methods 0.000 description 3
• 238000001990 intravenous administration Methods 0.000 description 3
• 239000008101 lactose Substances 0.000 description 3
• 229940073577 lithium chloride Drugs 0.000 description 3
• 238000011866 long-term treatment Methods 0.000 description 3
• 235000019359 magnesium stearate Nutrition 0.000 description 3
• 230000007246 mechanism Effects 0.000 description 3
• 229960001344 methylphenidate Drugs 0.000 description 3
• 150000007522 mineralic acids Chemical class 0.000 description 3
• 230000035772 mutation Effects 0.000 description 3
• 230000008587 neuronal excitability Effects 0.000 description 3
• 150000007524 organic acids Chemical class 0.000 description 3
• 150000002916 oxazoles Chemical class 0.000 description 3
• 208000002851 paranoid schizophrenia Diseases 0.000 description 3
• 230000007310 pathophysiology Effects 0.000 description 3
• 239000004033 plastic Substances 0.000 description 3
• 229920003023 plastic Polymers 0.000 description 3
• 239000013641 positive control Substances 0.000 description 3
• 230000002265 prevention Effects 0.000 description 3
• 230000000750 progressive effect Effects 0.000 description 3
• 102000004169 proteins and genes Human genes 0.000 description 3
• 150000003233 pyrroles Chemical class 0.000 description 3
• 150000003248 quinolines Chemical class 0.000 description 3
• 230000003014 reinforcing effect Effects 0.000 description 3
• 230000033764 rhythmic process Effects 0.000 description 3
• 208000022610 schizoaffective disease Diseases 0.000 description 3
• 230000035941 sexual motivation Effects 0.000 description 3
• 230000003019 stabilising effect Effects 0.000 description 3
• 238000011272 standard treatment Methods 0.000 description 3
• 238000007619 statistical method Methods 0.000 description 3
• 229940124530 sulfonamide Drugs 0.000 description 3
• 230000002459 sustained effect Effects 0.000 description 3
• ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 3
• 230000004580 weight loss Effects 0.000 description 3
• 208000016261 weight loss Diseases 0.000 description 3
• FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 2
• BGRJTUBHPOOWDU-NSHDSACASA-N (S)-(-)-sulpiride Chemical compound CCN1CCC[C@H]1CNC(=O)C1=CC(S(N)(=O)=O)=CC=C1OC BGRJTUBHPOOWDU-NSHDSACASA-N 0.000 description 2
• GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
• IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 description 2
• VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
• KJUGUADJHNHALS-UHFFFAOYSA-N 1H-tetrazole Substances C=1N=NNN=1 KJUGUADJHNHALS-UHFFFAOYSA-N 0.000 description 2
• HBEDSQVIWPRPAY-UHFFFAOYSA-N 2,3-dihydrobenzofuran Chemical class C1=CC=C2OCCC2=C1 HBEDSQVIWPRPAY-UHFFFAOYSA-N 0.000 description 2
• HBAVDOFSYDZLMI-UHFFFAOYSA-N 2-amino-4-methyl-n-[2-methyl-4-[[4-(trifluoromethyl)phenyl]methylamino]phenyl]pentanamide Chemical compound C1=C(C)C(NC(=O)C(N)CC(C)C)=CC=C1NCC1=CC=C(C(F)(F)F)C=C1 HBAVDOFSYDZLMI-UHFFFAOYSA-N 0.000 description 2
• IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 description 2
• NAGLCRMKHJCLNJ-UHFFFAOYSA-N 2-methyl-4-morpholin-4-yl-6-(trifluoromethyl)aniline Chemical compound FC(F)(F)C1=C(N)C(C)=CC(N2CCOCC2)=C1 NAGLCRMKHJCLNJ-UHFFFAOYSA-N 0.000 description 2
• LSBDFXRDZJMBSC-UHFFFAOYSA-N 2-phenylacetamide Chemical compound NC(=O)CC1=CC=CC=C1 LSBDFXRDZJMBSC-UHFFFAOYSA-N 0.000 description 2
• 206010002942 Apathy Diseases 0.000 description 2
• CEUORZQYGODEFX-UHFFFAOYSA-N Aripirazole Chemical compound ClC1=CC=CC(N2CCN(CCCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1Cl CEUORZQYGODEFX-UHFFFAOYSA-N 0.000 description 2
• 206010005885 Blunted affect Diseases 0.000 description 2
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
• 206010013654 Drug abuse Diseases 0.000 description 2
• 206010052804 Drug tolerance Diseases 0.000 description 2
• 208000012661 Dyskinesia Diseases 0.000 description 2
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
• 101000994656 Homo sapiens Potassium voltage-gated channel subfamily KQT member 5 Proteins 0.000 description 2
• 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
• WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
• WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 2
• 206010024870 Loss of libido Diseases 0.000 description 2
• TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
• 235000019759 Maize starch Nutrition 0.000 description 2
• 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
• 238000012347 Morris Water Maze Methods 0.000 description 2
• 208000013716 Motor tics Diseases 0.000 description 2
• 208000001089 Multiple system atrophy Diseases 0.000 description 2
• 238000011785 NMRI mouse Methods 0.000 description 2
• 208000025966 Neurological disease Diseases 0.000 description 2
• 206010031127 Orthostatic hypotension Diseases 0.000 description 2
• 208000027089 Parkinsonian disease Diseases 0.000 description 2
• 206010034010 Parkinsonism Diseases 0.000 description 2
• 208000013717 Phonic tics Diseases 0.000 description 2
• 102100034365 Potassium voltage-gated channel subfamily KQT member 5 Human genes 0.000 description 2
• 102000003946 Prolactin Human genes 0.000 description 2
• 108010057464 Prolactin Proteins 0.000 description 2
• 208000008409 Romano-Ward Syndrome Diseases 0.000 description 2
• 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
• FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 2
• 206010047513 Vision blurred Diseases 0.000 description 2
• RHLKSWFHGDVAHT-UHFFFAOYSA-N [2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]carbamic acid Chemical compound C=1C=C(NC(O)=O)C(Cl)=CC=1N(C)CC1=CC=C(Cl)S1 RHLKSWFHGDVAHT-UHFFFAOYSA-N 0.000 description 2
• 238000009825 accumulation Methods 0.000 description 2
• 235000011054 acetic acid Nutrition 0.000 description 2
• 238000013019 agitation Methods 0.000 description 2
• 229960003036 amisulpride Drugs 0.000 description 2
• NTJOBXMMWNYJFB-UHFFFAOYSA-N amisulpride Chemical compound CCN1CCCC1CNC(=O)C1=CC(S(=O)(=O)CC)=C(N)C=C1OC NTJOBXMMWNYJFB-UHFFFAOYSA-N 0.000 description 2
• 150000003863 ammonium salts Chemical class 0.000 description 2
• 230000003466 anti-cipated effect Effects 0.000 description 2
• 229960004372 aripiprazole Drugs 0.000 description 2
• 125000005129 aryl carbonyl group Chemical group 0.000 description 2
• 238000003556 assay Methods 0.000 description 2
• METKIMKYRPQLGS-UHFFFAOYSA-N atenolol Chemical compound CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-UHFFFAOYSA-N 0.000 description 2
• ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 2
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
• 230000015572 biosynthetic process Effects 0.000 description 2
• 238000004364 calculation method Methods 0.000 description 2
• KXDHJXZQYSOELW-UHFFFAOYSA-N carbonic acid monoamide Natural products NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 2
• 230000001413 cellular effect Effects 0.000 description 2
• ANTSCNMPPGJYLG-UHFFFAOYSA-N chlordiazepoxide Chemical compound O=N=1CC(NC)=NC2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 ANTSCNMPPGJYLG-UHFFFAOYSA-N 0.000 description 2
• 229960004782 chlordiazepoxide Drugs 0.000 description 2
• VEZNCHDBSQWUHQ-UHFFFAOYSA-N chlorocyclopropane Chemical compound ClC1CC1 VEZNCHDBSQWUHQ-UHFFFAOYSA-N 0.000 description 2
• 230000003930 cognitive ability Effects 0.000 description 2
• 238000004891 communication Methods 0.000 description 2
• 230000008878 coupling Effects 0.000 description 2
• 238000010168 coupling process Methods 0.000 description 2
• 238000005859 coupling reaction Methods 0.000 description 2
• 229960003368 croscarmellose sodium type a Drugs 0.000 description 2
• VZFUCHSFHOYXIS-UHFFFAOYSA-N cycloheptane carboxylic acid Natural products OC(=O)C1CCCCCC1 VZFUCHSFHOYXIS-UHFFFAOYSA-N 0.000 description 2
• NLUNLVTVUDIHFE-UHFFFAOYSA-N cyclooctylcyclooctane Chemical group C1CCCCCCC1C1CCCCCCC1 NLUNLVTVUDIHFE-UHFFFAOYSA-N 0.000 description 2
• 230000006378 damage Effects 0.000 description 2
• 230000034994 death Effects 0.000 description 2
• 230000003001 depressive effect Effects 0.000 description 2
• 238000013461 design Methods 0.000 description 2
• 238000003745 diagnosis Methods 0.000 description 2
• 239000000385 dialysis solution Substances 0.000 description 2
• 235000014113 dietary fatty acids Nutrition 0.000 description 2
• 239000006185 dispersion Substances 0.000 description 2
• 208000002173 dizziness Diseases 0.000 description 2
• 206010013663 drug dependence Diseases 0.000 description 2
• 238000003255 drug test Methods 0.000 description 2
• 230000004064 dysfunction Effects 0.000 description 2
• 238000000835 electrochemical detection Methods 0.000 description 2
• 230000002996 emotional effect Effects 0.000 description 2
• 230000010326 executive functioning Effects 0.000 description 2
• 239000000194 fatty acid Substances 0.000 description 2
• 229930195729 fatty acid Natural products 0.000 description 2
• 239000000796 flavoring agent Substances 0.000 description 2
• 230000002068 genetic effect Effects 0.000 description 2
• 239000008187 granular material Substances 0.000 description 2
• 230000026781 habituation Effects 0.000 description 2
• 230000000971 hippocampal effect Effects 0.000 description 2
• 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
• 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
• 230000001505 hypomanic effect Effects 0.000 description 2
• 230000001771 impaired effect Effects 0.000 description 2
• 230000006872 improvement Effects 0.000 description 2
• 230000005032 impulse control Effects 0.000 description 2
• 150000002475 indoles Chemical class 0.000 description 2
• 206010022437 insomnia Diseases 0.000 description 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
• 230000003993 interaction Effects 0.000 description 2
• 208000015046 intermittent explosive disease Diseases 0.000 description 2
• 238000007913 intrathecal administration Methods 0.000 description 2
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
• 230000000366 juvenile effect Effects 0.000 description 2
• 230000013016 learning Effects 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 201000006908 long QT syndrome 1 Diseases 0.000 description 2
• 239000007937 lozenge Substances 0.000 description 2
• 238000002483 medication Methods 0.000 description 2
• 229910052751 metal Inorganic materials 0.000 description 2
• 239000002184 metal Substances 0.000 description 2
• LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
• 238000001690 micro-dialysis Methods 0.000 description 2
• 229940016286 microcrystalline cellulose Drugs 0.000 description 2
• 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
• 239000008108 microcrystalline cellulose Substances 0.000 description 2
• 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
• UNFUYWDGSFDHCW-UHFFFAOYSA-N monochlorocyclohexane Chemical compound ClC1CCCCC1 UNFUYWDGSFDHCW-UHFFFAOYSA-N 0.000 description 2
• PCHKLVYYPQCHED-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]-2-(4-chlorophenyl)acetamide Chemical compound C=1C=C(NC(=O)CC=2C=CC(Cl)=CC=2)C(Cl)=CC=1N(C)CC1=CC=C(Cl)S1 PCHKLVYYPQCHED-UHFFFAOYSA-N 0.000 description 2
• 239000003921 oil Substances 0.000 description 2
• 210000000287 oocyte Anatomy 0.000 description 2
• 235000005985 organic acids Nutrition 0.000 description 2
• 238000007911 parenteral administration Methods 0.000 description 2
• 230000008506 pathogenesis Effects 0.000 description 2
• 239000000546 pharmaceutical excipient Substances 0.000 description 2
• 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 2
• 239000000902 placebo Substances 0.000 description 2
• 229940068196 placebo Drugs 0.000 description 2
• 229960001289 prazosin Drugs 0.000 description 2
• 239000003755 preservative agent Substances 0.000 description 2
• 238000002203 pretreatment Methods 0.000 description 2
• 108090000765 processed proteins & peptides Proteins 0.000 description 2
• 229940097325 prolactin Drugs 0.000 description 2
• 230000002035 prolonged effect Effects 0.000 description 2
• QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
• 229960004431 quetiapine Drugs 0.000 description 2
• URKOMYMAXPYINW-UHFFFAOYSA-N quetiapine Chemical compound C1CN(CCOCCO)CCN1C1=NC2=CC=CC=C2SC2=CC=CC=C12 URKOMYMAXPYINW-UHFFFAOYSA-N 0.000 description 2
• RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 description 2
• 229960001534 risperidone Drugs 0.000 description 2
• 238000011808 rodent model Methods 0.000 description 2
• 229940085605 saccharin sodium Drugs 0.000 description 2
• GZKLJWGUPQBVJQ-UHFFFAOYSA-N sertindole Chemical compound C1=CC(F)=CC=C1N1C2=CC=C(Cl)C=C2C(C2CCN(CCN3C(NCC3)=O)CC2)=C1 GZKLJWGUPQBVJQ-UHFFFAOYSA-N 0.000 description 2
• 229960000652 sertindole Drugs 0.000 description 2
• 230000035939 shock Effects 0.000 description 2
• 230000007958 sleep Effects 0.000 description 2
• 208000019116 sleep disease Diseases 0.000 description 2
• 208000022925 sleep disturbance Diseases 0.000 description 2
• 230000011273 social behavior Effects 0.000 description 2
• 229910052708 sodium Inorganic materials 0.000 description 2
• 239000011734 sodium Substances 0.000 description 2
• 239000002904 solvent Substances 0.000 description 2
• 239000000600 sorbitol Substances 0.000 description 2
• 230000006641 stabilisation Effects 0.000 description 2
• 238000001356 surgical procedure Methods 0.000 description 2
• 210000000225 synapse Anatomy 0.000 description 2
• 229940124597 therapeutic agent Drugs 0.000 description 2
• 231100001274 therapeutic index Toxicity 0.000 description 2
• 230000001052 transient effect Effects 0.000 description 2
• NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
• WFPIAZLQTJBIFN-DVZOWYKESA-N zuclopenthixol Chemical compound C1CN(CCO)CCN1CC\C=C\1C2=CC(Cl)=CC=C2SC2=CC=CC=C2/1 WFPIAZLQTJBIFN-DVZOWYKESA-N 0.000 description 2
• FHZUOZWUOXJEHV-UHFFFAOYSA-N (2-chlorophenyl)methyl n-(2,4-dimethyl-6-morpholin-4-ylpyridin-3-yl)carbamate Chemical compound CC1=CC(N2CCOCC2)=NC(C)=C1NC(=O)OCC1=CC=CC=C1Cl FHZUOZWUOXJEHV-UHFFFAOYSA-N 0.000 description 1
• FDONRMIZVSGMJB-UHFFFAOYSA-N (2-chlorophenyl)methyl n-(2,6-dimethyl-4-morpholin-4-ylphenyl)carbamate Chemical compound CC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)OCC1=CC=CC=C1Cl FDONRMIZVSGMJB-UHFFFAOYSA-N 0.000 description 1
• RIWKCXYUIMTQHW-UHFFFAOYSA-N (2-chlorophenyl)methyl n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]carbamate Chemical compound C=1C=C(NC(=O)OCC=2C(=CC=CC=2)Cl)C(Cl)=CC=1N(C)CC1=CC=C(Cl)S1 RIWKCXYUIMTQHW-UHFFFAOYSA-N 0.000 description 1
• OOMFPKMRUNSGGI-LJQANCHMSA-N (2r)-2-amino-n-[2,6-dimethyl-4-[[4-(trifluoromethyl)phenyl]methylamino]phenyl]-4-methylpentanamide Chemical compound C1=C(C)C(NC(=O)[C@H](N)CC(C)C)=C(C)C=C1NCC1=CC=C(C(F)(F)F)C=C1 OOMFPKMRUNSGGI-LJQANCHMSA-N 0.000 description 1
• SGBNXBBEMOZSSZ-IBGZPJMESA-N (2s)-2-amino-n-[2,6-dimethyl-4-[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]phenyl]-3-methylbutanamide Chemical compound C1=C(C)C(NC(=O)[C@@H](N)C(C)C)=C(C)C=C1N(C)CC1=CC=C(C(F)(F)F)C=C1 SGBNXBBEMOZSSZ-IBGZPJMESA-N 0.000 description 1
• KPPMLIQTECGRGP-FQEVSTJZSA-N (2s)-2-amino-n-[2,6-dimethyl-4-[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]phenyl]-4-methylpentanamide Chemical compound C1=C(C)C(NC(=O)[C@@H](N)CC(C)C)=C(C)C=C1N(C)CC1=CC=C(C(F)(F)F)C=C1 KPPMLIQTECGRGP-FQEVSTJZSA-N 0.000 description 1
• PIQCXJAFLBNPHH-UHFFFAOYSA-N (4-nitrophenyl)methyl n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]carbamate Chemical compound C=1C=C(NC(=O)OCC=2C=CC(=CC=2)[N+]([O-])=O)C(Cl)=CC=1N(C)CC1=CC=C(Cl)S1 PIQCXJAFLBNPHH-UHFFFAOYSA-N 0.000 description 1
• 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 1
• KWTSXDURSIMDCE-MRVPVSSYSA-N (R)-amphetamine Chemical compound C[C@@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-MRVPVSSYSA-N 0.000 description 1
• VSWBSWWIRNCQIJ-GJZGRUSLSA-N (R,R)-asenapine Chemical compound O1C2=CC=CC=C2[C@@H]2CN(C)C[C@H]2C2=CC(Cl)=CC=C21 VSWBSWWIRNCQIJ-GJZGRUSLSA-N 0.000 description 1
• WSPOMRSOLSGNFJ-AUWJEWJLSA-N (Z)-chlorprothixene Chemical compound C1=C(Cl)C=C2C(=C/CCN(C)C)\C3=CC=CC=C3SC2=C1 WSPOMRSOLSGNFJ-AUWJEWJLSA-N 0.000 description 1
• XYGVIBXOJOOCFR-BTJKTKAUSA-N (z)-but-2-enedioic acid;8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo[1,5-a][1,4]benzodiazepine Chemical compound OC(=O)\C=C/C(O)=O.C12=CC(Cl)=CC=C2N2C(C)=NC=C2CN=C1C1=CC=CC=C1F XYGVIBXOJOOCFR-BTJKTKAUSA-N 0.000 description 1
• PXUIZULXJVRBPC-UHFFFAOYSA-N 1'-[3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]hexahydro-2H-spiro[imidazo[1,2-a]pyridine-3,4'-piperidin]-2-one Chemical compound C12=CC(Cl)=CC=C2CCC2=CC=CC=C2N1CCCN1CCC2(C(NC3CCCCN32)=O)CC1 PXUIZULXJVRBPC-UHFFFAOYSA-N 0.000 description 1
• IUVSEUFHPNITEQ-UHFFFAOYSA-N 1-(2,3-dihydro-1,4-benzodioxin-5-yl)-4-[[5-(4-fluorophenyl)pyridin-3-yl]methyl]piperazine Chemical compound C1=CC(F)=CC=C1C1=CN=CC(CN2CCN(CC2)C=2C=3OCCOC=3C=CC=2)=C1 IUVSEUFHPNITEQ-UHFFFAOYSA-N 0.000 description 1
• DKMFBWQBDIGMHM-UHFFFAOYSA-N 1-(4-fluorophenyl)-4-(4-methyl-1-piperidinyl)-1-butanone Chemical compound C1CC(C)CCN1CCCC(=O)C1=CC=C(F)C=C1 DKMFBWQBDIGMHM-UHFFFAOYSA-N 0.000 description 1
• UGBLISDIHDMHJX-UHFFFAOYSA-N 1-(4-fluorophenyl)-4-[4-(2-methoxyphenyl)piperazin-1-yl]butan-1-one;hydrochloride Chemical compound [Cl-].COC1=CC=CC=C1N1CC[NH+](CCCC(=O)C=2C=CC(F)=CC=2)CC1 UGBLISDIHDMHJX-UHFFFAOYSA-N 0.000 description 1
• XXORMBACYMRYFK-UHFFFAOYSA-N 1-[2-cyclopentyloxy-4-[(4-fluorophenyl)methyl-methylamino]phenyl]-3-ethylurea Chemical compound CCNC(=O)NC1=CC=C(N(C)CC=2C=CC(F)=CC=2)C=C1OC1CCCC1 XXORMBACYMRYFK-UHFFFAOYSA-N 0.000 description 1
• MDLAAYDRRZXJIF-UHFFFAOYSA-N 1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]-4-piperidinol Chemical compound C1CC(O)(C=2C=C(C(Cl)=CC=2)C(F)(F)F)CCN1CCCC(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 MDLAAYDRRZXJIF-UHFFFAOYSA-N 0.000 description 1
• YNNPZLJSEXYKHU-UHFFFAOYSA-N 1-amino-n-[2-methyl-4-[[4-(trifluoromethyl)phenyl]methylamino]phenyl]cyclopropane-1-carboxamide Chemical compound C=1C=C(NC(=O)C2(N)CC2)C(C)=CC=1NCC1=CC=C(C(F)(F)F)C=C1 YNNPZLJSEXYKHU-UHFFFAOYSA-N 0.000 description 1
• 125000006017 1-propenyl group Chemical group 0.000 description 1
• 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
• NHUKLKFWYRPWKW-UHFFFAOYSA-N 2,2,2-trichloro-n-[4-[(5-chlorothiophen-2-yl)methyl-methylamino]-2-methylphenyl]acetamide Chemical compound C=1C=C(NC(=O)C(Cl)(Cl)Cl)C(C)=CC=1N(C)CC1=CC=C(Cl)S1 NHUKLKFWYRPWKW-UHFFFAOYSA-N 0.000 description 1
• GRPYQETWCYYASI-UHFFFAOYSA-N 2,2-dimethyl-n-[2-methyl-4-[(3-methyl-5-phenyl-1,2-oxazol-4-yl)methylamino]phenyl]propanamide Chemical compound CC1=NOC(C=2C=CC=CC=2)=C1CNC1=CC=C(NC(=O)C(C)(C)C)C(C)=C1 GRPYQETWCYYASI-UHFFFAOYSA-N 0.000 description 1
• GLHVEYVVFXLYTL-UHFFFAOYSA-N 2,2-dimethyl-n-[2-methyl-4-[(6-phenoxypyridin-3-yl)methylamino]phenyl]propanamide Chemical compound C1=C(NC(=O)C(C)(C)C)C(C)=CC(NCC=2C=NC(OC=3C=CC=CC=3)=CC=2)=C1 GLHVEYVVFXLYTL-UHFFFAOYSA-N 0.000 description 1
• DEVMYXUBWJWPOI-UHFFFAOYSA-N 2,2-dimethyl-n-[6-nitro-1-[[4-(trifluoromethyl)phenyl]methyl]-2,3-dihydroindol-5-yl]propanamide Chemical compound C1=2C=C([N+]([O-])=O)C(NC(=O)C(C)(C)C)=CC=2CCN1CC1=CC=C(C(F)(F)F)C=C1 DEVMYXUBWJWPOI-UHFFFAOYSA-N 0.000 description 1
• JDEUUKYNTHHAQH-UHFFFAOYSA-N 2,2-dimethylbutanamide Chemical compound CCC(C)(C)C(N)=O JDEUUKYNTHHAQH-UHFFFAOYSA-N 0.000 description 1
• OXBLVCZKDOZZOJ-UHFFFAOYSA-N 2,3-Dihydrothiophene Chemical compound C1CC=CS1 OXBLVCZKDOZZOJ-UHFFFAOYSA-N 0.000 description 1
• JKTCBAGSMQIFNL-UHFFFAOYSA-N 2,3-dihydrofuran Chemical compound C1CC=CO1 JKTCBAGSMQIFNL-UHFFFAOYSA-N 0.000 description 1
• LPMZGLWTJXFVTO-UHFFFAOYSA-N 2,4-dimethyl-6-morpholin-4-ylpyridin-3-amine Chemical compound CC1=C(N)C(C)=CC(N2CCOCC2)=N1 LPMZGLWTJXFVTO-UHFFFAOYSA-N 0.000 description 1
• BKYHSCLAVOQZHZ-UHFFFAOYSA-N 2,6-dimethyl-4-morpholin-4-ylaniline Chemical compound CC1=C(N)C(C)=CC(N2CCOCC2)=C1 BKYHSCLAVOQZHZ-UHFFFAOYSA-N 0.000 description 1
• MBGBDCSGKYOPEA-UHFFFAOYSA-N 2-(2-chlorophenyl)-n-(2,6-dimethyl-4-morpholin-4-ylphenyl)acetamide Chemical compound CC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CC1=CC=CC=C1Cl MBGBDCSGKYOPEA-UHFFFAOYSA-N 0.000 description 1
• QISAOICMWIDZAV-UHFFFAOYSA-N 2-(3,4-dichlorophenyl)-n-(2,6-dimethyl-4-morpholin-4-ylphenyl)acetamide;n-(2,6-dimethyl-4-morpholin-4-ylphenyl)-2-phenylacetamide Chemical compound CC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CC1=CC=CC=C1.CC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CC1=CC=C(Cl)C(Cl)=C1 QISAOICMWIDZAV-UHFFFAOYSA-N 0.000 description 1
• IRYKZAAWGNDZJR-UHFFFAOYSA-N 2-(3,4-difluorophenyl)-n-(2,6-dimethyl-4-morpholin-4-ylphenyl)acetamide Chemical compound CC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CC1=CC=C(F)C(F)=C1 IRYKZAAWGNDZJR-UHFFFAOYSA-N 0.000 description 1
• LJUSTXRGYUENLJ-UHFFFAOYSA-N 2-(3,4-difluorophenyl)-n-(2-methoxy-6-methyl-4-morpholin-4-ylphenyl)acetamide Chemical compound COC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CC1=CC=C(F)C(F)=C1 LJUSTXRGYUENLJ-UHFFFAOYSA-N 0.000 description 1
• LOBHSNZQHCWYLU-UHFFFAOYSA-N 2-(3,4-difluorophenyl)-n-(4,6-dimethyl-2-morpholin-4-ylpyrimidin-5-yl)acetamide Chemical compound CC1=NC(N2CCOCC2)=NC(C)=C1NC(=O)CC1=CC=C(F)C(F)=C1 LOBHSNZQHCWYLU-UHFFFAOYSA-N 0.000 description 1
• FFWKKIGLIPFFKJ-UHFFFAOYSA-N 2-(3-bicyclo[2.2.1]heptanyl)-n-(2,4-difluoro-6-morpholin-4-ylphenyl)acetamide Chemical compound C=1C(F)=CC(F)=C(NC(=O)CC2C3CCC(C3)C2)C=1N1CCOCC1 FFWKKIGLIPFFKJ-UHFFFAOYSA-N 0.000 description 1
• ILHJZFCXQIZPDX-UHFFFAOYSA-N 2-(3-bicyclo[2.2.1]heptanyl)-n-(2,6-difluoro-4-morpholin-4-ylphenyl)acetamide Chemical compound C=1C(F)=C(NC(=O)CC2C3CCC(C3)C2)C(F)=CC=1N1CCOCC1 ILHJZFCXQIZPDX-UHFFFAOYSA-N 0.000 description 1
• QYSLJXPOHRZRIG-UHFFFAOYSA-N 2-(3-bicyclo[2.2.1]heptanyl)-n-(2-methoxy-6-methyl-4-morpholin-4-ylphenyl)acetamide Chemical compound C=1C(C)=C(NC(=O)CC2C3CCC(C3)C2)C(OC)=CC=1N1CCOCC1 QYSLJXPOHRZRIG-UHFFFAOYSA-N 0.000 description 1
• HJIGCVIPHPXEAG-UHFFFAOYSA-N 2-(3-bromophenyl)-n-(2,6-dimethyl-4-morpholin-4-ylphenyl)acetamide Chemical compound CC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CC1=CC=CC(Br)=C1 HJIGCVIPHPXEAG-UHFFFAOYSA-N 0.000 description 1
• NBHOSDYTOKFPRM-UHFFFAOYSA-N 2-(3-chlorophenyl)-n-(2,6-dimethyl-4-morpholin-4-ylphenyl)acetamide Chemical compound CC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CC1=CC=CC(Cl)=C1 NBHOSDYTOKFPRM-UHFFFAOYSA-N 0.000 description 1
• SUSVXXUDGGTLSU-UHFFFAOYSA-N 2-(3-fluorophenyl)-n-(2-methoxy-6-methyl-4-morpholin-4-ylphenyl)acetamide Chemical compound COC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CC1=CC=CC(F)=C1 SUSVXXUDGGTLSU-UHFFFAOYSA-N 0.000 description 1
• NWZHLVIUDQICHI-UHFFFAOYSA-N 2-(4-chlorophenyl)-n-(2,6-dimethyl-4-morpholin-4-ylphenyl)acetamide Chemical compound CC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CC1=CC=C(Cl)C=C1 NWZHLVIUDQICHI-UHFFFAOYSA-N 0.000 description 1
• AFRIITXJFGWUIR-UHFFFAOYSA-N 2-(4-chlorophenyl)-n-[4-[(5-chlorothiophen-2-yl)methyl-methylamino]-2-methylphenyl]acetamide Chemical compound C=1C=C(NC(=O)CC=2C=CC(Cl)=CC=2)C(C)=CC=1N(C)CC1=CC=C(Cl)S1 AFRIITXJFGWUIR-UHFFFAOYSA-N 0.000 description 1
• BVVODLBVDQPGLE-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[2-(2-methoxyphenyl)-4,6-dimethylphenyl]acetamide Chemical compound COC1=CC=CC=C1C1=CC(C)=CC(C)=C1NC(=O)CC1=CC=C(F)C=C1 BVVODLBVDQPGLE-UHFFFAOYSA-N 0.000 description 1
• NZPNIYSWXIODAQ-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[2-(3-hydroxyphenyl)-4,6-dimethylphenyl]acetamide Chemical compound C=1C=CC(O)=CC=1C1=CC(C)=CC(C)=C1NC(=O)CC1=CC=C(F)C=C1 NZPNIYSWXIODAQ-UHFFFAOYSA-N 0.000 description 1
• PJDXAWQBHMKTGT-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[2-(4-fluorophenyl)-4,6-dimethylphenyl]acetamide Chemical compound C=1C=C(F)C=CC=1C1=CC(C)=CC(C)=C1NC(=O)CC1=CC=C(F)C=C1 PJDXAWQBHMKTGT-UHFFFAOYSA-N 0.000 description 1
• SWBMVGKDTGXPPJ-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[2-(4-hydroxy-3-methoxyphenyl)-4,6-dimethylphenyl]acetamide Chemical compound C1=C(O)C(OC)=CC(C=2C(=C(C)C=C(C)C=2)NC(=O)CC=2C=CC(F)=CC=2)=C1 SWBMVGKDTGXPPJ-UHFFFAOYSA-N 0.000 description 1
• GYRGAOXFXFTXRY-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[2-[2-(methanesulfonamido)phenyl]-4,6-dimethylphenyl]acetamide Chemical compound C=1C=CC=C(NS(C)(=O)=O)C=1C1=CC(C)=CC(C)=C1NC(=O)CC1=CC=C(F)C=C1 GYRGAOXFXFTXRY-UHFFFAOYSA-N 0.000 description 1
• DNHDTULZZSOSBN-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[2-methyl-4-[[6-(trifluoromethyl)pyridin-3-yl]methylamino]phenyl]acetamide Chemical compound C=1C=C(NC(=O)CC=2C=CC(F)=CC=2)C(C)=CC=1NCC1=CC=C(C(F)(F)F)N=C1 DNHDTULZZSOSBN-UHFFFAOYSA-N 0.000 description 1
• UJNJKBYTNPBNBN-UHFFFAOYSA-N 2-chloro-4-N-[(5-chlorothiophen-2-yl)methyl]benzene-1,4-diamine Chemical compound C1=C(Cl)C(N)=CC=C1NCC1=CC=C(Cl)S1 UJNJKBYTNPBNBN-UHFFFAOYSA-N 0.000 description 1
• VUAMDENGEUCDEU-UHFFFAOYSA-N 2-cycloheptyl-n-(2,6-dimethyl-4-morpholin-4-ylphenyl)acetamide Chemical compound CC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CC1CCCCCC1 VUAMDENGEUCDEU-UHFFFAOYSA-N 0.000 description 1
• TZAZWGAJSJSJCU-UHFFFAOYSA-N 2-cyclohexyl-n-(2,6-dimethyl-4-morpholin-4-ylphenyl)acetamide Chemical compound CC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CC1CCCCC1 TZAZWGAJSJSJCU-UHFFFAOYSA-N 0.000 description 1
• SHIXPWQRHRYAPF-UHFFFAOYSA-N 2-cyclopent-2-en-1-yl-n-(2,6-difluoro-4-morpholin-4-ylphenyl)acetamide Chemical compound FC1=CC(N2CCOCC2)=CC(F)=C1NC(=O)CC1CCC=C1 SHIXPWQRHRYAPF-UHFFFAOYSA-N 0.000 description 1
• NSJRMPWZUISROM-UHFFFAOYSA-N 2-cyclopent-2-en-1-yl-n-(2,6-dimethyl-4-morpholin-4-ylphenyl)acetamide Chemical compound CC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CC1CCC=C1 NSJRMPWZUISROM-UHFFFAOYSA-N 0.000 description 1
• ZIRYOJPIWUDDFZ-UHFFFAOYSA-N 2-cyclopent-2-en-1-yl-n-(2-methoxy-6-methyl-4-morpholin-4-ylphenyl)acetamide Chemical compound COC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CC1CCC=C1 ZIRYOJPIWUDDFZ-UHFFFAOYSA-N 0.000 description 1
• LTINJHGWWBUWHC-UHFFFAOYSA-N 2-cyclopent-2-en-1-yl-n-[2-methyl-4-morpholin-4-yl-6-(trifluoromethyl)phenyl]acetamide Chemical compound CC1=CC(N2CCOCC2)=CC(C(F)(F)F)=C1NC(=O)CC1CCC=C1 LTINJHGWWBUWHC-UHFFFAOYSA-N 0.000 description 1
• ULKJRSJOIDFZPK-UHFFFAOYSA-N 2-cyclopentyl-n-(2,4-dimethyl-6-phenylphenyl)acetamide Chemical compound C=1C=CC=CC=1C1=CC(C)=CC(C)=C1NC(=O)CC1CCCC1 ULKJRSJOIDFZPK-UHFFFAOYSA-N 0.000 description 1
• RUAANJRZGQTEQK-UHFFFAOYSA-N 2-cyclopentyl-n-(2,6-diethyl-4-morpholin-4-ylphenyl)acetamide Chemical compound CCC1=CC(N2CCOCC2)=CC(CC)=C1NC(=O)CC1CCCC1 RUAANJRZGQTEQK-UHFFFAOYSA-N 0.000 description 1
• XBHFMQFTDNMLBJ-UHFFFAOYSA-N 2-cyclopentyl-n-(2,6-difluoro-4-morpholin-4-ylphenyl)acetamide Chemical compound FC1=CC(N2CCOCC2)=CC(F)=C1NC(=O)CC1CCCC1 XBHFMQFTDNMLBJ-UHFFFAOYSA-N 0.000 description 1
• DUSXFTDHIFENLP-UHFFFAOYSA-N 2-cyclopentyl-n-(2,6-dimethyl-4-pyrrol-1-ylphenyl)acetamide Chemical compound CC1=CC(N2C=CC=C2)=CC(C)=C1NC(=O)CC1CCCC1 DUSXFTDHIFENLP-UHFFFAOYSA-N 0.000 description 1
• IKPVUBMYZIWNRW-UHFFFAOYSA-N 2-cyclopentyl-n-(2,6-dimethyl-4-thiomorpholin-4-ylphenyl)acetamide Chemical compound CC1=CC(N2CCSCC2)=CC(C)=C1NC(=O)CC1CCCC1 IKPVUBMYZIWNRW-UHFFFAOYSA-N 0.000 description 1
• NDPLBCRXHOVZML-UHFFFAOYSA-N 2-cyclopentyl-n-[2,6-dichloro-4-[(4-fluoroanilino)methyl]phenyl]acetamide Chemical compound C1=CC(F)=CC=C1NCC(C=C1Cl)=CC(Cl)=C1NC(=O)CC1CCCC1 NDPLBCRXHOVZML-UHFFFAOYSA-N 0.000 description 1
• AXEGVKSLGNHUDL-UHFFFAOYSA-N 2-cyclopentyl-n-[2,6-dichloro-4-[[[5-(trifluoromethyl)pyridin-2-yl]amino]methyl]phenyl]acetamide Chemical compound N1=CC(C(F)(F)F)=CC=C1NCC(C=C1Cl)=CC(Cl)=C1NC(=O)CC1CCCC1 AXEGVKSLGNHUDL-UHFFFAOYSA-N 0.000 description 1
• WAVXDFUOPQGUBX-UHFFFAOYSA-N 2-cyclopentyl-n-[2,6-dimethyl-4-(2-phenylthiomorpholin-4-yl)phenyl]acetamide Chemical compound CC1=CC(N2CC(SCC2)C=2C=CC=CC=2)=CC(C)=C1NC(=O)CC1CCCC1 WAVXDFUOPQGUBX-UHFFFAOYSA-N 0.000 description 1
• WNTSBBJWRJVJGJ-UHFFFAOYSA-N 2-cyclopentyl-n-[2,6-dimethyl-4-(3-pyridin-3-ylthiomorpholin-4-yl)phenyl]acetamide Chemical compound CC1=CC(N2C(CSCC2)C=2C=NC=CC=2)=CC(C)=C1NC(=O)CC1CCCC1 WNTSBBJWRJVJGJ-UHFFFAOYSA-N 0.000 description 1
• WRDIBHFRJFDWAW-UHFFFAOYSA-N 2-cyclopentyl-n-[2,6-dimethyl-4-[(4-methylanilino)methyl]phenyl]acetamide Chemical compound C1=CC(C)=CC=C1NCC(C=C1C)=CC(C)=C1NC(=O)CC1CCCC1 WRDIBHFRJFDWAW-UHFFFAOYSA-N 0.000 description 1
• PMAATXNYIJEXNJ-UHFFFAOYSA-N 2-cyclopentyl-n-[2,6-dimethyl-4-[2-[4-(trifluoromethyl)phenyl]pyrrolidin-1-yl]phenyl]acetamide Chemical compound CC1=CC(N2C(CCC2)C=2C=CC(=CC=2)C(F)(F)F)=CC(C)=C1NC(=O)CC1CCCC1 PMAATXNYIJEXNJ-UHFFFAOYSA-N 0.000 description 1
• FKTVZYJYGPVDFU-UHFFFAOYSA-N 2-cyclopentyl-n-[2,6-dimethyl-4-[2-[4-(trifluoromethyl)phenyl]thiomorpholin-4-yl]phenyl]acetamide Chemical compound CC1=CC(N2CC(SCC2)C=2C=CC(=CC=2)C(F)(F)F)=CC(C)=C1NC(=O)CC1CCCC1 FKTVZYJYGPVDFU-UHFFFAOYSA-N 0.000 description 1
• BHVKYMSGYOOSCM-UHFFFAOYSA-N 2-cyclopentyl-n-[2,6-dimethyl-4-[[3-(trifluoromethyl)anilino]methyl]phenyl]acetamide Chemical compound C=1C(C)=C(NC(=O)CC2CCCC2)C(C)=CC=1CNC1=CC=CC(C(F)(F)F)=C1 BHVKYMSGYOOSCM-UHFFFAOYSA-N 0.000 description 1
• CUDFPNFQWMAENQ-UHFFFAOYSA-N 2-cyclopentyl-n-[2,6-dimethyl-4-[[4-(trifluoromethyl)anilino]methyl]phenyl]acetamide Chemical compound C=1C(C)=C(NC(=O)CC2CCCC2)C(C)=CC=1CNC1=CC=C(C(F)(F)F)C=C1 CUDFPNFQWMAENQ-UHFFFAOYSA-N 0.000 description 1
• RSXOPFCHOGTEKQ-UHFFFAOYSA-N 2-cyclopentyl-n-[2,6-dimethyl-4-[[4-(trifluoromethyl)phenyl]methylamino]phenyl]acetamide Chemical compound C=1C(C)=C(NC(=O)CC2CCCC2)C(C)=CC=1NCC1=CC=C(C(F)(F)F)C=C1 RSXOPFCHOGTEKQ-UHFFFAOYSA-N 0.000 description 1
• DLDVNHYJIZFLMR-UHFFFAOYSA-N 2-cyclopentyl-n-[2,6-dimethyl-4-[[6-(trifluoromethyl)pyridin-3-yl]methylamino]phenyl]acetamide Chemical compound C=1C(C)=C(NC(=O)CC2CCCC2)C(C)=CC=1NCC1=CC=C(C(F)(F)F)N=C1 DLDVNHYJIZFLMR-UHFFFAOYSA-N 0.000 description 1
• UDQPWRNCCSSDOQ-UHFFFAOYSA-N 2-cyclopentyl-n-[2,6-dimethyl-4-[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]phenyl]acetamide Chemical compound C=1C(C)=C(NC(=O)CC2CCCC2)C(C)=CC=1N(C)CC1=CC=C(C(F)(F)F)C=C1 UDQPWRNCCSSDOQ-UHFFFAOYSA-N 0.000 description 1
• ZEIHZBPMFYBKDA-UHFFFAOYSA-N 2-cyclopentyl-n-[2-(4-fluorophenyl)-4-morpholin-4-yl-6-(trifluoromethyl)phenyl]acetamide Chemical compound C1=CC(F)=CC=C1C1=CC(N2CCOCC2)=CC(C(F)(F)F)=C1NC(=O)CC1CCCC1 ZEIHZBPMFYBKDA-UHFFFAOYSA-N 0.000 description 1
• OGNZSCJYYOGBKZ-UHFFFAOYSA-N 2-cyclopentyl-n-[2-methyl-4-morpholin-4-yl-6-(trifluoromethyl)phenyl]acetamide Chemical compound CC1=CC(N2CCOCC2)=CC(C(F)(F)F)=C1NC(=O)CC1CCCC1 OGNZSCJYYOGBKZ-UHFFFAOYSA-N 0.000 description 1
• LCYQPINKRYIIOS-UHFFFAOYSA-N 2-cyclopentyl-n-[4-[(3,4-difluoroanilino)methyl]-2,6-dimethylphenyl]acetamide Chemical compound C=1C(C)=C(NC(=O)CC2CCCC2)C(C)=CC=1CNC1=CC=C(F)C(F)=C1 LCYQPINKRYIIOS-UHFFFAOYSA-N 0.000 description 1
• AMWMRPRVCNJRRI-UHFFFAOYSA-N 2-cyclopentyl-n-[4-[(3,5-difluoroanilino)methyl]-2,6-dimethylphenyl]acetamide Chemical compound C=1C(C)=C(NC(=O)CC2CCCC2)C(C)=CC=1CNC1=CC(F)=CC(F)=C1 AMWMRPRVCNJRRI-UHFFFAOYSA-N 0.000 description 1
• QZCCCEGFZZERCR-UHFFFAOYSA-N 2-cyclopentyl-n-[4-[(3-fluoroanilino)methyl]-2,6-dimethylphenyl]acetamide Chemical compound C=1C(C)=C(NC(=O)CC2CCCC2)C(C)=CC=1CNC1=CC=CC(F)=C1 QZCCCEGFZZERCR-UHFFFAOYSA-N 0.000 description 1
• BPVGYTFULZLUOK-UHFFFAOYSA-N 2-cyclopentyl-n-[4-[(3-methoxyanilino)methyl]-2,6-dimethylphenyl]acetamide Chemical compound COC1=CC=CC(NCC=2C=C(C)C(NC(=O)CC3CCCC3)=C(C)C=2)=C1 BPVGYTFULZLUOK-UHFFFAOYSA-N 0.000 description 1
• AQEXWXASGXBTCS-UHFFFAOYSA-N 2-cyclopentyl-n-[4-[[(2,6-dichloropyridin-4-yl)amino]methyl]-2,6-dimethylphenyl]acetamide Chemical compound C=1C(C)=C(NC(=O)CC2CCCC2)C(C)=CC=1CNC1=CC(Cl)=NC(Cl)=C1 AQEXWXASGXBTCS-UHFFFAOYSA-N 0.000 description 1
• SEMYLXWJGQSZRH-UHFFFAOYSA-N 2-cyclopentyl-n-[4-morpholin-4-yl-2,6-di(propan-2-yl)phenyl]acetamide Chemical compound CC(C)C1=CC(N2CCOCC2)=CC(C(C)C)=C1NC(=O)CC1CCCC1 SEMYLXWJGQSZRH-UHFFFAOYSA-N 0.000 description 1
• PRRCZFLHDUNRPA-UHFFFAOYSA-N 2-cyclopentyl-n-[4-morpholin-4-yl-2-phenyl-6-(trifluoromethyl)phenyl]acetamide Chemical compound C1CCCC1CC(=O)NC=1C(C(F)(F)F)=CC(N2CCOCC2)=CC=1C1=CC=CC=C1 PRRCZFLHDUNRPA-UHFFFAOYSA-N 0.000 description 1
• ZLWDSPAALMHRPZ-UHFFFAOYSA-N 2-cyclopentyl-n-[4-morpholin-4-yl-2-pyridin-3-yl-6-(trifluoromethyl)phenyl]acetamide Chemical compound C1CCCC1CC(=O)NC=1C(C(F)(F)F)=CC(N2CCOCC2)=CC=1C1=CC=CN=C1 ZLWDSPAALMHRPZ-UHFFFAOYSA-N 0.000 description 1
• XWWAVPLALCOCTA-UHFFFAOYSA-N 2-methoxy-6-methyl-4-morpholin-4-ylaniline Chemical compound CC1=C(N)C(OC)=CC(N2CCOCC2)=C1 XWWAVPLALCOCTA-UHFFFAOYSA-N 0.000 description 1
• UYUQLIZCUOSRRQ-UHFFFAOYSA-N 2-methoxyethyl n-[2,6-dimethyl-4-[[4-(trifluoromethyl)anilino]methyl]phenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCOC)=C(C)C=C1CNC1=CC=C(C(F)(F)F)C=C1 UYUQLIZCUOSRRQ-UHFFFAOYSA-N 0.000 description 1
• NNJPKMLLSQRIQX-UHFFFAOYSA-N 2-methylpropyl n-(2,4-dimethyl-6-morpholin-4-ylpyridin-3-yl)carbamate Chemical compound N1=C(C)C(NC(=O)OCC(C)C)=C(C)C=C1N1CCOCC1 NNJPKMLLSQRIQX-UHFFFAOYSA-N 0.000 description 1
• WJLXTOBWTZRKRD-UHFFFAOYSA-N 2-methylpropyl n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCC(C)C)=CC=C1N(C)CC1=CC=C(Cl)S1 WJLXTOBWTZRKRD-UHFFFAOYSA-N 0.000 description 1
• YMRUQXQUIXXZSF-UHFFFAOYSA-N 2-phenylmethoxyethyl n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]carbamate Chemical compound C=1C=C(NC(=O)OCCOCC=2C=CC=CC=2)C(Cl)=CC=1N(C)CC1=CC=C(Cl)S1 YMRUQXQUIXXZSF-UHFFFAOYSA-N 0.000 description 1
• 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
• RSEBUVRVKCANEP-UHFFFAOYSA-N 2-pyrroline Chemical compound C1CC=CN1 RSEBUVRVKCANEP-UHFFFAOYSA-N 0.000 description 1
• FUWZLYDFJFRKGG-UHFFFAOYSA-N 3,3-dimethyl-n-[2-methyl-4-[(2-phenylpyrimidin-5-yl)methylamino]phenyl]butanamide Chemical compound C1=C(NC(=O)CC(C)(C)C)C(C)=CC(NCC=2C=NC(=NC=2)C=2C=CC=CC=2)=C1 FUWZLYDFJFRKGG-UHFFFAOYSA-N 0.000 description 1
• NJUKIJYUAQHUKN-UHFFFAOYSA-N 3,3-dimethyl-n-[2-methyl-4-[[6-(4-methylphenoxy)pyridin-3-yl]methylamino]phenyl]butanamide Chemical compound C1=CC(C)=CC=C1OC(N=C1)=CC=C1CNC1=CC=C(NC(=O)CC(C)(C)C)C(C)=C1 NJUKIJYUAQHUKN-UHFFFAOYSA-N 0.000 description 1
• YDSRFTJYQRXZCE-UHFFFAOYSA-N 3,3-dimethyl-n-[2-methyl-4-morpholin-4-yl-6-(trifluoromethyl)phenyl]butanamide Chemical compound FC(F)(F)C1=C(NC(=O)CC(C)(C)C)C(C)=CC(N2CCOCC2)=C1 YDSRFTJYQRXZCE-UHFFFAOYSA-N 0.000 description 1
• VQCVVNXKJURFIV-UHFFFAOYSA-N 3,3-dimethyl-n-[2-methyl-6-morpholin-4-yl-4-[[4-(trifluoromethyl)phenyl]methylamino]phenyl]butanamide Chemical compound C=1C(N2CCOCC2)=C(NC(=O)CC(C)(C)C)C(C)=CC=1NCC1=CC=C(C(F)(F)F)C=C1 VQCVVNXKJURFIV-UHFFFAOYSA-N 0.000 description 1
• XWLHXKMXYSTIJX-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-n-(2,6-dimethyl-4-morpholin-4-ylphenyl)propanamide Chemical compound CC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CCC1=CC=C(F)C(F)=C1 XWLHXKMXYSTIJX-UHFFFAOYSA-N 0.000 description 1
• XBLDZJXJCQTOHW-UHFFFAOYSA-N 3-(3-chlorophenyl)-n-(2,6-dimethyl-4-morpholin-4-ylphenyl)propanamide Chemical compound CC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CCC1=CC=CC(Cl)=C1 XBLDZJXJCQTOHW-UHFFFAOYSA-N 0.000 description 1
• FEBOTPHFXYHVPL-UHFFFAOYSA-N 3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidinyl]-1H-benzimidazol-2-one Chemical compound C1=CC(F)=CC=C1C(=O)CCCN1CCC(N2C(NC3=CC=CC=C32)=O)CC1 FEBOTPHFXYHVPL-UHFFFAOYSA-N 0.000 description 1
• SJAIYFDQCITQLJ-UHFFFAOYSA-N 3-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]-1-methyl-1-propylurea Chemical compound C1=C(Cl)C(NC(=O)N(C)CCC)=CC=C1N(C)CC1=CC=C(Cl)S1 SJAIYFDQCITQLJ-UHFFFAOYSA-N 0.000 description 1
• GUJRSXAPGDDABA-NSHDSACASA-N 3-bromo-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2,6-dimethoxybenzamide Chemical compound CCN1CCC[C@H]1CNC(=O)C1=C(OC)C=CC(Br)=C1OC GUJRSXAPGDDABA-NSHDSACASA-N 0.000 description 1
• NKRSJPBJRWPWTO-UHFFFAOYSA-N 3-chloropropyl n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]carbamate Chemical compound C=1C=C(NC(=O)OCCCCl)C(Cl)=CC=1N(C)CC1=CC=C(Cl)S1 NKRSJPBJRWPWTO-UHFFFAOYSA-N 0.000 description 1
• FFJSHGKHOFZMRC-UHFFFAOYSA-N 3-cyclohexyl-n-(2,6-dimethyl-4-morpholin-4-ylphenyl)propanamide Chemical compound CC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CCC1CCCCC1 FFJSHGKHOFZMRC-UHFFFAOYSA-N 0.000 description 1
• FQHLBMKMJMGTSG-UHFFFAOYSA-N 3-cyclopentyl-n-(2,6-dimethyl-4-morpholin-4-ylphenyl)propanamide Chemical compound CC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CCC1CCCC1 FQHLBMKMJMGTSG-UHFFFAOYSA-N 0.000 description 1
• BIAVGWDGIJKWRM-FQEVSTJZSA-N 3-hydroxy-2-phenyl-n-[(1s)-1-phenylpropyl]quinoline-4-carboxamide Chemical compound N([C@@H](CC)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=C(O)C=1C1=CC=CC=C1 BIAVGWDGIJKWRM-FQEVSTJZSA-N 0.000 description 1
• PMXMIIMHBWHSKN-UHFFFAOYSA-N 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCC(O)C4=NC=3C)=NOC2=C1 PMXMIIMHBWHSKN-UHFFFAOYSA-N 0.000 description 1
• UNBMPKNTYKDYCG-UHFFFAOYSA-N 4-methylpentan-2-amine Chemical compound CC(C)CC(C)N UNBMPKNTYKDYCG-UHFFFAOYSA-N 0.000 description 1
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
• QOYHHIBFXOOADH-UHFFFAOYSA-N 8-[4,4-bis(4-fluorophenyl)butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)CCCN1CCC2(C(NCN2C=2C=CC=CC=2)=O)CC1 QOYHHIBFXOOADH-UHFFFAOYSA-N 0.000 description 1
• SKTFQHRVFFOHTQ-UHFFFAOYSA-N 8-bromo-1,3-dimethyl-7h-purine-2,6-dione Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC(Br)=N2 SKTFQHRVFFOHTQ-UHFFFAOYSA-N 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 206010001928 Amenorrhoea Diseases 0.000 description 1
• 101710137189 Amyloid-beta A4 protein Proteins 0.000 description 1
• 101710151993 Amyloid-beta precursor protein Proteins 0.000 description 1
• 102100022704 Amyloid-beta precursor protein Human genes 0.000 description 1
• 208000019901 Anxiety disease Diseases 0.000 description 1
• 235000017060 Arachis glabrata Nutrition 0.000 description 1
• 244000105624 Arachis hypogaea Species 0.000 description 1
• 235000010777 Arachis hypogaea Nutrition 0.000 description 1
• 235000018262 Arachis monticola Nutrition 0.000 description 1
• 208000008882 Benign Neonatal Epilepsy Diseases 0.000 description 1
• 206010067866 Benign familial neonatal convulsions Diseases 0.000 description 1
• XVGOZDAJGBALKS-UHFFFAOYSA-N Blonanserin Chemical compound C1CN(CC)CCN1C1=CC(C=2C=CC(F)=CC=2)=C(CCCCCC2)C2=N1 XVGOZDAJGBALKS-UHFFFAOYSA-N 0.000 description 1
• RKLNONIVDFXQRX-UHFFFAOYSA-N Bromperidol Chemical compound C1CC(O)(C=2C=CC(Br)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 RKLNONIVDFXQRX-UHFFFAOYSA-N 0.000 description 1
• COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
• 125000006374 C2-C10 alkenyl group Chemical group 0.000 description 1
• 125000004649 C2-C8 alkynyl group Chemical group 0.000 description 1
• ANDGGVOPIJEHOF-UHFFFAOYSA-N CX-516 Chemical compound C=1C=C2N=CC=NC2=CC=1C(=O)N1CCCCC1 ANDGGVOPIJEHOF-UHFFFAOYSA-N 0.000 description 1
• 101100161887 Caenorhabditis elegans acr-5 gene Proteins 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
• 241001631457 Cannula Species 0.000 description 1
• WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
• 229920001412 Chicle Polymers 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
• GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
• KAAZGXDPUNNEFN-UHFFFAOYSA-N Clotiapine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2SC2=CC=C(Cl)C=C12 KAAZGXDPUNNEFN-UHFFFAOYSA-N 0.000 description 1
• 208000028698 Cognitive impairment Diseases 0.000 description 1
• 206010010144 Completed suicide Diseases 0.000 description 1
• 241000699800 Cricetinae Species 0.000 description 1
• HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 1
• ODKSFYDXXFIFQN-SCSAIBSYSA-N D-arginine Chemical compound OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 description 1
• 206010012735 Diarrhoea Diseases 0.000 description 1
• 241001269524 Dura Species 0.000 description 1
• 206010014557 Emotional poverty Diseases 0.000 description 1
• 206010016759 Flat affect Diseases 0.000 description 1
• PLDUPXSUYLZYBN-UHFFFAOYSA-N Fluphenazine Chemical compound C1CN(CCO)CCN1CCCN1C2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C21 PLDUPXSUYLZYBN-UHFFFAOYSA-N 0.000 description 1
• 206010017600 Galactorrhoea Diseases 0.000 description 1
• INJOMKTZOLKMBF-UHFFFAOYSA-N Guanfacine Chemical compound NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl INJOMKTZOLKMBF-UHFFFAOYSA-N 0.000 description 1
• 206010019070 Hallucination, auditory Diseases 0.000 description 1
• 239000012981 Hank's balanced salt solution Substances 0.000 description 1
• 206010019851 Hepatotoxicity Diseases 0.000 description 1
• 101000823051 Homo sapiens Amyloid-beta precursor protein Proteins 0.000 description 1
• 101000974726 Homo sapiens Potassium voltage-gated channel subfamily E member 1 Proteins 0.000 description 1
• 206010020651 Hyperkinesia Diseases 0.000 description 1
• 208000000269 Hyperkinesis Diseases 0.000 description 1
• 206010021030 Hypomania Diseases 0.000 description 1
• 208000001953 Hypotension Diseases 0.000 description 1
• 206010021567 Impulsive behaviour Diseases 0.000 description 1
• 206010021588 Inappropriate affect Diseases 0.000 description 1
• 102000004877 Insulin Human genes 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 102000004310 Ion Channels Human genes 0.000 description 1
• 108090000862 Ion Channels Proteins 0.000 description 1
• 206010022998 Irritability Diseases 0.000 description 1
• 108010011185 KCNQ1 Potassium Channel Proteins 0.000 description 1
• 240000007472 Leucaena leucocephala Species 0.000 description 1
• 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
• 239000004425 Makrolon Substances 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 240000001794 Manilkara zapota Species 0.000 description 1
• 235000011339 Manilkara zapota Nutrition 0.000 description 1
• 208000003863 Marijuana Abuse Diseases 0.000 description 1
• 208000019695 Migraine disease Diseases 0.000 description 1
• KLPWJLBORRMFGK-UHFFFAOYSA-N Molindone Chemical compound O=C1C=2C(CC)=C(C)NC=2CCC1CN1CCOCC1 KLPWJLBORRMFGK-UHFFFAOYSA-N 0.000 description 1
• 241000699660 Mus musculus Species 0.000 description 1
• 102000014415 Muscarinic acetylcholine receptor Human genes 0.000 description 1
• 108050003473 Muscarinic acetylcholine receptor Proteins 0.000 description 1
• WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
• JTVPZMFULRWINT-UHFFFAOYSA-N N-[2-(diethylamino)ethyl]-2-methoxy-5-methylsulfonylbenzamide Chemical compound CCN(CC)CCNC(=O)C1=CC(S(C)(=O)=O)=CC=C1OC JTVPZMFULRWINT-UHFFFAOYSA-N 0.000 description 1
• JNNOSTQEZICQQP-UHFFFAOYSA-N N-desmethylclozapine Chemical compound N=1C2=CC(Cl)=CC=C2NC2=CC=CC=C2C=1N1CCNCC1 JNNOSTQEZICQQP-UHFFFAOYSA-N 0.000 description 1
• 206010028813 Nausea Diseases 0.000 description 1
• GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical class O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
• ZZQNEJILGNNOEP-UHFFFAOYSA-N Ocaperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC3=C(C)N=C4N(C3=O)C=CC=C4C)=NOC2=C1 ZZQNEJILGNNOEP-UHFFFAOYSA-N 0.000 description 1
• 206010030295 Oligomenorrhoea Diseases 0.000 description 1
• XCWPUUGSGHNIDZ-UHFFFAOYSA-N Oxypertine Chemical compound C1=2C=C(OC)C(OC)=CC=2NC(C)=C1CCN(CC1)CCN1C1=CC=CC=C1 XCWPUUGSGHNIDZ-UHFFFAOYSA-N 0.000 description 1
• 235000019483 Peanut oil Nutrition 0.000 description 1
• RGCVKNLCSQQDEP-UHFFFAOYSA-N Perphenazine Chemical compound C1CN(CCO)CCN1CCCN1C2=CC(Cl)=CC=C2SC2=CC=CC=C21 RGCVKNLCSQQDEP-UHFFFAOYSA-N 0.000 description 1
• 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
• 102100022755 Potassium voltage-gated channel subfamily E member 1 Human genes 0.000 description 1
• 102100037444 Potassium voltage-gated channel subfamily KQT member 1 Human genes 0.000 description 1
• ZGUGWUXLJSTTMA-UHFFFAOYSA-N Promazinum Chemical compound C1=CC=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZGUGWUXLJSTTMA-UHFFFAOYSA-N 0.000 description 1
• 206010037249 Psychotic behaviour Diseases 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• 239000012891 Ringer solution Substances 0.000 description 1
• 206010039424 Salivary hypersecretion Diseases 0.000 description 1
• 244000000231 Sesamum indicum Species 0.000 description 1
• 235000003434 Sesamum indicum Nutrition 0.000 description 1
• 208000008630 Sialorrhea Diseases 0.000 description 1
• 206010041243 Social avoidant behaviour Diseases 0.000 description 1
• 235000021355 Stearic acid Nutrition 0.000 description 1
• 238000000692 Student's t-test Methods 0.000 description 1
• 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• 206010042464 Suicide attempt Diseases 0.000 description 1
• UNRHXEPDKXPRTM-UHFFFAOYSA-N Sultopride Chemical compound CCN1CCCC1CNC(=O)C1=CC(S(=O)(=O)CC)=CC=C1OC UNRHXEPDKXPRTM-UHFFFAOYSA-N 0.000 description 1
• 208000001871 Tachycardia Diseases 0.000 description 1
• 206010043118 Tardive Dyskinesia Diseases 0.000 description 1
• ZFXYFBGIUFBOJW-UHFFFAOYSA-N Theophylline Natural products O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 1
• 241000906446 Theraps Species 0.000 description 1
• KLBQZWRITKRQQV-UHFFFAOYSA-N Thioridazine Chemical compound C12=CC(SC)=CC=C2SC2=CC=CC=C2N1CCC1CCCCN1C KLBQZWRITKRQQV-UHFFFAOYSA-N 0.000 description 1
• GFBKORZTTCHDGY-UWVJOHFNSA-N Thiothixene Chemical compound C12=CC(S(=O)(=O)N(C)C)=CC=C2SC2=CC=CC=C2\C1=C\CCN1CCN(C)CC1 GFBKORZTTCHDGY-UWVJOHFNSA-N 0.000 description 1
• 229940123445 Tricyclic antidepressant Drugs 0.000 description 1
• 238000010162 Tukey test Methods 0.000 description 1
• 229930003427 Vitamin E Natural products 0.000 description 1
• RCMJIAHRUOSPBR-UHFFFAOYSA-N [2-methyl-4-[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]phenyl]carbamic acid Chemical compound CC1=C(C=CC(=C1)N(CC1=CC=C(C=C1)C(F)(F)F)C)NC(O)=O RCMJIAHRUOSPBR-UHFFFAOYSA-N 0.000 description 1
• JJAIPKWIFQODBY-UHFFFAOYSA-N [4-[(4-tert-butylphenyl)methyl-methylamino]-2-(trifluoromethyl)phenyl]carbamic acid Chemical compound C(C)(C)(C)C1=CC=C(CN(C2=CC(=C(C=C2)NC(O)=O)C(F)(F)F)C)C=C1 JJAIPKWIFQODBY-UHFFFAOYSA-N 0.000 description 1
• TZIHQPAIPUEJLN-UHFFFAOYSA-N [4-[(5-bromothiophen-2-yl)methylamino]-2-methoxyphenyl]carbamic acid Chemical compound BrC1=CC=C(S1)CNC1=CC(=C(C=C1)NC(O)=O)OC TZIHQPAIPUEJLN-UHFFFAOYSA-N 0.000 description 1
• AAARNRLAQSMSBQ-UHFFFAOYSA-N [4-[(5-chlorothiophen-2-yl)methylamino]-2-(furan-2-yl)phenyl]carbamic acid Chemical compound ClC1=CC=C(S1)CNC1=CC(=C(C=C1)NC(O)=O)C=1OC=CC1 AAARNRLAQSMSBQ-UHFFFAOYSA-N 0.000 description 1
• MKOGQYOKHYXXIY-UHFFFAOYSA-N [4-[(5-chlorothiophen-2-yl)methylamino]-2-quinolin-3-ylphenyl]carbamic acid Chemical compound ClC1=CC=C(S1)CNC1=CC(=C(C=C1)NC(O)=O)C=1C=NC2=CC=CC=C2C=1 MKOGQYOKHYXXIY-UHFFFAOYSA-N 0.000 description 1
• FKESDIGRMWCZGD-UHFFFAOYSA-N [4-[methyl-[(4-propan-2-ylphenyl)methyl]amino]-2-(trifluoromethyl)phenyl]carbamic acid Chemical compound C(C)(C)C1=CC=C(CN(C2=CC(=C(C=C2)NC(O)=O)C(F)(F)F)C)C=C1 FKESDIGRMWCZGD-UHFFFAOYSA-N 0.000 description 1
• 229960005054 acepromazine Drugs 0.000 description 1
• NOSIYYJFMPDDSA-UHFFFAOYSA-N acepromazine Chemical compound C1=C(C(C)=O)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 NOSIYYJFMPDDSA-UHFFFAOYSA-N 0.000 description 1
• 229960000276 acetophenazine Drugs 0.000 description 1
• WNTYBHLDCKXEOT-UHFFFAOYSA-N acetophenazine Chemical compound C12=CC(C(=O)C)=CC=C2SC2=CC=CC=C2N1CCCN1CCN(CCO)CC1 WNTYBHLDCKXEOT-UHFFFAOYSA-N 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 239000003522 acrylic cement Substances 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 230000006978 adaptation Effects 0.000 description 1
• 230000000996 additive effect Effects 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• 235000010419 agar Nutrition 0.000 description 1
• 230000008484 agonism Effects 0.000 description 1
• 239000000556 agonist Substances 0.000 description 1
• 125000003158 alcohol group Chemical group 0.000 description 1
• 150000005215 alkyl ethers Chemical class 0.000 description 1
• VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
• 150000001408 amides Chemical class 0.000 description 1
• 125000006295 amino methylene group Chemical group [H]N(*)C([H])([H])* 0.000 description 1
• DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 description 1
• 230000003444 anaesthetic effect Effects 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 230000003042 antagnostic effect Effects 0.000 description 1
• 208000004793 anterograde amnesia Diseases 0.000 description 1
• 230000002082 anti-convulsion Effects 0.000 description 1
• 230000003556 anti-epileptic effect Effects 0.000 description 1
• 229940124604 anti-psychotic medication Drugs 0.000 description 1
• 229940125681 anticonvulsant agent Drugs 0.000 description 1
• 229940030600 antihypertensive agent Drugs 0.000 description 1
• 239000002220 antihypertensive agent Substances 0.000 description 1
• 239000000228 antimanic agent Substances 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 235000006708 antioxidants Nutrition 0.000 description 1
• 230000036506 anxiety Effects 0.000 description 1
• 230000036528 appetite Effects 0.000 description 1
• 235000019789 appetite Nutrition 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• 239000012736 aqueous medium Substances 0.000 description 1
• 206010003119 arrhythmia Diseases 0.000 description 1
• 229960005245 asenapine Drugs 0.000 description 1
• 230000003935 attention Effects 0.000 description 1
• 230000002238 attenuated effect Effects 0.000 description 1
• 239000003693 atypical antipsychotic agent Substances 0.000 description 1
• 229940127236 atypical antipsychotics Drugs 0.000 description 1
• 239000002585 base Substances 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• 201000003452 benign familial neonatal epilepsy Diseases 0.000 description 1
• 201000010295 benign neonatal seizures Diseases 0.000 description 1
• 229960002507 benperidol Drugs 0.000 description 1
• RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
• 125000005605 benzo group Chemical group 0.000 description 1
• 229940049706 benzodiazepine Drugs 0.000 description 1
• 150000001557 benzodiazepines Chemical class 0.000 description 1
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
• KAEMILXLUFFLSU-UHFFFAOYSA-N benzyl n-(2,4-dimethyl-6-morpholin-4-ylpyridin-3-yl)carbamate Chemical compound CC1=CC(N2CCOCC2)=NC(C)=C1NC(=O)OCC1=CC=CC=C1 KAEMILXLUFFLSU-UHFFFAOYSA-N 0.000 description 1
• DDAWRADOFRFSCU-UHFFFAOYSA-N benzyl n-(2,6-dimethyl-4-morpholin-4-ylphenyl)carbamate Chemical compound CC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)OCC1=CC=CC=C1 DDAWRADOFRFSCU-UHFFFAOYSA-N 0.000 description 1
• QIUJJJVRYWFJPB-UHFFFAOYSA-N benzyl n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]carbamate Chemical compound C=1C=C(NC(=O)OCC=2C=CC=CC=2)C(Cl)=CC=1N(C)CC1=CC=C(Cl)S1 QIUJJJVRYWFJPB-UHFFFAOYSA-N 0.000 description 1
• GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
• 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
• 239000002876 beta blocker Substances 0.000 description 1
• 230000007321 biological mechanism Effects 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• 229950002871 blonanserin Drugs 0.000 description 1
• 230000036760 body temperature Effects 0.000 description 1
• 229940006004 bromotheophylline Drugs 0.000 description 1
• 229960004037 bromperidol Drugs 0.000 description 1
• 244000309464 bull Species 0.000 description 1
• GFLUXUNNWRGAJS-UHFFFAOYSA-N but-2-ynyl n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCC#CC)=CC=C1N(C)CC1=CC=C(Cl)S1 GFLUXUNNWRGAJS-UHFFFAOYSA-N 0.000 description 1
• NTCMMLFINXWYDI-UHFFFAOYSA-N but-3-enyl n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]carbamate Chemical compound C=1C=C(NC(=O)OCCC=C)C(Cl)=CC=1N(C)CC1=CC=C(Cl)S1 NTCMMLFINXWYDI-UHFFFAOYSA-N 0.000 description 1
• QDHFHIQKOVNCNC-UHFFFAOYSA-N butane-1-sulfonic acid Chemical compound CCCCS(O)(=O)=O QDHFHIQKOVNCNC-UHFFFAOYSA-N 0.000 description 1
• 229960000608 butaperazine Drugs 0.000 description 1
• DVLBYTMYSMAKHP-UHFFFAOYSA-N butaperazine Chemical compound C12=CC(C(=O)CCC)=CC=C2SC2=CC=CC=C2N1CCCN1CCN(C)CC1 DVLBYTMYSMAKHP-UHFFFAOYSA-N 0.000 description 1
• CSWQFUWZYDMBLR-UHFFFAOYSA-N butyl n-(2,6-dimethyl-4-morpholin-4-ylphenyl)carbamate Chemical compound C1=C(C)C(NC(=O)OCCCC)=C(C)C=C1N1CCOCC1 CSWQFUWZYDMBLR-UHFFFAOYSA-N 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 239000001110 calcium chloride Substances 0.000 description 1
• 229910001628 calcium chloride Inorganic materials 0.000 description 1
• 235000011148 calcium chloride Nutrition 0.000 description 1
• OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
• 230000001914 calming effect Effects 0.000 description 1
• MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical class C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
• 201000009322 cannabis abuse Diseases 0.000 description 1
• 201000001843 cannabis dependence Diseases 0.000 description 1
• 229960000623 carbamazepine Drugs 0.000 description 1
• FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 1
• 229960005123 cariprazine Drugs 0.000 description 1
• KPWSJANDNDDRMB-QAQDUYKDSA-N cariprazine Chemical compound C1C[C@@H](NC(=O)N(C)C)CC[C@@H]1CCN1CCN(C=2C(=C(Cl)C=CC=2)Cl)CC1 KPWSJANDNDDRMB-QAQDUYKDSA-N 0.000 description 1
• 230000000768 catecholaminergic effect Effects 0.000 description 1
• 210000005056 cell body Anatomy 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 235000010980 cellulose Nutrition 0.000 description 1
• 210000003169 central nervous system Anatomy 0.000 description 1
• BPHHNXJPFPEJOF-UHFFFAOYSA-J chembl296966 Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]S(=O)(=O)C1=CC(S([O-])(=O)=O)=C(N)C2=C(O)C(N=NC3=CC=C(C=C3OC)C=3C=C(C(=CC=3)N=NC=3C(=C4C(N)=C(C=C(C4=CC=3)S([O-])(=O)=O)S([O-])(=O)=O)O)OC)=CC=C21 BPHHNXJPFPEJOF-UHFFFAOYSA-J 0.000 description 1
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
• RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
• 229960002327 chloral hydrate Drugs 0.000 description 1
• 125000000068 chlorophenyl group Chemical group 0.000 description 1
• 229960003030 chlorproethazine Drugs 0.000 description 1
• DBOUGBAQLIXZLV-UHFFFAOYSA-N chlorproethazine Chemical compound C1=C(Cl)C=C2N(CCCN(CC)CC)C3=CC=CC=C3SC2=C1 DBOUGBAQLIXZLV-UHFFFAOYSA-N 0.000 description 1
• 229960001076 chlorpromazine Drugs 0.000 description 1
• ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
• 229960001552 chlorprothixene Drugs 0.000 description 1
• 238000004587 chromatography analysis Methods 0.000 description 1
• 231100000749 chronicity Toxicity 0.000 description 1
• NJMYODHXAKYRHW-DVZOWYKESA-N cis-flupenthixol Chemical compound C1CN(CCO)CCN1CC\C=C\1C2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C2/1 NJMYODHXAKYRHW-DVZOWYKESA-N 0.000 description 1
• 229960002896 clonidine Drugs 0.000 description 1
• 229960001184 clopenthixol Drugs 0.000 description 1
• 229960003864 clotiapine Drugs 0.000 description 1
• 229960004170 clozapine Drugs 0.000 description 1
• QZUDBNBUXVUHMW-UHFFFAOYSA-N clozapine Chemical compound C1CN(C)CCN1C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12 QZUDBNBUXVUHMW-UHFFFAOYSA-N 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 210000003477 cochlea Anatomy 0.000 description 1
• 230000019771 cognition Effects 0.000 description 1
• 230000007278 cognition impairment Effects 0.000 description 1
• 230000006999 cognitive decline Effects 0.000 description 1
• 238000004040 coloring Methods 0.000 description 1
• 238000002648 combination therapy Methods 0.000 description 1
• 230000000052 comparative effect Effects 0.000 description 1
• 230000002508 compound effect Effects 0.000 description 1
• 239000000470 constituent Substances 0.000 description 1
• 238000013270 controlled release Methods 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 230000002920 convulsive effect Effects 0.000 description 1
• 230000000056 copulatory effect Effects 0.000 description 1
• 239000008120 corn starch Substances 0.000 description 1
• 238000003869 coulometry Methods 0.000 description 1
• 230000001955 cumulated effect Effects 0.000 description 1
• 229960004278 cyamemazine Drugs 0.000 description 1
• SLFGIOIONGJGRT-UHFFFAOYSA-N cyamemazine Chemical compound C1=C(C#N)C=C2N(CC(CN(C)C)C)C3=CC=CC=C3SC2=C1 SLFGIOIONGJGRT-UHFFFAOYSA-N 0.000 description 1
• WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 description 1
• 230000001351 cycling effect Effects 0.000 description 1
• 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
• 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
• 125000000298 cyclopropenyl group Chemical group [H]C1=C([H])C1([H])* 0.000 description 1
• 238000007405 data analysis Methods 0.000 description 1
• DWLTUUXCVGVRAV-XWRHUKJGSA-N davunetide Chemical compound N([C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(O)=O)C(C)C)C(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O DWLTUUXCVGVRAV-XWRHUKJGSA-N 0.000 description 1
• 125000003493 decenyl group Chemical group [H]C([*])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 206010061428 decreased appetite Diseases 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 125000005070 decynyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C#C* 0.000 description 1
• 230000002939 deleterious effect Effects 0.000 description 1
• 239000007933 dermal patch Substances 0.000 description 1
• 230000001066 destructive effect Effects 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 238000000502 dialysis Methods 0.000 description 1
• 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
• 238000010252 digital analysis Methods 0.000 description 1
• BGRWYRAHAFMIBJ-UHFFFAOYSA-N diisopropylcarbodiimide Natural products CC(C)NC(=O)NC(C)C BGRWYRAHAFMIBJ-UHFFFAOYSA-N 0.000 description 1
• 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
• 208000037765 diseases and disorders Diseases 0.000 description 1
• 229960005146 dixyrazine Drugs 0.000 description 1
• MSYUMPGNGDNTIQ-UHFFFAOYSA-N dixyrazine Chemical compound C12=CC=CC=C2SC2=CC=CC=C2N1CC(C)CN1CCN(CCOCCO)CC1 MSYUMPGNGDNTIQ-UHFFFAOYSA-N 0.000 description 1
• 239000008298 dragée Substances 0.000 description 1
• IQQBRKLVEALROM-UHFFFAOYSA-N drinabant Chemical compound C=1C(F)=CC(F)=CC=1N(S(=O)(=O)C)C(C1)CN1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 IQQBRKLVEALROM-UHFFFAOYSA-N 0.000 description 1
• RMEDXOLNCUSCGS-UHFFFAOYSA-N droperidol Chemical compound C1=CC(F)=CC=C1C(=O)CCCN1CC=C(N2C(NC3=CC=CC=C32)=O)CC1 RMEDXOLNCUSCGS-UHFFFAOYSA-N 0.000 description 1
• 229960000394 droperidol Drugs 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 238000002635 electroconvulsive therapy Methods 0.000 description 1
• 230000002124 endocrine Effects 0.000 description 1
• 239000002702 enteric coating Substances 0.000 description 1
• 238000009505 enteric coating Methods 0.000 description 1
• 230000001037 epileptic effect Effects 0.000 description 1
• 229950000789 eplivanserin Drugs 0.000 description 1
• VAIOZOCLKVMIMN-PRJWTAEASA-N eplivanserin Chemical compound C=1C=CC=C(F)C=1\C(=N/OCCN(C)C)\C=C\C1=CC=C(O)C=C1 VAIOZOCLKVMIMN-PRJWTAEASA-N 0.000 description 1
• YYIFYTOIDVFSJM-UHFFFAOYSA-N ethyl n-(4-bromo-2,6-dimethylphenyl)carbamate Chemical compound CCOC(=O)NC1=C(C)C=C(Br)C=C1C YYIFYTOIDVFSJM-UHFFFAOYSA-N 0.000 description 1
• IECMFWSPQDIVPW-UHFFFAOYSA-N ethyl n-[2,6-dimethyl-4-[[4-(trifluoromethyl)anilino]methyl]phenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCC)=C(C)C=C1CNC1=CC=C(C(F)(F)F)C=C1 IECMFWSPQDIVPW-UHFFFAOYSA-N 0.000 description 1
• LVDKVOBNMQQEAL-UHFFFAOYSA-N ethyl n-[2-(4-chlorophenyl)-4-[(3-fluoroanilino)methyl]phenyl]carbamate Chemical compound C1=C(C=2C=CC(Cl)=CC=2)C(NC(=O)OCC)=CC=C1CNC1=CC=CC(F)=C1 LVDKVOBNMQQEAL-UHFFFAOYSA-N 0.000 description 1
• JBASQAITBFAGGZ-UHFFFAOYSA-N ethyl n-[2-(4-chlorophenyl)-4-[[4-(trifluoromethyl)anilino]methyl]phenyl]carbamate Chemical compound C1=C(C=2C=CC(Cl)=CC=2)C(NC(=O)OCC)=CC=C1CNC1=CC=C(C(F)(F)F)C=C1 JBASQAITBFAGGZ-UHFFFAOYSA-N 0.000 description 1
• AVLRKXVHQCYJLZ-UHFFFAOYSA-N ethyl n-[2-[4-(dimethylamino)phenyl]-4-[(3-fluoroanilino)methyl]phenyl]carbamate Chemical compound C1=C(C=2C=CC(=CC=2)N(C)C)C(NC(=O)OCC)=CC=C1CNC1=CC=CC(F)=C1 AVLRKXVHQCYJLZ-UHFFFAOYSA-N 0.000 description 1
• TYFOODIYYYOWKK-UHFFFAOYSA-N ethyl n-[2-[4-(dimethylamino)phenyl]-4-[[4-(trifluoromethyl)anilino]methyl]phenyl]carbamate Chemical compound C1=C(C=2C=CC(=CC=2)N(C)C)C(NC(=O)OCC)=CC=C1CNC1=CC=C(C(F)(F)F)C=C1 TYFOODIYYYOWKK-UHFFFAOYSA-N 0.000 description 1
• KXYHFTARJIQOMA-UHFFFAOYSA-N ethyl n-[2-amino-4-(1-benzothiophen-3-ylmethylamino)phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1NCC1=CSC2=CC=CC=C12 KXYHFTARJIQOMA-UHFFFAOYSA-N 0.000 description 1
• PAUMPFSSOXRDEJ-UHFFFAOYSA-N ethyl n-[2-amino-4-(anilinomethyl)phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC=CC=C1 PAUMPFSSOXRDEJ-UHFFFAOYSA-N 0.000 description 1
• CYVMSJCKTMVSRR-UHFFFAOYSA-N ethyl n-[2-amino-4-(thiophen-2-ylmethylamino)phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1NCC1=CC=CS1 CYVMSJCKTMVSRR-UHFFFAOYSA-N 0.000 description 1
• WALRLVHHRQJWMT-UHFFFAOYSA-N ethyl n-[2-amino-4-(thiophen-3-ylmethylamino)phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1NCC1=CSC=C1 WALRLVHHRQJWMT-UHFFFAOYSA-N 0.000 description 1
• XFNGDUVFJSECBN-UHFFFAOYSA-N ethyl n-[2-amino-4-[(2,3-dichloroanilino)methyl]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC=CC(Cl)=C1Cl XFNGDUVFJSECBN-UHFFFAOYSA-N 0.000 description 1
• NPFOVUKAFGUSQL-UHFFFAOYSA-N ethyl n-[2-amino-4-[(2,3-dihydro-1h-inden-5-ylamino)methyl]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC=C(CCC2)C2=C1 NPFOVUKAFGUSQL-UHFFFAOYSA-N 0.000 description 1
• MPNLUKUAXMXGGU-UHFFFAOYSA-N ethyl n-[2-amino-4-[(2,4-dichloroanilino)methyl]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC=C(Cl)C=C1Cl MPNLUKUAXMXGGU-UHFFFAOYSA-N 0.000 description 1
• VDDRKSVFMCGVKS-UHFFFAOYSA-N ethyl n-[2-amino-4-[(2-fluoroanilino)methyl]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC=CC=C1F VDDRKSVFMCGVKS-UHFFFAOYSA-N 0.000 description 1
• YCMRKXZMNUMKST-UHFFFAOYSA-N ethyl n-[2-amino-4-[(3,4-dichloroanilino)methyl]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC=C(Cl)C(Cl)=C1 YCMRKXZMNUMKST-UHFFFAOYSA-N 0.000 description 1
• PJFKUBNCMZLCEL-UHFFFAOYSA-N ethyl n-[2-amino-4-[(3,4-difluoroanilino)methyl]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC=C(F)C(F)=C1 PJFKUBNCMZLCEL-UHFFFAOYSA-N 0.000 description 1
• HFTMLRRJCMKHCO-UHFFFAOYSA-N ethyl n-[2-amino-4-[(3,5-dichloroanilino)methyl]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC(Cl)=CC(Cl)=C1 HFTMLRRJCMKHCO-UHFFFAOYSA-N 0.000 description 1
• STCYUEYAARANPB-UHFFFAOYSA-N ethyl n-[2-amino-4-[(3-chloroanilino)methyl]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC=CC(Cl)=C1 STCYUEYAARANPB-UHFFFAOYSA-N 0.000 description 1
• NGFUMNQGNPBYMN-UHFFFAOYSA-N ethyl n-[2-amino-4-[(3-chlorothiophen-2-yl)methylamino]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1NCC1=C(Cl)C=CS1 NGFUMNQGNPBYMN-UHFFFAOYSA-N 0.000 description 1
• RAVCWWJMYAMNLK-UHFFFAOYSA-N ethyl n-[2-amino-4-[(3-fluoroanilino)methyl]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC=CC(F)=C1 RAVCWWJMYAMNLK-UHFFFAOYSA-N 0.000 description 1
• RNFBDOBYXLGUBY-UHFFFAOYSA-N ethyl n-[2-amino-4-[(3-methylanilino)methyl]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC=CC(C)=C1 RNFBDOBYXLGUBY-UHFFFAOYSA-N 0.000 description 1
• QVJISOGPNWUYBI-UHFFFAOYSA-N ethyl n-[2-amino-4-[(3-methylthiophen-2-yl)methylamino]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1NCC1=C(C)C=CS1 QVJISOGPNWUYBI-UHFFFAOYSA-N 0.000 description 1
• BSQFTTSXMOOOGH-UHFFFAOYSA-N ethyl n-[2-amino-4-[(4-bromo-3-methoxythiophen-2-yl)methylamino]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1NCC1=C(OC)C(Br)=CS1 BSQFTTSXMOOOGH-UHFFFAOYSA-N 0.000 description 1
• PZWXBOANAHDGDV-UHFFFAOYSA-N ethyl n-[2-amino-4-[(4-butylanilino)methyl]phenyl]carbamate Chemical compound C1=CC(CCCC)=CC=C1NCC1=CC=C(NC(=O)OCC)C(N)=C1 PZWXBOANAHDGDV-UHFFFAOYSA-N 0.000 description 1
• UACNDMSYYWUJNP-UHFFFAOYSA-N ethyl n-[2-amino-4-[(4-chloro-3-fluoroanilino)methyl]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC=C(Cl)C(F)=C1 UACNDMSYYWUJNP-UHFFFAOYSA-N 0.000 description 1
• DWSPCTCHYKCYFR-UHFFFAOYSA-N ethyl n-[2-amino-4-[(4-chloroanilino)methyl]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC=C(Cl)C=C1 DWSPCTCHYKCYFR-UHFFFAOYSA-N 0.000 description 1
• BYARLUNDODGUSF-UHFFFAOYSA-N ethyl n-[2-amino-4-[(4-cyanoanilino)methyl]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC=C(C#N)C=C1 BYARLUNDODGUSF-UHFFFAOYSA-N 0.000 description 1
• LLYSQBCINNSNKO-UHFFFAOYSA-N ethyl n-[2-amino-4-[(4-cyclohexylanilino)methyl]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC=C(C2CCCCC2)C=C1 LLYSQBCINNSNKO-UHFFFAOYSA-N 0.000 description 1
• NQNXMCDBIPXRFF-UHFFFAOYSA-N ethyl n-[2-amino-4-[(4-fluoroanilino)methyl]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC=C(F)C=C1 NQNXMCDBIPXRFF-UHFFFAOYSA-N 0.000 description 1
• BSCJHOFVPMMXGC-UHFFFAOYSA-N ethyl n-[2-amino-4-[(4-methoxyanilino)methyl]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC=C(OC)C=C1 BSCJHOFVPMMXGC-UHFFFAOYSA-N 0.000 description 1
• CIYWTQMAZIEXNG-UHFFFAOYSA-N ethyl n-[2-amino-4-[(4-methylanilino)methyl]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC=C(C)C=C1 CIYWTQMAZIEXNG-UHFFFAOYSA-N 0.000 description 1
• NVOFZLPWTFWFDQ-UHFFFAOYSA-N ethyl n-[2-amino-4-[(4-phenylanilino)methyl]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC=C(C=2C=CC=CC=2)C=C1 NVOFZLPWTFWFDQ-UHFFFAOYSA-N 0.000 description 1
• OVMRYCWHBHWHDB-UHFFFAOYSA-N ethyl n-[2-amino-4-[(4-propan-2-ylanilino)methyl]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC=C(C(C)C)C=C1 OVMRYCWHBHWHDB-UHFFFAOYSA-N 0.000 description 1
• YGDMFPQYDCZIMM-UHFFFAOYSA-N ethyl n-[2-amino-4-[(4-tert-butylanilino)methyl]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC=C(C(C)(C)C)C=C1 YGDMFPQYDCZIMM-UHFFFAOYSA-N 0.000 description 1
• WXSQDZHUDQVVFR-UHFFFAOYSA-N ethyl n-[2-amino-4-[(5-bromothiophen-2-yl)methylamino]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1NCC1=CC=C(Br)S1 WXSQDZHUDQVVFR-UHFFFAOYSA-N 0.000 description 1
• IJHUAAPUXUHKRF-UHFFFAOYSA-N ethyl n-[2-amino-4-[(5-chlorothiophen-2-yl)methyl-ethylamino]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1N(CC)CC1=CC=C(Cl)S1 IJHUAAPUXUHKRF-UHFFFAOYSA-N 0.000 description 1
• OWMAWWXIMWNHSI-UHFFFAOYSA-N ethyl n-[2-amino-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1N(C)CC1=CC=C(Cl)S1 OWMAWWXIMWNHSI-UHFFFAOYSA-N 0.000 description 1
• OCOIXRNXFUKTKY-UHFFFAOYSA-N ethyl n-[2-amino-4-[(5-ethylthiophen-2-yl)methylamino]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1NCC1=CC=C(CC)S1 OCOIXRNXFUKTKY-UHFFFAOYSA-N 0.000 description 1
• ITKAHTLJWIBUCZ-UHFFFAOYSA-N ethyl n-[2-amino-4-[(5-fluorothiophen-2-yl)methylamino]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1NCC1=CC=C(F)S1 ITKAHTLJWIBUCZ-UHFFFAOYSA-N 0.000 description 1
• HNUMRLQROUPWNJ-UHFFFAOYSA-N ethyl n-[2-amino-4-[(5-methylthiophen-2-yl)methylamino]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1NCC1=CC=C(C)S1 HNUMRLQROUPWNJ-UHFFFAOYSA-N 0.000 description 1
• PNYDZEMORIWFHF-UHFFFAOYSA-N ethyl n-[2-amino-4-[(5-phenylthiophen-2-yl)methylamino]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1NCC1=CC=C(C=2C=CC=CC=2)S1 PNYDZEMORIWFHF-UHFFFAOYSA-N 0.000 description 1
• KKTKRODPSKTNPL-UHFFFAOYSA-N ethyl n-[2-amino-4-[(6-chloro-3-methoxy-1-benzothiophen-2-yl)methylamino]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1NCC1=C(OC)C2=CC=C(Cl)C=C2S1 KKTKRODPSKTNPL-UHFFFAOYSA-N 0.000 description 1
• IMAVPOSIWIUFQB-UHFFFAOYSA-N ethyl n-[2-amino-4-[(naphthalen-2-ylamino)methyl]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC=C(C=CC=C2)C2=C1 IMAVPOSIWIUFQB-UHFFFAOYSA-N 0.000 description 1
• AEBTUIWNDWVQNE-UHFFFAOYSA-N ethyl n-[2-amino-4-[[3-(trifluoromethyl)anilino]methyl]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1CNC1=CC=CC(C(F)(F)F)=C1 AEBTUIWNDWVQNE-UHFFFAOYSA-N 0.000 description 1
• AQQQGRCQQUTKHH-UHFFFAOYSA-N ethyl n-[2-amino-4-[methyl-[(5-methylthiophen-2-yl)methyl]amino]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1N(C)CC1=CC=C(C)S1 AQQQGRCQQUTKHH-UHFFFAOYSA-N 0.000 description 1
• JFKOOJKAUOELLK-UHFFFAOYSA-N ethyl n-[2-amino-6-methyl-4-[[4-(trifluoromethyl)phenyl]methylamino]phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCC)=C(C)C=C1NCC1=CC=C(C(F)(F)F)C=C1 JFKOOJKAUOELLK-UHFFFAOYSA-N 0.000 description 1
• PJQJLRQLLHQJMP-UHFFFAOYSA-N ethyl n-[2-chloro-4-[(3,4-dichloroanilino)methyl]phenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCC)=CC=C1CNC1=CC=C(Cl)C(Cl)=C1 PJQJLRQLLHQJMP-UHFFFAOYSA-N 0.000 description 1
• HIDMNWJFCJAMQI-UHFFFAOYSA-N ethyl n-[2-chloro-4-[(3-fluoroanilino)methyl]phenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCC)=CC=C1CNC1=CC=CC(F)=C1 HIDMNWJFCJAMQI-UHFFFAOYSA-N 0.000 description 1
• YZOXDNFQASBYLT-UHFFFAOYSA-N ethyl n-[2-chloro-4-[(4-chloro-3-fluoroanilino)methyl]phenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCC)=CC=C1CNC1=CC=C(Cl)C(F)=C1 YZOXDNFQASBYLT-UHFFFAOYSA-N 0.000 description 1
• URAKWDASUSFXKH-UHFFFAOYSA-N ethyl n-[2-chloro-4-[(4-chloroanilino)methyl]phenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCC)=CC=C1CNC1=CC=C(Cl)C=C1 URAKWDASUSFXKH-UHFFFAOYSA-N 0.000 description 1
• XPAYAFCWAGCEME-UHFFFAOYSA-N ethyl n-[2-chloro-4-[(4-fluoroanilino)methyl]phenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCC)=CC=C1CNC1=CC=C(F)C=C1 XPAYAFCWAGCEME-UHFFFAOYSA-N 0.000 description 1
• AMWAUBYTNYONBR-UHFFFAOYSA-N ethyl n-[2-chloro-4-[(4-propan-2-ylphenyl)methylamino]phenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCC)=CC=C1NCC1=CC=C(C(C)C)C=C1 AMWAUBYTNYONBR-UHFFFAOYSA-N 0.000 description 1
• UJHAKAHMBMEMNW-UHFFFAOYSA-N ethyl n-[2-chloro-4-[(5-chlorothiophen-2-yl)methylamino]phenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCC)=CC=C1NCC1=CC=C(Cl)S1 UJHAKAHMBMEMNW-UHFFFAOYSA-N 0.000 description 1
• UVHHGQGCILHVPA-UHFFFAOYSA-N ethyl n-[2-chloro-4-[methyl-[(4-methylsulfanylphenyl)methyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCC)=CC=C1N(C)CC1=CC=C(SC)C=C1 UVHHGQGCILHVPA-UHFFFAOYSA-N 0.000 description 1
• PXJYWPAJYQOYAU-UHFFFAOYSA-N ethyl n-[2-chloro-4-[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCC)=CC=C1N(C)CC1=CC=C(C(F)(F)F)C=C1 PXJYWPAJYQOYAU-UHFFFAOYSA-N 0.000 description 1
• MTYCZZYJZDRZKZ-UHFFFAOYSA-N ethyl n-[2-cyano-4-[(4-propan-2-ylphenyl)methylamino]phenyl]carbamate Chemical compound C1=C(C#N)C(NC(=O)OCC)=CC=C1NCC1=CC=C(C(C)C)C=C1 MTYCZZYJZDRZKZ-UHFFFAOYSA-N 0.000 description 1
• GRAKJGFHEIJYDP-UHFFFAOYSA-N ethyl n-[2-cyclopentyloxy-4-[(3-fluoro-2-methylphenyl)methylamino]phenyl]carbamate Chemical compound C1=C(OC2CCCC2)C(NC(=O)OCC)=CC=C1NCC1=CC=CC(F)=C1C GRAKJGFHEIJYDP-UHFFFAOYSA-N 0.000 description 1
• QYUKOZHZSRWMNG-UHFFFAOYSA-N ethyl n-[2-cyclopentyloxy-4-[(4-methoxyphenyl)methylamino]phenyl]carbamate Chemical compound C1=C(OC2CCCC2)C(NC(=O)OCC)=CC=C1NCC1=CC=C(OC)C=C1 QYUKOZHZSRWMNG-UHFFFAOYSA-N 0.000 description 1
• HIFLWUPIVYIOKB-UHFFFAOYSA-N ethyl n-[2-methoxy-4-[(3-methylthiophen-2-yl)methylamino]phenyl]carbamate Chemical compound C1=C(OC)C(NC(=O)OCC)=CC=C1NCC1=C(C)C=CS1 HIFLWUPIVYIOKB-UHFFFAOYSA-N 0.000 description 1
• DBGKFRUFUABFLM-UHFFFAOYSA-N ethyl n-[2-methoxy-4-[(4-propan-2-ylphenyl)methylamino]phenyl]carbamate Chemical compound C1=C(OC)C(NC(=O)OCC)=CC=C1NCC1=CC=C(C(C)C)C=C1 DBGKFRUFUABFLM-UHFFFAOYSA-N 0.000 description 1
• GPLMHGDAOVFNCU-UHFFFAOYSA-N ethyl n-[2-methyl-4-[(4-propan-2-ylphenyl)methylamino]phenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCC)=CC=C1NCC1=CC=C(C(C)C)C=C1 GPLMHGDAOVFNCU-UHFFFAOYSA-N 0.000 description 1
• VLIKNAITKKRTJV-UHFFFAOYSA-N ethyl n-[2-methyl-4-[(5-phenylthiophen-2-yl)methylamino]phenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCC)=CC=C1NCC1=CC=C(C=2C=CC=CC=2)S1 VLIKNAITKKRTJV-UHFFFAOYSA-N 0.000 description 1
• FJGJSYHAKOHFMZ-UHFFFAOYSA-N ethyl n-[2-methyl-4-[[4-(trifluoromethyl)phenyl]methylamino]phenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCC)=CC=C1NCC1=CC=C(C(F)(F)F)C=C1 FJGJSYHAKOHFMZ-UHFFFAOYSA-N 0.000 description 1
• XYIVNKLPSJLTHT-UHFFFAOYSA-N ethyl n-[4-(1,3-benzodioxol-5-ylmethylamino)-2-propan-2-yloxyphenyl]carbamate Chemical compound C1=C(OC(C)C)C(NC(=O)OCC)=CC=C1NCC1=CC=C(OCO2)C2=C1 XYIVNKLPSJLTHT-UHFFFAOYSA-N 0.000 description 1
• LBPNSUIVYSELKA-UHFFFAOYSA-N ethyl n-[4-(1-benzothiophen-2-ylmethylamino)-2-chlorophenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCC)=CC=C1NCC1=CC2=CC=CC=C2S1 LBPNSUIVYSELKA-UHFFFAOYSA-N 0.000 description 1
• MBZCXPYDDKNMKD-UHFFFAOYSA-N ethyl n-[4-(1-benzothiophen-2-ylmethylamino)-2-methylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCC)=CC=C1NCC1=CC2=CC=CC=C2S1 MBZCXPYDDKNMKD-UHFFFAOYSA-N 0.000 description 1
• DTOYTZIERSGENB-UHFFFAOYSA-N ethyl n-[4-(1-benzothiophen-3-ylmethylamino)-2-cyclopentyloxyphenyl]carbamate Chemical compound CCOC(=O)NC1=CC=C(NCC=2C3=CC=CC=C3SC=2)C=C1OC1CCCC1 DTOYTZIERSGENB-UHFFFAOYSA-N 0.000 description 1
• XDKSFHCRKBLVPN-UHFFFAOYSA-N ethyl n-[4-[(2,4-difluorophenyl)methylamino]-2-methoxyphenyl]carbamate Chemical compound C1=C(OC)C(NC(=O)OCC)=CC=C1NCC1=CC=C(F)C=C1F XDKSFHCRKBLVPN-UHFFFAOYSA-N 0.000 description 1
• PSRTZGHRXNJOEO-UHFFFAOYSA-N ethyl n-[4-[(3,4-difluoroanilino)methyl]-2-methylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCC)=CC=C1CNC1=CC=C(F)C(F)=C1 PSRTZGHRXNJOEO-UHFFFAOYSA-N 0.000 description 1
• DHNIHGLWXHLYGU-UHFFFAOYSA-N ethyl n-[4-[(3-fluoro-2-methylphenyl)methylamino]-2-(2-phenylethoxy)phenyl]carbamate Chemical compound C1=C(OCCC=2C=CC=CC=2)C(NC(=O)OCC)=CC=C1NCC1=CC=CC(F)=C1C DHNIHGLWXHLYGU-UHFFFAOYSA-N 0.000 description 1
• DDLKIMUNVILAIR-UHFFFAOYSA-N ethyl n-[4-[(3-fluoro-2-methylphenyl)methylamino]-2-phenylmethoxyphenyl]carbamate Chemical compound C1=C(OCC=2C=CC=CC=2)C(NC(=O)OCC)=CC=C1NCC1=CC=CC(F)=C1C DDLKIMUNVILAIR-UHFFFAOYSA-N 0.000 description 1
• CVTJQRXEUAZWTQ-UHFFFAOYSA-N ethyl n-[4-[(3-fluoro-2-methylphenyl)methylamino]-2-propan-2-yloxyphenyl]carbamate Chemical compound C1=C(OC(C)C)C(NC(=O)OCC)=CC=C1NCC1=CC=CC(F)=C1C CVTJQRXEUAZWTQ-UHFFFAOYSA-N 0.000 description 1
• QEYNFGCIULPLPC-UHFFFAOYSA-N ethyl n-[4-[(3-fluoroanilino)methyl]-2,6-dimethylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCC)=C(C)C=C1CNC1=CC=CC(F)=C1 QEYNFGCIULPLPC-UHFFFAOYSA-N 0.000 description 1
• YFYLMPIYVCSHPH-UHFFFAOYSA-N ethyl n-[4-[(3-fluoroanilino)methyl]-2-methylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCC)=CC=C1CNC1=CC=CC(F)=C1 YFYLMPIYVCSHPH-UHFFFAOYSA-N 0.000 description 1
• IMLUDSPLHDRIPO-UHFFFAOYSA-N ethyl n-[4-[(3-fluorophenyl)methylamino]-2-methoxyphenyl]carbamate Chemical compound C1=C(OC)C(NC(=O)OCC)=CC=C1NCC1=CC=CC(F)=C1 IMLUDSPLHDRIPO-UHFFFAOYSA-N 0.000 description 1
• LCEODKNUZATZLW-UHFFFAOYSA-N ethyl n-[4-[(3-methoxyphenyl)methylamino]-2-phenylmethoxyphenyl]carbamate Chemical compound C1=C(OCC=2C=CC=CC=2)C(NC(=O)OCC)=CC=C1NCC1=CC=CC(OC)=C1 LCEODKNUZATZLW-UHFFFAOYSA-N 0.000 description 1
• TZNQYORNTRQEJV-UHFFFAOYSA-N ethyl n-[4-[(4-chloro-3-fluoroanilino)methyl]-2-fluorophenyl]carbamate Chemical compound C1=C(F)C(NC(=O)OCC)=CC=C1CNC1=CC=C(Cl)C(F)=C1 TZNQYORNTRQEJV-UHFFFAOYSA-N 0.000 description 1
• RUVLMXALVIBXME-UHFFFAOYSA-N ethyl n-[4-[(4-chloroanilino)methyl]-2-fluorophenyl]carbamate Chemical compound C1=C(F)C(NC(=O)OCC)=CC=C1CNC1=CC=C(Cl)C=C1 RUVLMXALVIBXME-UHFFFAOYSA-N 0.000 description 1
• DPIDNSCETUXASM-UHFFFAOYSA-N ethyl n-[4-[(4-chloroanilino)methyl]-2-methylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCC)=CC=C1CNC1=CC=C(Cl)C=C1 DPIDNSCETUXASM-UHFFFAOYSA-N 0.000 description 1
• JRMWXXMVCOHXCB-UHFFFAOYSA-N ethyl n-[4-[(4-chloroanilino)methyl]phenyl]carbamate Chemical compound C1=CC(NC(=O)OCC)=CC=C1CNC1=CC=C(Cl)C=C1 JRMWXXMVCOHXCB-UHFFFAOYSA-N 0.000 description 1
• QCEHDLKQWVGPFI-UHFFFAOYSA-N ethyl n-[4-[(4-chlorophenyl)methylamino]-2-methylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCC)=CC=C1NCC1=CC=C(Cl)C=C1 QCEHDLKQWVGPFI-UHFFFAOYSA-N 0.000 description 1
• HCLUFHIOGAXFCC-UHFFFAOYSA-N ethyl n-[4-[(4-fluoroanilino)methyl]-2-methylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCC)=CC=C1CNC1=CC=C(F)C=C1 HCLUFHIOGAXFCC-UHFFFAOYSA-N 0.000 description 1
• NWLXPWFNBKJVKX-UHFFFAOYSA-N ethyl n-[4-[(4-fluorophenyl)methyl-methylamino]-2-propan-2-yloxyphenyl]carbamate Chemical compound C1=C(OC(C)C)C(NC(=O)OCC)=CC=C1N(C)CC1=CC=C(F)C=C1 NWLXPWFNBKJVKX-UHFFFAOYSA-N 0.000 description 1
• XKSCLMWYIAIGGH-UHFFFAOYSA-N ethyl n-[4-[(4-methylsulfanylphenyl)methylamino]-2-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(NC(=O)OCC)=CC=C1NCC1=CC=C(SC)C=C1 XKSCLMWYIAIGGH-UHFFFAOYSA-N 0.000 description 1
• FUOWMPZQNQMKQJ-UHFFFAOYSA-N ethyl n-[4-[(4-methylsulfanylphenyl)methylamino]-2-phenylmethoxyphenyl]carbamate Chemical compound C1=C(OCC=2C=CC=CC=2)C(NC(=O)OCC)=CC=C1NCC1=CC=C(SC)C=C1 FUOWMPZQNQMKQJ-UHFFFAOYSA-N 0.000 description 1
• AYJLXGFLEJCNSS-UHFFFAOYSA-N ethyl n-[4-[(4-tert-butylphenyl)methyl-methylamino]-2-chlorophenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCC)=CC=C1N(C)CC1=CC=C(C(C)(C)C)C=C1 AYJLXGFLEJCNSS-UHFFFAOYSA-N 0.000 description 1
• JHNNJXNHEUWQQI-UHFFFAOYSA-N ethyl n-[4-[(4-tert-butylphenyl)methylamino]-2-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(NC(=O)OCC)=CC=C1NCC1=CC=C(C(C)(C)C)C=C1 JHNNJXNHEUWQQI-UHFFFAOYSA-N 0.000 description 1
• LZCPHDBEDLLPCH-UHFFFAOYSA-N ethyl n-[4-[(5-bromothiophen-2-yl)methyl-methylamino]-2-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(NC(=O)OCC)=CC=C1N(C)CC1=CC=C(Br)S1 LZCPHDBEDLLPCH-UHFFFAOYSA-N 0.000 description 1
• CZIYBKSESQHEMY-UHFFFAOYSA-N ethyl n-[4-[(5-bromothiophen-2-yl)methylamino]-2-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(NC(=O)OCC)=CC=C1NCC1=CC=C(Br)S1 CZIYBKSESQHEMY-UHFFFAOYSA-N 0.000 description 1
• BNRZQCLVVKMSIW-UHFFFAOYSA-N ethyl n-[4-[(5-bromothiophen-2-yl)methylamino]-2-chlorophenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCC)=CC=C1NCC1=CC=C(Br)S1 BNRZQCLVVKMSIW-UHFFFAOYSA-N 0.000 description 1
• URCRJUUPLVVVDL-UHFFFAOYSA-N ethyl n-[4-[(5-chlorothiophen-2-yl)methyl-methylamino]-2-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(NC(=O)OCC)=CC=C1N(C)CC1=CC=C(Cl)S1 URCRJUUPLVVVDL-UHFFFAOYSA-N 0.000 description 1
• AKLXLTKONNDHHV-UHFFFAOYSA-N ethyl n-[4-[(5-chlorothiophen-2-yl)methylamino]-2-(6-methoxypyridin-3-yl)phenyl]carbamate Chemical compound C1=C(C=2C=NC(OC)=CC=2)C(NC(=O)OCC)=CC=C1NCC1=CC=C(Cl)S1 AKLXLTKONNDHHV-UHFFFAOYSA-N 0.000 description 1
• JBIFACVOFRVYLT-UHFFFAOYSA-N ethyl n-[4-[(5-chlorothiophen-2-yl)methylamino]-2-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(NC(=O)OCC)=CC=C1NCC1=CC=C(Cl)S1 JBIFACVOFRVYLT-UHFFFAOYSA-N 0.000 description 1
• XXUITLDPXQQWMX-UHFFFAOYSA-N ethyl n-[4-[(5-chlorothiophen-2-yl)methylamino]-2-cyanophenyl]carbamate Chemical compound C1=C(C#N)C(NC(=O)OCC)=CC=C1NCC1=CC=C(Cl)S1 XXUITLDPXQQWMX-UHFFFAOYSA-N 0.000 description 1
• PPNRDWUDMHIESH-UHFFFAOYSA-N ethyl n-[4-[(5-chlorothiophen-2-yl)methylamino]-2-iodophenyl]carbamate Chemical compound C1=C(I)C(NC(=O)OCC)=CC=C1NCC1=CC=C(Cl)S1 PPNRDWUDMHIESH-UHFFFAOYSA-N 0.000 description 1
• ZWTUCGJBUWCVJO-UHFFFAOYSA-N ethyl n-[4-[(5-chlorothiophen-2-yl)methylamino]-2-methylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCC)=CC=C1NCC1=CC=C(Cl)S1 ZWTUCGJBUWCVJO-UHFFFAOYSA-N 0.000 description 1
• BHONFRQFLYRMJR-UHFFFAOYSA-N ethyl n-[4-[(5-chlorothiophen-2-yl)methylamino]-2-pyridin-3-ylphenyl]carbamate Chemical compound C1=C(C=2C=NC=CC=2)C(NC(=O)OCC)=CC=C1NCC1=CC=C(Cl)S1 BHONFRQFLYRMJR-UHFFFAOYSA-N 0.000 description 1
• HWRLUDVUXQLMIH-UHFFFAOYSA-N ethyl n-[4-[(5-chlorothiophen-2-yl)methylamino]-2-pyridin-4-ylphenyl]carbamate Chemical compound C1=C(C=2C=CN=CC=2)C(NC(=O)OCC)=CC=C1NCC1=CC=C(Cl)S1 HWRLUDVUXQLMIH-UHFFFAOYSA-N 0.000 description 1
• KPERHISRLWKTQA-UHFFFAOYSA-N ethyl n-[4-[(5-chlorothiophen-2-yl)methylamino]-2-quinolin-5-ylphenyl]carbamate Chemical compound C1=C(C=2C3=CC=CN=C3C=CC=2)C(NC(=O)OCC)=CC=C1NCC1=CC=C(Cl)S1 KPERHISRLWKTQA-UHFFFAOYSA-N 0.000 description 1
• NIEWPONKIRMTPH-UHFFFAOYSA-N ethyl n-[4-[(6-methoxy-1-benzothiophen-2-yl)methylamino]-2-methylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCC)=CC=C1NCC1=CC2=CC=C(OC)C=C2S1 NIEWPONKIRMTPH-UHFFFAOYSA-N 0.000 description 1
• KLNBESIFXRZEPF-UHFFFAOYSA-N ethyl n-[4-[[3-fluoro-4-(trifluoromethyl)phenyl]methylamino]-2-methylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCC)=CC=C1NCC1=CC=C(C(F)(F)F)C(F)=C1 KLNBESIFXRZEPF-UHFFFAOYSA-N 0.000 description 1
• GCFCPEZENZTFAY-UHFFFAOYSA-N ethyl n-[4-[[4-(trifluoromethyl)anilino]methyl]phenyl]carbamate Chemical compound C1=CC(NC(=O)OCC)=CC=C1CNC1=CC=C(C(F)(F)F)C=C1 GCFCPEZENZTFAY-UHFFFAOYSA-N 0.000 description 1
• GAYMQGPGTVLOQU-UHFFFAOYSA-N ethyl n-[4-[methyl-[(4-methylsulfanylphenyl)methyl]amino]-2-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(NC(=O)OCC)=CC=C1N(C)CC1=CC=C(SC)C=C1 GAYMQGPGTVLOQU-UHFFFAOYSA-N 0.000 description 1
• IMUOXPRZLBQDQK-UHFFFAOYSA-N ethyl n-[4-[methyl-[(4-propan-2-ylphenyl)methyl]amino]-2-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(NC(=O)OCC)=CC=C1N(C)CC1=CC=C(C(C)C)C=C1 IMUOXPRZLBQDQK-UHFFFAOYSA-N 0.000 description 1
• 230000005713 exacerbation Effects 0.000 description 1
• 239000002360 explosive Substances 0.000 description 1
• 229950010629 farampator Drugs 0.000 description 1
• XFVRBYKKGGDPAJ-UHFFFAOYSA-N farampator Chemical compound C1=CC2=NON=C2C=C1C(=O)N1CCCCC1 XFVRBYKKGGDPAJ-UHFFFAOYSA-N 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 210000003191 femoral vein Anatomy 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 238000011049 filling Methods 0.000 description 1
• 235000019634 flavors Nutrition 0.000 description 1
• IRYFCWPNDIUQOW-UHFFFAOYSA-N fluanisone Chemical compound COC1=CC=CC=C1N1CCN(CCCC(=O)C=2C=CC(F)=CC=2)CC1 IRYFCWPNDIUQOW-UHFFFAOYSA-N 0.000 description 1
• 229960005220 fluanisone Drugs 0.000 description 1
• 125000001207 fluorophenyl group Chemical group 0.000 description 1
• 229960002419 flupentixol Drugs 0.000 description 1
• 229960002690 fluphenazine Drugs 0.000 description 1
• 229960003532 fluspirilene Drugs 0.000 description 1
• 238000001640 fractional crystallisation Methods 0.000 description 1
• WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
• 239000000499 gel Substances 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 230000004153 glucose metabolism Effects 0.000 description 1
• 229940074045 glyceryl distearate Drugs 0.000 description 1
• 229940075507 glyceryl monostearate Drugs 0.000 description 1
• 229960002048 guanfacine Drugs 0.000 description 1
• 201000000079 gynecomastia Diseases 0.000 description 1
• 210000002768 hair cell Anatomy 0.000 description 1
• 230000005802 health problem Effects 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 230000007686 hepatotoxicity Effects 0.000 description 1
• 231100000304 hepatotoxicity Toxicity 0.000 description 1
• 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 125000006038 hexenyl group Chemical group 0.000 description 1
• JLNYLDRCNCLJQY-UHFFFAOYSA-N hexyl n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCCCCCC)=CC=C1N(C)CC1=CC=C(Cl)S1 JLNYLDRCNCLJQY-UHFFFAOYSA-N 0.000 description 1
• 125000005980 hexynyl group Chemical group 0.000 description 1
• 238000004128 high performance liquid chromatography Methods 0.000 description 1
• 210000004295 hippocampal neuron Anatomy 0.000 description 1
• 230000000742 histaminergic effect Effects 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• 150000004677 hydrates Chemical class 0.000 description 1
• 230000003379 hyperdopaminergic effect Effects 0.000 description 1
• 230000036543 hypotension Effects 0.000 description 1
• 229960003162 iloperidone Drugs 0.000 description 1
• XMXHEBAFVSFQEX-UHFFFAOYSA-N iloperidone Chemical compound COC1=CC(C(C)=O)=CC=C1OCCCN1CCC(C=2C3=CC=C(F)C=C3ON=2)CC1 XMXHEBAFVSFQEX-UHFFFAOYSA-N 0.000 description 1
• 150000002460 imidazoles Chemical class 0.000 description 1
• 239000007943 implant Substances 0.000 description 1
• 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 description 1
• 238000011534 incubation Methods 0.000 description 1
• 208000000509 infertility Diseases 0.000 description 1
• 230000036512 infertility Effects 0.000 description 1
• 231100000535 infertility Toxicity 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 239000007972 injectable composition Substances 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 239000007928 intraperitoneal injection Substances 0.000 description 1
• 230000001788 irregular Effects 0.000 description 1
• 210000003292 kidney cell Anatomy 0.000 description 1
• 229960001848 lamotrigine Drugs 0.000 description 1
• PYZRQGJRPPTADH-UHFFFAOYSA-N lamotrigine Chemical compound NC1=NC(N)=NN=C1C1=CC=CC(Cl)=C1Cl PYZRQGJRPPTADH-UHFFFAOYSA-N 0.000 description 1
• 230000002045 lasting effect Effects 0.000 description 1
• 201000002364 leukopenia Diseases 0.000 description 1
• 231100001022 leukopenia Toxicity 0.000 description 1
• 229950005223 levamfetamine Drugs 0.000 description 1
• 229960004145 levosulpiride Drugs 0.000 description 1
• 230000002197 limbic effect Effects 0.000 description 1
• 210000003715 limbic system Anatomy 0.000 description 1
• 230000037356 lipid metabolism Effects 0.000 description 1
• 239000008297 liquid dosage form Substances 0.000 description 1
• 239000006193 liquid solution Substances 0.000 description 1
• 239000006194 liquid suspension Substances 0.000 description 1
• 230000003137 locomotive effect Effects 0.000 description 1
• 230000007787 long-term memory Effects 0.000 description 1
• 229960000423 loxapine Drugs 0.000 description 1
• XJGVXQDUIWGIRW-UHFFFAOYSA-N loxapine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2OC2=CC=C(Cl)C=C12 XJGVXQDUIWGIRW-UHFFFAOYSA-N 0.000 description 1
• 229960001432 lurasidone Drugs 0.000 description 1
• PQXKDMSYBGKCJA-CVTJIBDQSA-N lurasidone Chemical compound C1=CC=C2C(N3CCN(CC3)C[C@@H]3CCCC[C@H]3CN3C(=O)[C@@H]4[C@H]5CC[C@H](C5)[C@@H]4C3=O)=NSC2=C1 PQXKDMSYBGKCJA-CVTJIBDQSA-N 0.000 description 1
• 229910001629 magnesium chloride Inorganic materials 0.000 description 1
• 159000000003 magnesium salts Chemical class 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 230000001404 mediated effect Effects 0.000 description 1
• 229960001861 melperone Drugs 0.000 description 1
• 230000004630 mental health Effects 0.000 description 1
• SLVMESMUVMCQIY-UHFFFAOYSA-N mesoridazine Chemical compound CN1CCCCC1CCN1C2=CC(S(C)=O)=CC=C2SC2=CC=CC=C21 SLVMESMUVMCQIY-UHFFFAOYSA-N 0.000 description 1
• 229960000300 mesoridazine Drugs 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 1
• 229940042053 methotrimeprazine Drugs 0.000 description 1
• VRQVVMDWGGWHTJ-CQSZACIVSA-N methotrimeprazine Chemical compound C1=CC=C2N(C[C@H](C)CN(C)C)C3=CC(OC)=CC=C3SC2=C1 VRQVVMDWGGWHTJ-CQSZACIVSA-N 0.000 description 1
• ZWBZSWWTAABAAW-UHFFFAOYSA-N methyl 3-[4-[(5-chlorothiophen-2-yl)methyl-methylamino]-2-methylanilino]-3-oxopropanoate Chemical compound C1=C(C)C(NC(=O)CC(=O)OC)=CC=C1N(C)CC1=CC=C(Cl)S1 ZWBZSWWTAABAAW-UHFFFAOYSA-N 0.000 description 1
• 150000004702 methyl esters Chemical class 0.000 description 1
• ZRCLMLJAAYQKFH-UHFFFAOYSA-N methyl n-[4-(1-benzothiophen-2-ylmethylamino)-2-methoxyphenyl]carbamate Chemical compound C1=C(OC)C(NC(=O)OC)=CC=C1NCC1=CC2=CC=CC=C2S1 ZRCLMLJAAYQKFH-UHFFFAOYSA-N 0.000 description 1
• 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
• 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
• 229960002216 methylparaben Drugs 0.000 description 1
• 238000000520 microinjection Methods 0.000 description 1
• 206010027599 migraine Diseases 0.000 description 1
• 208000027061 mild cognitive impairment Diseases 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 229960004938 molindone Drugs 0.000 description 1
• 230000001730 monoaminergic effect Effects 0.000 description 1
• 229940127237 mood stabilizer Drugs 0.000 description 1
• AGAHNABIDCTLHW-UHFFFAOYSA-N moperone Chemical compound C1=CC(C)=CC=C1C1(O)CCN(CCCC(=O)C=2C=CC(F)=CC=2)CC1 AGAHNABIDCTLHW-UHFFFAOYSA-N 0.000 description 1
• 229960000758 moperone Drugs 0.000 description 1
• STUHQDIOZQUPGP-UHFFFAOYSA-N morpholin-4-ium-4-carboxylate Chemical compound OC(=O)N1CCOCC1 STUHQDIOZQUPGP-UHFFFAOYSA-N 0.000 description 1
• 229960003894 mosapramine Drugs 0.000 description 1
• 230000001095 motoneuron effect Effects 0.000 description 1
• 230000004118 muscle contraction Effects 0.000 description 1
• MRNPWIWBKMYBTH-UHFFFAOYSA-N n-(2,4-dimethyl-6-morpholin-4-ylpyridin-3-yl)-2-phenylcyclopropane-1-carboxamide Chemical compound CC1=CC(N2CCOCC2)=NC(C)=C1NC(=O)C1CC1C1=CC=CC=C1 MRNPWIWBKMYBTH-UHFFFAOYSA-N 0.000 description 1
• WVSKXMHDWLIKIR-UHFFFAOYSA-N n-(2,4-dimethyl-6-morpholin-4-ylpyridin-3-yl)-3,5,5-trimethylhexanamide Chemical compound N1=C(C)C(NC(=O)CC(C)CC(C)(C)C)=C(C)C=C1N1CCOCC1 WVSKXMHDWLIKIR-UHFFFAOYSA-N 0.000 description 1
• BLESCNKLEXGCBO-UHFFFAOYSA-N n-(2,4-dimethyl-6-morpholin-4-ylpyridin-3-yl)-4-methylpentanamide Chemical compound N1=C(C)C(NC(=O)CCC(C)C)=C(C)C=C1N1CCOCC1 BLESCNKLEXGCBO-UHFFFAOYSA-N 0.000 description 1
• RZPBJOUKSLGPAK-UHFFFAOYSA-N n-(2,4-dimethyl-6-morpholin-4-ylpyridin-3-yl)heptanamide Chemical compound N1=C(C)C(NC(=O)CCCCCC)=C(C)C=C1N1CCOCC1 RZPBJOUKSLGPAK-UHFFFAOYSA-N 0.000 description 1
• SAHHONAYVKIMTP-UHFFFAOYSA-N n-(2,4-dimethyl-6-morpholin-4-ylpyridin-3-yl)hexanamide Chemical compound N1=C(C)C(NC(=O)CCCCC)=C(C)C=C1N1CCOCC1 SAHHONAYVKIMTP-UHFFFAOYSA-N 0.000 description 1
• QHRDANBBSJKUAT-UHFFFAOYSA-N n-(2,4-dimethyl-6-morpholin-4-ylpyridin-3-yl)octanamide Chemical compound N1=C(C)C(NC(=O)CCCCCCC)=C(C)C=C1N1CCOCC1 QHRDANBBSJKUAT-UHFFFAOYSA-N 0.000 description 1
• UANXUOHOUIPKAT-UHFFFAOYSA-N n-(2,4-dimethyl-6-quinolin-3-ylphenyl)-2-(4-fluorophenyl)acetamide Chemical compound C=1N=C2C=CC=CC2=CC=1C1=CC(C)=CC(C)=C1NC(=O)CC1=CC=C(F)C=C1 UANXUOHOUIPKAT-UHFFFAOYSA-N 0.000 description 1
• QFBRGGLYIZJDNP-UHFFFAOYSA-N n-(2,6-difluoro-4-morpholin-4-ylphenyl)-2-(3-fluorophenyl)acetamide Chemical compound FC1=CC=CC(CC(=O)NC=2C(=CC(=CC=2F)N2CCOCC2)F)=C1 QFBRGGLYIZJDNP-UHFFFAOYSA-N 0.000 description 1
• PCQHZOFRMZIDSO-UHFFFAOYSA-N n-(2,6-difluoro-4-morpholin-4-ylphenyl)-3,3-dimethylbutanamide Chemical compound C1=C(F)C(NC(=O)CC(C)(C)C)=C(F)C=C1N1CCOCC1 PCQHZOFRMZIDSO-UHFFFAOYSA-N 0.000 description 1
• RQMWEJOBHGLLHJ-UHFFFAOYSA-N n-(2,6-dimethyl-4-morpholin-4-ylphenyl)-2,3-dihydro-1-benzofuran-2-carboxamide Chemical compound C=1C(C)=C(NC(=O)C2OC3=CC=CC=C3C2)C(C)=CC=1N1CCOCC1 RQMWEJOBHGLLHJ-UHFFFAOYSA-N 0.000 description 1
• RZHYJMWCLWAHFW-UHFFFAOYSA-N n-(2,6-dimethyl-4-morpholin-4-ylphenyl)-2-(3,4-dimethylphenyl)acetamide Chemical compound C1=C(C)C(C)=CC=C1CC(=O)NC1=C(C)C=C(N2CCOCC2)C=C1C RZHYJMWCLWAHFW-UHFFFAOYSA-N 0.000 description 1
• BWTFEOVRRVXFIS-UHFFFAOYSA-N n-(2,6-dimethyl-4-morpholin-4-ylphenyl)-2-(3-fluorophenyl)acetamide Chemical compound CC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CC1=CC=CC(F)=C1 BWTFEOVRRVXFIS-UHFFFAOYSA-N 0.000 description 1
• BHJCRISXCWZQNL-UHFFFAOYSA-N n-(2,6-dimethyl-4-morpholin-4-ylphenyl)-2-(3-methylphenyl)acetamide Chemical compound CC1=CC=CC(CC(=O)NC=2C(=CC(=CC=2C)N2CCOCC2)C)=C1 BHJCRISXCWZQNL-UHFFFAOYSA-N 0.000 description 1
• FQXJKHBCIJGCQO-UHFFFAOYSA-N n-(2,6-dimethyl-4-morpholin-4-ylphenyl)-2-(4-fluorophenyl)acetamide Chemical compound CC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CC1=CC=C(F)C=C1 FQXJKHBCIJGCQO-UHFFFAOYSA-N 0.000 description 1
• LWXZAWFLFOVWCD-UHFFFAOYSA-N n-(2,6-dimethyl-4-morpholin-4-ylphenyl)-2-(4-methylphenyl)acetamide Chemical compound C1=CC(C)=CC=C1CC(=O)NC1=C(C)C=C(N2CCOCC2)C=C1C LWXZAWFLFOVWCD-UHFFFAOYSA-N 0.000 description 1
• WZSQCEVOMHBPFJ-UHFFFAOYSA-N n-(2,6-dimethyl-4-morpholin-4-ylphenyl)-2-[3-(trifluoromethyl)phenyl]acetamide Chemical compound CC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CC1=CC=CC(C(F)(F)F)=C1 WZSQCEVOMHBPFJ-UHFFFAOYSA-N 0.000 description 1
• DBQFAOANWIBIGE-UHFFFAOYSA-N n-(2,6-dimethyl-4-morpholin-4-ylphenyl)-2-naphthalen-2-ylacetamide Chemical compound C=1C(C)=C(NC(=O)CC=2C=C3C=CC=CC3=CC=2)C(C)=CC=1N1CCOCC1 DBQFAOANWIBIGE-UHFFFAOYSA-N 0.000 description 1
• IQZIDXSIVOBHBG-UHFFFAOYSA-N n-(2,6-dimethyl-4-morpholin-4-ylphenyl)-2-thiophen-2-ylacetamide Chemical compound CC1=CC(N2CCOCC2)=CC(C)=C1NC(=O)CC1=CC=CS1 IQZIDXSIVOBHBG-UHFFFAOYSA-N 0.000 description 1
• UULFYDWHIRAODG-UHFFFAOYSA-N n-(2,6-dimethyl-4-morpholin-4-ylphenyl)-3,5,5-trimethylhexanamide Chemical compound C1=C(C)C(NC(=O)CC(C)CC(C)(C)C)=C(C)C=C1N1CCOCC1 UULFYDWHIRAODG-UHFFFAOYSA-N 0.000 description 1
• CPXXAHUMOPUBQF-UHFFFAOYSA-N n-(2,6-dimethyl-4-morpholin-4-ylphenyl)-3-ethylpentanamide Chemical compound C1=C(C)C(NC(=O)CC(CC)CC)=C(C)C=C1N1CCOCC1 CPXXAHUMOPUBQF-UHFFFAOYSA-N 0.000 description 1
• QDYMTVOPTQMLIP-UHFFFAOYSA-N n-(2,6-dimethyl-4-morpholin-4-ylphenyl)-3-methylpentanamide Chemical compound C1=C(C)C(NC(=O)CC(C)CC)=C(C)C=C1N1CCOCC1 QDYMTVOPTQMLIP-UHFFFAOYSA-N 0.000 description 1
• TVSPKPCWJNRGPB-UHFFFAOYSA-N n-(2,6-dimethyl-4-morpholin-4-ylphenyl)-4-methylpentanamide Chemical compound C1=C(C)C(NC(=O)CCC(C)C)=C(C)C=C1N1CCOCC1 TVSPKPCWJNRGPB-UHFFFAOYSA-N 0.000 description 1
• WZMQBLIZLSZDTE-UHFFFAOYSA-N n-(2,6-dimethyl-4-morpholin-4-ylphenyl)heptanamide Chemical compound C1=C(C)C(NC(=O)CCCCCC)=C(C)C=C1N1CCOCC1 WZMQBLIZLSZDTE-UHFFFAOYSA-N 0.000 description 1
• RPVLAQSRQQXWEJ-UHFFFAOYSA-N n-(2,6-dimethyl-4-morpholin-4-ylphenyl)hex-5-enamide Chemical compound CC1=C(NC(=O)CCCC=C)C(C)=CC(N2CCOCC2)=C1 RPVLAQSRQQXWEJ-UHFFFAOYSA-N 0.000 description 1
• RJPNBZXKFWESKX-UHFFFAOYSA-N n-(2,6-dimethyl-4-morpholin-4-ylphenyl)hexanamide Chemical compound C1=C(C)C(NC(=O)CCCCC)=C(C)C=C1N1CCOCC1 RJPNBZXKFWESKX-UHFFFAOYSA-N 0.000 description 1
• ZYQZHRXKSVPLEG-UHFFFAOYSA-N n-(2,6-dimethyl-4-morpholin-4-ylphenyl)octanamide Chemical compound C1=C(C)C(NC(=O)CCCCCCC)=C(C)C=C1N1CCOCC1 ZYQZHRXKSVPLEG-UHFFFAOYSA-N 0.000 description 1
• FLNIDPUBPDBGTL-UHFFFAOYSA-N n-(2,6-dimethyl-4-morpholin-4-ylphenyl)pentanamide Chemical compound C1=C(C)C(NC(=O)CCCC)=C(C)C=C1N1CCOCC1 FLNIDPUBPDBGTL-UHFFFAOYSA-N 0.000 description 1
• JQAHNNUCWWVTBF-UHFFFAOYSA-N n-(2-amino-4-bromo-6-methylphenyl)-3,3-dimethylbutanamide Chemical compound CC1=CC(Br)=CC(N)=C1NC(=O)CC(C)(C)C JQAHNNUCWWVTBF-UHFFFAOYSA-N 0.000 description 1
• LMHIKBQBDWYIPR-UHFFFAOYSA-N n-(2-bromo-4,6-dichlorophenyl)-2-(4-fluorophenyl)acetamide Chemical compound C1=CC(F)=CC=C1CC(=O)NC1=C(Cl)C=C(Cl)C=C1Br LMHIKBQBDWYIPR-UHFFFAOYSA-N 0.000 description 1
• AYWFSTLPGFXGPN-UHFFFAOYSA-N n-(2-bromo-4,6-dichlorophenyl)-2-cyclopentylacetamide Chemical compound BrC1=CC(Cl)=CC(Cl)=C1NC(=O)CC1CCCC1 AYWFSTLPGFXGPN-UHFFFAOYSA-N 0.000 description 1
• VBTXCZKHCJLZGV-UHFFFAOYSA-N n-(2-bromo-4,6-dichlorophenyl)-3,3-dimethylbutanamide Chemical compound CC(C)(C)CC(=O)NC1=C(Cl)C=C(Cl)C=C1Br VBTXCZKHCJLZGV-UHFFFAOYSA-N 0.000 description 1
• KGYPPALBQMVEFK-UHFFFAOYSA-N n-(2-bromo-4,6-dimethylphenyl)-2-(4-fluorophenyl)acetamide Chemical compound BrC1=CC(C)=CC(C)=C1NC(=O)CC1=CC=C(F)C=C1 KGYPPALBQMVEFK-UHFFFAOYSA-N 0.000 description 1
• NOGJERYUQWFZSH-UHFFFAOYSA-N n-(2-bromo-4,6-dimethylphenyl)-2-cyclopentylacetamide Chemical compound BrC1=CC(C)=CC(C)=C1NC(=O)CC1CCCC1 NOGJERYUQWFZSH-UHFFFAOYSA-N 0.000 description 1
• OBGRLHUKTLMALQ-UHFFFAOYSA-N n-(2-bromo-4,6-dimethylphenyl)-3,3-dimethylbutanamide Chemical compound CC1=CC(C)=C(NC(=O)CC(C)(C)C)C(Br)=C1 OBGRLHUKTLMALQ-UHFFFAOYSA-N 0.000 description 1
• ORMUPENLTSWLSB-UHFFFAOYSA-N n-(2-chloro-6-cyano-4-morpholin-4-ylphenyl)-3-cyclohexylpropanamide Chemical compound ClC1=CC(N2CCOCC2)=CC(C#N)=C1NC(=O)CCC1CCCCC1 ORMUPENLTSWLSB-UHFFFAOYSA-N 0.000 description 1
• CZXDPWCUNYIWRD-UHFFFAOYSA-N n-(2-chloro-6-methyl-4-morpholin-4-ylphenyl)-2-(3-fluorophenyl)acetamide Chemical compound CC1=CC(N2CCOCC2)=CC(Cl)=C1NC(=O)CC1=CC=CC(F)=C1 CZXDPWCUNYIWRD-UHFFFAOYSA-N 0.000 description 1
• KWQRIEAEGLFRKZ-UHFFFAOYSA-N n-(2-chloro-6-methyl-4-morpholin-4-ylphenyl)-2-cyclopentylacetamide Chemical compound CC1=CC(N2CCOCC2)=CC(Cl)=C1NC(=O)CC1CCCC1 KWQRIEAEGLFRKZ-UHFFFAOYSA-N 0.000 description 1
• BZNCUGFPSDUISB-UHFFFAOYSA-N n-(2-methoxy-6-methyl-4-morpholin-4-ylphenyl)-3,3-dimethylbutanamide Chemical compound CC1=C(NC(=O)CC(C)(C)C)C(OC)=CC(N2CCOCC2)=C1 BZNCUGFPSDUISB-UHFFFAOYSA-N 0.000 description 1
• KIEKLHLDPVXZRI-UHFFFAOYSA-N n-(2-methoxy-6-methyl-4-morpholin-4-ylphenyl)-4-methylpentanamide Chemical compound CC1=C(NC(=O)CCC(C)C)C(OC)=CC(N2CCOCC2)=C1 KIEKLHLDPVXZRI-UHFFFAOYSA-N 0.000 description 1
• WEIMMECSAQVSGO-UHFFFAOYSA-N n-(3-hydroxy-4-propylphenyl)acetamide Chemical compound CCCC1=CC=C(NC(C)=O)C=C1O WEIMMECSAQVSGO-UHFFFAOYSA-N 0.000 description 1
• CZEOTFCOTGFZPR-UHFFFAOYSA-N n-(4,6-dimethyl-2-morpholin-4-ylpyrimidin-5-yl)-2-(3-fluorophenyl)acetamide Chemical compound CC1=NC(N2CCOCC2)=NC(C)=C1NC(=O)CC1=CC=CC(F)=C1 CZEOTFCOTGFZPR-UHFFFAOYSA-N 0.000 description 1
• BGZXWAKABKRXEW-UHFFFAOYSA-N n-(4,6-dimethyl-2-morpholin-4-ylpyrimidin-5-yl)-3,3-dimethylbutanamide Chemical compound CC1=C(NC(=O)CC(C)(C)C)C(C)=NC(N2CCOCC2)=N1 BGZXWAKABKRXEW-UHFFFAOYSA-N 0.000 description 1
• CUYIVYGWYZOZCL-UHFFFAOYSA-N n-(4,6-dimethyl-2-morpholin-4-ylpyrimidin-5-yl)hexanamide Chemical compound N1=C(C)C(NC(=O)CCCCC)=C(C)N=C1N1CCOCC1 CUYIVYGWYZOZCL-UHFFFAOYSA-N 0.000 description 1
• CRNGWJTUEOBSCH-UHFFFAOYSA-N n-(4-bromo-2,6-dimethylphenyl)-2-(4-chlorophenyl)acetamide Chemical compound CC1=CC(Br)=CC(C)=C1NC(=O)CC1=CC=C(Cl)C=C1 CRNGWJTUEOBSCH-UHFFFAOYSA-N 0.000 description 1
• GHQWOAYHLGEKSK-UHFFFAOYSA-N n-(4-bromo-2,6-dimethylphenyl)-2-(4-fluorophenyl)acetamide Chemical compound CC1=CC(Br)=CC(C)=C1NC(=O)CC1=CC=C(F)C=C1 GHQWOAYHLGEKSK-UHFFFAOYSA-N 0.000 description 1
• GLBDFDMKCASXQQ-UHFFFAOYSA-N n-(4-bromo-2,6-dimethylphenyl)-2-cyclopentylacetamide Chemical compound CC1=CC(Br)=CC(C)=C1NC(=O)CC1CCCC1 GLBDFDMKCASXQQ-UHFFFAOYSA-N 0.000 description 1
• YBULBCNOKRWWDW-UHFFFAOYSA-N n-(4-bromo-2,6-dimethylphenyl)-2-phenylcyclopropane-1-carboxamide Chemical compound CC1=CC(Br)=CC(C)=C1NC(=O)C1C(C=2C=CC=CC=2)C1 YBULBCNOKRWWDW-UHFFFAOYSA-N 0.000 description 1
• BRSMPKRBMIMHTN-UHFFFAOYSA-N n-(4-bromo-2,6-dimethylphenyl)-2-thiophen-2-ylacetamide Chemical compound CC1=CC(Br)=CC(C)=C1NC(=O)CC1=CC=CS1 BRSMPKRBMIMHTN-UHFFFAOYSA-N 0.000 description 1
• INNYRLVBOHMVMN-UHFFFAOYSA-N n-(4-bromo-2,6-dimethylphenyl)cyclohexanecarboxamide Chemical compound CC1=CC(Br)=CC(C)=C1NC(=O)C1CCCCC1 INNYRLVBOHMVMN-UHFFFAOYSA-N 0.000 description 1
• HFNKFBFHZHFTGW-UHFFFAOYSA-N n-(4-bromo-2,6-dimethylphenyl)heptanamide Chemical compound CCCCCCC(=O)NC1=C(C)C=C(Br)C=C1C HFNKFBFHZHFTGW-UHFFFAOYSA-N 0.000 description 1
• MCBBKIXEHFOEKH-UHFFFAOYSA-N n-(4-bromo-2,6-dimethylphenyl)hexanamide Chemical compound CCCCCC(=O)NC1=C(C)C=C(Br)C=C1C MCBBKIXEHFOEKH-UHFFFAOYSA-N 0.000 description 1
• UQDDTPPOICDUBZ-UHFFFAOYSA-N n-(4-bromo-2,6-dimethylphenyl)octanamide Chemical compound CCCCCCCC(=O)NC1=C(C)C=C(Br)C=C1C UQDDTPPOICDUBZ-UHFFFAOYSA-N 0.000 description 1
• RWXAELOLLOUEEU-UHFFFAOYSA-N n-(4-bromo-2,6-dimethylphenyl)pentanamide Chemical compound CCCCC(=O)NC1=C(C)C=C(Br)C=C1C RWXAELOLLOUEEU-UHFFFAOYSA-N 0.000 description 1
• MVPLWTHYLWWKGV-UHFFFAOYSA-N n-(4-bromo-2-methyl-6-morpholin-4-ylphenyl)-3,3-dimethylbutanamide Chemical compound CC1=CC(Br)=CC(N2CCOCC2)=C1NC(=O)CC(C)(C)C MVPLWTHYLWWKGV-UHFFFAOYSA-N 0.000 description 1
• JBNREMLAUOUYRB-UHFFFAOYSA-N n-[1-(1-benzothiophen-2-ylmethyl)-2,3-dihydroindol-5-yl]-2-(4-fluorophenyl)acetamide Chemical compound C1=CC(F)=CC=C1CC(=O)NC1=CC=C(N(CC=2SC3=CC=CC=C3C=2)CC2)C2=C1 JBNREMLAUOUYRB-UHFFFAOYSA-N 0.000 description 1
• YLOCKEYFOVMFIT-UHFFFAOYSA-N n-[1-(1-benzothiophen-2-ylmethyl)-2,3-dihydroindol-5-yl]-3,3-dimethylbutanamide Chemical compound C1=CC=C2SC(CN3C4=CC=C(C=C4CC3)NC(=O)CC(C)(C)C)=CC2=C1 YLOCKEYFOVMFIT-UHFFFAOYSA-N 0.000 description 1
• JRMUSINHKOFJFV-UHFFFAOYSA-N n-[2,4-dimethyl-6-(2,2,5-trimethyl-3h-1-benzofuran-7-yl)phenyl]-2-(4-fluorophenyl)acetamide Chemical compound C=1C(C)=CC=2CC(C)(C)OC=2C=1C1=CC(C)=CC(C)=C1NC(=O)CC1=CC=C(F)C=C1 JRMUSINHKOFJFV-UHFFFAOYSA-N 0.000 description 1
• XAONIUOGFLUMOE-UHFFFAOYSA-N n-[2,4-dimethyl-6-(4-propan-2-ylphenyl)phenyl]-3,3-dimethylbutanamide Chemical compound C1=CC(C(C)C)=CC=C1C1=CC(C)=CC(C)=C1NC(=O)CC(C)(C)C XAONIUOGFLUMOE-UHFFFAOYSA-N 0.000 description 1
• DNUHYUKYPLADFM-UHFFFAOYSA-N n-[2,4-dimethyl-6-[3-(trifluoromethoxy)phenyl]phenyl]-2-(4-fluorophenyl)acetamide Chemical compound C=1C=CC(OC(F)(F)F)=CC=1C1=CC(C)=CC(C)=C1NC(=O)CC1=CC=C(F)C=C1 DNUHYUKYPLADFM-UHFFFAOYSA-N 0.000 description 1
• DAVKBZXKNMPEHG-UHFFFAOYSA-N n-[2,6-dimethyl-4-[[4-(trifluoromethyl)phenyl]methylamino]phenyl]acetamide Chemical compound C1=C(C)C(NC(=O)C)=C(C)C=C1NCC1=CC=C(C(F)(F)F)C=C1 DAVKBZXKNMPEHG-UHFFFAOYSA-N 0.000 description 1
• NPKGBLZCKDGMPK-UHFFFAOYSA-N n-[2,6-dimethyl-4-[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]phenyl]acetamide Chemical compound C=1C(C)=C(NC(C)=O)C(C)=CC=1N(C)CC1=CC=C(C(F)(F)F)C=C1 NPKGBLZCKDGMPK-UHFFFAOYSA-N 0.000 description 1
• HYADKSBTWYHMRC-UHFFFAOYSA-N n-[2-(3-acetamidophenyl)-4,6-dimethylphenyl]-2-(4-fluorophenyl)acetamide Chemical compound CC(=O)NC1=CC=CC(C=2C(=C(C)C=C(C)C=2)NC(=O)CC=2C=CC(F)=CC=2)=C1 HYADKSBTWYHMRC-UHFFFAOYSA-N 0.000 description 1
• XYJIVBJRAKFODH-UHFFFAOYSA-N n-[2-(3-aminophenyl)-4,6-dimethylphenyl]-2-(4-fluorophenyl)acetamide Chemical compound C=1C=CC(N)=CC=1C1=CC(C)=CC(C)=C1NC(=O)CC1=CC=C(F)C=C1 XYJIVBJRAKFODH-UHFFFAOYSA-N 0.000 description 1
• SXSIMUQLWHAEGS-UHFFFAOYSA-N n-[2-(3-cyanophenyl)-4,6-dimethylphenyl]-2-(4-fluorophenyl)acetamide Chemical compound C=1C=CC(C#N)=CC=1C1=CC(C)=CC(C)=C1NC(=O)CC1=CC=C(F)C=C1 SXSIMUQLWHAEGS-UHFFFAOYSA-N 0.000 description 1
• KECGJWZRAYXEMQ-UHFFFAOYSA-N n-[2-(4-ethenylphenyl)-4,6-dimethylphenyl]-2-(4-fluorophenyl)acetamide Chemical compound C=1C=C(C=C)C=CC=1C1=CC(C)=CC(C)=C1NC(=O)CC1=CC=C(F)C=C1 KECGJWZRAYXEMQ-UHFFFAOYSA-N 0.000 description 1
• LXGHGBFMMWWRPL-UHFFFAOYSA-N n-[2-[3,5-bis(trifluoromethyl)phenyl]-4,6-dimethylphenyl]-2-(4-fluorophenyl)acetamide Chemical compound C=1C(C(F)(F)F)=CC(C(F)(F)F)=CC=1C1=CC(C)=CC(C)=C1NC(=O)CC1=CC=C(F)C=C1 LXGHGBFMMWWRPL-UHFFFAOYSA-N 0.000 description 1
• ISMXZIBRJLAXBF-UHFFFAOYSA-N n-[2-[4-(dimethylamino)phenyl]-4,6-dimethylphenyl]-2-(4-fluorophenyl)acetamide Chemical compound C1=CC(N(C)C)=CC=C1C1=CC(C)=CC(C)=C1NC(=O)CC1=CC=C(F)C=C1 ISMXZIBRJLAXBF-UHFFFAOYSA-N 0.000 description 1
• ILXWQQLVKRBUAO-UHFFFAOYSA-N n-[2-amino-4-[(3-fluoroanilino)methyl]phenyl]-2,2-dimethylpropanamide Chemical compound C1=C(N)C(NC(=O)C(C)(C)C)=CC=C1CNC1=CC=CC(F)=C1 ILXWQQLVKRBUAO-UHFFFAOYSA-N 0.000 description 1
• GOXFPLZEUOSYNS-UHFFFAOYSA-N n-[2-amino-4-[(5-chlorothiophen-2-yl)methylamino]phenyl]-2-(4-fluorophenyl)acetamide Chemical compound C=1C=C(NC(=O)CC=2C=CC(F)=CC=2)C(N)=CC=1NCC1=CC=C(Cl)S1 GOXFPLZEUOSYNS-UHFFFAOYSA-N 0.000 description 1
• SNQCBOUYAWFQCM-UHFFFAOYSA-N n-[2-amino-4-[(5-chlorothiophen-2-yl)methylamino]phenyl]-3,3-dimethylbutanamide Chemical compound C1=C(N)C(NC(=O)CC(C)(C)C)=CC=C1NCC1=CC=C(Cl)S1 SNQCBOUYAWFQCM-UHFFFAOYSA-N 0.000 description 1
• IOILGKDZUBZKAY-UHFFFAOYSA-N n-[2-bromo-4-[(5-chlorothiophen-2-yl)methylamino]-6-(trifluoromethyl)phenyl]-3-cyclohexylpropanamide Chemical compound C=1C(Br)=C(NC(=O)CCC2CCCCC2)C(C(F)(F)F)=CC=1NCC1=CC=C(Cl)S1 IOILGKDZUBZKAY-UHFFFAOYSA-N 0.000 description 1
• JXVMTGLEBIWOHI-UHFFFAOYSA-N n-[2-bromo-4-morpholin-4-yl-6-(trifluoromethyl)phenyl]-2-(3-fluorophenyl)acetamide Chemical compound FC1=CC=CC(CC(=O)NC=2C(=CC(=CC=2Br)N2CCOCC2)C(F)(F)F)=C1 JXVMTGLEBIWOHI-UHFFFAOYSA-N 0.000 description 1
• RMGDROBIXZIMJN-UHFFFAOYSA-N n-[2-bromo-4-morpholin-4-yl-6-(trifluoromethyl)phenyl]-2-(4-fluorophenyl)acetamide Chemical compound C1=CC(F)=CC=C1CC(=O)NC1=C(Br)C=C(N2CCOCC2)C=C1C(F)(F)F RMGDROBIXZIMJN-UHFFFAOYSA-N 0.000 description 1
• VEZLUWKLAGYAPU-UHFFFAOYSA-N n-[2-bromo-4-morpholin-4-yl-6-(trifluoromethyl)phenyl]-2-cyclopentylacetamide Chemical compound FC(F)(F)C1=CC(N2CCOCC2)=CC(Br)=C1NC(=O)CC1CCCC1 VEZLUWKLAGYAPU-UHFFFAOYSA-N 0.000 description 1
• ZAWSOIRSBNEJNI-UHFFFAOYSA-N n-[2-bromo-4-morpholin-4-yl-6-(trifluoromethyl)phenyl]-3-cyclohexylpropanamide Chemical compound FC(F)(F)C1=CC(N2CCOCC2)=CC(Br)=C1NC(=O)CCC1CCCCC1 ZAWSOIRSBNEJNI-UHFFFAOYSA-N 0.000 description 1
• LNEODKACMQDIAF-UHFFFAOYSA-N n-[2-bromo-4-morpholin-4-yl-6-(trifluoromethyl)phenyl]-3-cyclopentylpropanamide Chemical compound FC(F)(F)C1=CC(N2CCOCC2)=CC(Br)=C1NC(=O)CCC1CCCC1 LNEODKACMQDIAF-UHFFFAOYSA-N 0.000 description 1
• FPUGBBDCGLIOFN-UHFFFAOYSA-N n-[2-bromo-4-morpholin-4-yl-6-(trifluoromethyl)phenyl]butanamide Chemical compound C1=C(C(F)(F)F)C(NC(=O)CCC)=C(Br)C=C1N1CCOCC1 FPUGBBDCGLIOFN-UHFFFAOYSA-N 0.000 description 1
• AOSDPVXNYCUYSW-UHFFFAOYSA-N n-[2-chloro-4-[(3,4-dichloroanilino)methyl]phenyl]butanamide Chemical compound C1=C(Cl)C(NC(=O)CCC)=CC=C1CNC1=CC=C(Cl)C(Cl)=C1 AOSDPVXNYCUYSW-UHFFFAOYSA-N 0.000 description 1
• HSXJTDIWKDHOPI-UHFFFAOYSA-N n-[2-chloro-4-[(3-fluoroanilino)methyl]phenyl]butanamide Chemical compound C1=C(Cl)C(NC(=O)CCC)=CC=C1CNC1=CC=CC(F)=C1 HSXJTDIWKDHOPI-UHFFFAOYSA-N 0.000 description 1
• DBLOEDMPCORMST-UHFFFAOYSA-N n-[2-chloro-4-[(4-chloro-3-fluoroanilino)methyl]phenyl]butanamide Chemical compound C1=C(Cl)C(NC(=O)CCC)=CC=C1CNC1=CC=C(Cl)C(F)=C1 DBLOEDMPCORMST-UHFFFAOYSA-N 0.000 description 1
• SHXIJKYXFWJGDT-UHFFFAOYSA-N n-[2-chloro-4-[(4-chloroanilino)methyl]phenyl]butanamide Chemical compound C1=C(Cl)C(NC(=O)CCC)=CC=C1CNC1=CC=C(Cl)C=C1 SHXIJKYXFWJGDT-UHFFFAOYSA-N 0.000 description 1
• HRQLXROTHVOVME-UHFFFAOYSA-N n-[2-chloro-4-[(4-fluoroanilino)methyl]phenyl]butanamide Chemical compound C1=C(Cl)C(NC(=O)CCC)=CC=C1CNC1=CC=C(F)C=C1 HRQLXROTHVOVME-UHFFFAOYSA-N 0.000 description 1
• DSPRNVSQYVZCFI-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]-2,2,2-trifluoroacetamide Chemical compound C=1C=C(NC(=O)C(F)(F)F)C(Cl)=CC=1N(C)CC1=CC=C(Cl)S1 DSPRNVSQYVZCFI-UHFFFAOYSA-N 0.000 description 1
• RJIRJOHWLZOJNX-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]-2-(3-methoxyphenyl)acetamide Chemical compound COC1=CC=CC(CC(=O)NC=2C(=CC(=CC=2)N(C)CC=2SC(Cl)=CC=2)Cl)=C1 RJIRJOHWLZOJNX-UHFFFAOYSA-N 0.000 description 1
• NHGMMGIROLDGFV-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]-2-(4-methoxyphenyl)acetamide Chemical compound C1=CC(OC)=CC=C1CC(=O)NC1=CC=C(N(C)CC=2SC(Cl)=CC=2)C=C1Cl NHGMMGIROLDGFV-UHFFFAOYSA-N 0.000 description 1
• HJUMLZPJCRCVMP-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]-2-thiophen-2-ylacetamide Chemical compound C=1C=C(NC(=O)CC=2SC=CC=2)C(Cl)=CC=1N(C)CC1=CC=C(Cl)S1 HJUMLZPJCRCVMP-UHFFFAOYSA-N 0.000 description 1
• WREHPYPXQIMPCQ-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]-3,3-dimethylbutanamide Chemical compound C=1C=C(NC(=O)CC(C)(C)C)C(Cl)=CC=1N(C)CC1=CC=C(Cl)S1 WREHPYPXQIMPCQ-UHFFFAOYSA-N 0.000 description 1
• QOJZWSIRHHMUND-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]-3-cyclohexylpropanamide Chemical compound C=1C=C(NC(=O)CCC2CCCCC2)C(Cl)=CC=1N(C)CC1=CC=C(Cl)S1 QOJZWSIRHHMUND-UHFFFAOYSA-N 0.000 description 1
• XEQYECZAIUQLSF-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]-3-phenylpropanamide Chemical compound C=1C=C(NC(=O)CCC=2C=CC=CC=2)C(Cl)=CC=1N(C)CC1=CC=C(Cl)S1 XEQYECZAIUQLSF-UHFFFAOYSA-N 0.000 description 1
• ZXIJIODJNIISBC-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]butanamide Chemical compound C1=C(Cl)C(NC(=O)CCC)=CC=C1N(C)CC1=CC=C(Cl)S1 ZXIJIODJNIISBC-UHFFFAOYSA-N 0.000 description 1
• ICTXQIPJUUCOJP-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]cyclobutanecarboxamide Chemical compound C=1C=C(NC(=O)C2CCC2)C(Cl)=CC=1N(C)CC1=CC=C(Cl)S1 ICTXQIPJUUCOJP-UHFFFAOYSA-N 0.000 description 1
• GTFNEWRWVYJMGD-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]cyclopentanecarboxamide Chemical compound C=1C=C(NC(=O)C2CCCC2)C(Cl)=CC=1N(C)CC1=CC=C(Cl)S1 GTFNEWRWVYJMGD-UHFFFAOYSA-N 0.000 description 1
• QVVCRTNUUALZJM-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]cyclopropanecarboxamide Chemical compound C=1C=C(NC(=O)C2CC2)C(Cl)=CC=1N(C)CC1=CC=C(Cl)S1 QVVCRTNUUALZJM-UHFFFAOYSA-N 0.000 description 1
• KTVYZDPJAAPEAD-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]pentanamide Chemical compound C1=C(Cl)C(NC(=O)CCCC)=CC=C1N(C)CC1=CC=C(Cl)S1 KTVYZDPJAAPEAD-UHFFFAOYSA-N 0.000 description 1
• UWLQXWWVEUDTNY-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methylamino]phenyl]-2,2,2-trifluoroacetamide Chemical compound C1=C(Cl)C(NC(=O)C(F)(F)F)=CC=C1NCC1=CC=C(Cl)S1 UWLQXWWVEUDTNY-UHFFFAOYSA-N 0.000 description 1
• YFDSOWUYPDFCDA-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methylamino]phenyl]-2,2-dimethylpropanamide Chemical compound C1=C(Cl)C(NC(=O)C(C)(C)C)=CC=C1NCC1=CC=C(Cl)S1 YFDSOWUYPDFCDA-UHFFFAOYSA-N 0.000 description 1
• BAZNEVZTWJPXMM-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methylamino]phenyl]-2,3-dihydro-1-benzofuran-5-carboxamide Chemical compound S1C(Cl)=CC=C1CNC(C=C1Cl)=CC=C1NC(=O)C1=CC=C(OCC2)C2=C1 BAZNEVZTWJPXMM-UHFFFAOYSA-N 0.000 description 1
• GZPCNLCZYOCMLW-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methylamino]phenyl]-2-(3-methoxyphenyl)acetamide Chemical compound COC1=CC=CC(CC(=O)NC=2C(=CC(NCC=3SC(Cl)=CC=3)=CC=2)Cl)=C1 GZPCNLCZYOCMLW-UHFFFAOYSA-N 0.000 description 1
• QPWADJHNRLEIQB-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methylamino]phenyl]-2-(4-chlorophenyl)acetamide Chemical compound S1C(Cl)=CC=C1CNC(C=C1Cl)=CC=C1NC(=O)CC1=CC=C(Cl)C=C1 QPWADJHNRLEIQB-UHFFFAOYSA-N 0.000 description 1
• VTUWOQKVXMNJRR-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methylamino]phenyl]-2-(4-fluorophenyl)acetamide Chemical compound C1=CC(F)=CC=C1CC(=O)NC(C(=C1)Cl)=CC=C1NCC1=CC=C(Cl)S1 VTUWOQKVXMNJRR-UHFFFAOYSA-N 0.000 description 1
• BCGYFDWDTFWDIR-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methylamino]phenyl]-2-phenoxyacetamide Chemical compound S1C(Cl)=CC=C1CNC(C=C1Cl)=CC=C1NC(=O)COC1=CC=CC=C1 BCGYFDWDTFWDIR-UHFFFAOYSA-N 0.000 description 1
• AEOSUEWFLMVAFB-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methylamino]phenyl]-2-phenylacetamide Chemical compound S1C(Cl)=CC=C1CNC(C=C1Cl)=CC=C1NC(=O)CC1=CC=CC=C1 AEOSUEWFLMVAFB-UHFFFAOYSA-N 0.000 description 1
• OOFJORNTRHEEFY-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methylamino]phenyl]-2-thiophen-2-ylacetamide Chemical compound S1C(Cl)=CC=C1CNC(C=C1Cl)=CC=C1NC(=O)CC1=CC=CS1 OOFJORNTRHEEFY-UHFFFAOYSA-N 0.000 description 1
• GBUJVXQGXXEWHN-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methylamino]phenyl]-3,3-dimethylbutanamide Chemical compound C1=C(Cl)C(NC(=O)CC(C)(C)C)=CC=C1NCC1=CC=C(Cl)S1 GBUJVXQGXXEWHN-UHFFFAOYSA-N 0.000 description 1
• UHHGGSIKLWJNOT-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methylamino]phenyl]-3-cyclohexylpropanamide Chemical compound S1C(Cl)=CC=C1CNC(C=C1Cl)=CC=C1NC(=O)CCC1CCCCC1 UHHGGSIKLWJNOT-UHFFFAOYSA-N 0.000 description 1
• PDZFLRVABUEWSZ-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methylamino]phenyl]butanamide Chemical compound C1=C(Cl)C(NC(=O)CCC)=CC=C1NCC1=CC=C(Cl)S1 PDZFLRVABUEWSZ-UHFFFAOYSA-N 0.000 description 1
• WMRAUBJGYGJYFV-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methylamino]phenyl]cyclobutanecarboxamide Chemical compound S1C(Cl)=CC=C1CNC(C=C1Cl)=CC=C1NC(=O)C1CCC1 WMRAUBJGYGJYFV-UHFFFAOYSA-N 0.000 description 1
• PABXVNVCLLFEJC-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methylamino]phenyl]cyclohexanecarboxamide Chemical compound S1C(Cl)=CC=C1CNC(C=C1Cl)=CC=C1NC(=O)C1CCCCC1 PABXVNVCLLFEJC-UHFFFAOYSA-N 0.000 description 1
• FVRNPBWTHTZVBH-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methylamino]phenyl]cyclopropanecarboxamide Chemical compound S1C(Cl)=CC=C1CNC(C=C1Cl)=CC=C1NC(=O)C1CC1 FVRNPBWTHTZVBH-UHFFFAOYSA-N 0.000 description 1
• HMSYDJFUVJCDSK-UHFFFAOYSA-N n-[2-chloro-4-[(5-chlorothiophen-2-yl)methylamino]phenyl]pentanamide Chemical compound C1=C(Cl)C(NC(=O)CCCC)=CC=C1NCC1=CC=C(Cl)S1 HMSYDJFUVJCDSK-UHFFFAOYSA-N 0.000 description 1
• SIONWVZOLMLQGG-UHFFFAOYSA-N n-[2-chloro-4-[[4-(trifluoromethyl)anilino]methyl]phenyl]butanamide Chemical compound C1=C(Cl)C(NC(=O)CCC)=CC=C1CNC1=CC=C(C(F)(F)F)C=C1 SIONWVZOLMLQGG-UHFFFAOYSA-N 0.000 description 1
• XSAPBUXDUGPCDB-UHFFFAOYSA-N n-[2-chloro-4-morpholin-4-yl-6-(trifluoromethyl)phenyl]-2-(3-fluorophenyl)acetamide Chemical compound FC1=CC=CC(CC(=O)NC=2C(=CC(=CC=2Cl)N2CCOCC2)C(F)(F)F)=C1 XSAPBUXDUGPCDB-UHFFFAOYSA-N 0.000 description 1
• VRZOMCHSAMLLPJ-UHFFFAOYSA-N n-[2-chloro-4-morpholin-4-yl-6-(trifluoromethyl)phenyl]-2-cyclopentylacetamide Chemical compound FC(F)(F)C1=CC(N2CCOCC2)=CC(Cl)=C1NC(=O)CC1CCCC1 VRZOMCHSAMLLPJ-UHFFFAOYSA-N 0.000 description 1
• NUVDMQHUVICNHC-UHFFFAOYSA-N n-[2-chloro-6-(trifluoromethyl)-4-[[4-(trifluoromethyl)phenyl]methylamino]phenyl]-2-cyclopentylacetamide Chemical compound C1=CC(C(F)(F)F)=CC=C1CNC(C=C1C(F)(F)F)=CC(Cl)=C1NC(=O)CC1CCCC1 NUVDMQHUVICNHC-UHFFFAOYSA-N 0.000 description 1
• VNXLQHITRXDULI-UHFFFAOYSA-N n-[2-fluoro-4-[(3-fluoroanilino)methyl]phenyl]butanamide Chemical compound C1=C(F)C(NC(=O)CCC)=CC=C1CNC1=CC=CC(F)=C1 VNXLQHITRXDULI-UHFFFAOYSA-N 0.000 description 1
• YIJKAGUJZZPFTO-UHFFFAOYSA-N n-[2-fluoro-4-[[4-(trifluoromethyl)anilino]methyl]phenyl]butanamide Chemical compound C1=C(F)C(NC(=O)CCC)=CC=C1CNC1=CC=C(C(F)(F)F)C=C1 YIJKAGUJZZPFTO-UHFFFAOYSA-N 0.000 description 1
• GEUIQJWDQZWGRE-UHFFFAOYSA-N n-[2-methoxy-4-[(4-propan-2-ylphenyl)methylamino]phenyl]butanamide Chemical compound C1=C(OC)C(NC(=O)CCC)=CC=C1NCC1=CC=C(C(C)C)C=C1 GEUIQJWDQZWGRE-UHFFFAOYSA-N 0.000 description 1
• TUXZGMKFRZJZSM-UHFFFAOYSA-N n-[2-methoxy-4-[[4-(trifluoromethyl)phenyl]methylamino]phenyl]butanamide Chemical compound C1=C(OC)C(NC(=O)CCC)=CC=C1NCC1=CC=C(C(F)(F)F)C=C1 TUXZGMKFRZJZSM-UHFFFAOYSA-N 0.000 description 1
• JSYCSVLZYSFSBB-UHFFFAOYSA-N n-[2-methyl-4-[[4-(trifluoromethyl)phenyl]methylamino]phenyl]-2-morpholin-4-ylacetamide Chemical compound C=1C=C(NC(=O)CN2CCOCC2)C(C)=CC=1NCC1=CC=C(C(F)(F)F)C=C1 JSYCSVLZYSFSBB-UHFFFAOYSA-N 0.000 description 1
• WGJUXKMIFGCNDM-UHFFFAOYSA-N n-[2-methyl-4-[[4-(trifluoromethyl)phenyl]methylamino]phenyl]butanamide Chemical compound C1=C(C)C(NC(=O)CCC)=CC=C1NCC1=CC=C(C(F)(F)F)C=C1 WGJUXKMIFGCNDM-UHFFFAOYSA-N 0.000 description 1
• ROGXWDNMPNMNEI-UHFFFAOYSA-N n-[2-methyl-4-morpholin-4-yl-6-(trifluoromethyl)phenyl]hexanamide Chemical compound C1=C(C(F)(F)F)C(NC(=O)CCCCC)=C(C)C=C1N1CCOCC1 ROGXWDNMPNMNEI-UHFFFAOYSA-N 0.000 description 1
• YYXJEXZKPIYXQH-UHFFFAOYSA-N n-[4-(azepan-1-yl)-2,6-dimethylphenyl]-2-cyclopentylacetamide Chemical compound CC1=CC(N2CCCCCC2)=CC(C)=C1NC(=O)CC1CCCC1 YYXJEXZKPIYXQH-UHFFFAOYSA-N 0.000 description 1
• NHXHKDUACVRVPF-UHFFFAOYSA-N n-[4-[(3,4-dichloroanilino)methyl]-2-fluorophenyl]butanamide Chemical compound C1=C(F)C(NC(=O)CCC)=CC=C1CNC1=CC=C(Cl)C(Cl)=C1 NHXHKDUACVRVPF-UHFFFAOYSA-N 0.000 description 1
• IIHYQCLDAORSCI-UHFFFAOYSA-N n-[4-[(3,4-dichloroanilino)methyl]-2-methylphenyl]butanamide Chemical compound C1=C(C)C(NC(=O)CCC)=CC=C1CNC1=CC=C(Cl)C(Cl)=C1 IIHYQCLDAORSCI-UHFFFAOYSA-N 0.000 description 1
• USVPVZBUNHDWDV-UHFFFAOYSA-N n-[4-[(3,4-dichloroanilino)methyl]phenyl]butanamide Chemical compound C1=CC(NC(=O)CCC)=CC=C1CNC1=CC=C(Cl)C(Cl)=C1 USVPVZBUNHDWDV-UHFFFAOYSA-N 0.000 description 1
• SGOJPZRZKYMFBN-UHFFFAOYSA-N n-[4-[(3-chloroanilino)methyl]-2,6-dimethylphenyl]-2-cyclopentylacetamide Chemical compound C=1C(C)=C(NC(=O)CC2CCCC2)C(C)=CC=1CNC1=CC=CC(Cl)=C1 SGOJPZRZKYMFBN-UHFFFAOYSA-N 0.000 description 1
• AJURBOPYTAEEME-UHFFFAOYSA-N n-[4-[(3-fluoroanilino)methyl]-2-methylphenyl]butanamide Chemical compound C1=C(C)C(NC(=O)CCC)=CC=C1CNC1=CC=CC(F)=C1 AJURBOPYTAEEME-UHFFFAOYSA-N 0.000 description 1
• ANCSKQQFJNCGFC-UHFFFAOYSA-N n-[4-[(4-chloro-3-fluoroanilino)methyl]-2-fluorophenyl]butanamide Chemical compound C1=C(F)C(NC(=O)CCC)=CC=C1CNC1=CC=C(Cl)C(F)=C1 ANCSKQQFJNCGFC-UHFFFAOYSA-N 0.000 description 1
• KEJHLHSTFNWOIR-UHFFFAOYSA-N n-[4-[(4-chloro-3-fluoroanilino)methyl]-2-methylphenyl]butanamide Chemical compound C1=C(C)C(NC(=O)CCC)=CC=C1CNC1=CC=C(Cl)C(F)=C1 KEJHLHSTFNWOIR-UHFFFAOYSA-N 0.000 description 1
• CKRMGYYYPLOCHM-UHFFFAOYSA-N n-[4-[(4-chloro-3-fluoroanilino)methyl]phenyl]butanamide Chemical compound C1=CC(NC(=O)CCC)=CC=C1CNC1=CC=C(Cl)C(F)=C1 CKRMGYYYPLOCHM-UHFFFAOYSA-N 0.000 description 1
• ZHOSOIRHYDABAJ-UHFFFAOYSA-N n-[4-[(4-chloroanilino)methyl]-2,6-dimethylphenyl]-2-(4-chlorophenyl)acetamide Chemical compound C=1C(C)=C(NC(=O)CC=2C=CC(Cl)=CC=2)C(C)=CC=1CNC1=CC=C(Cl)C=C1 ZHOSOIRHYDABAJ-UHFFFAOYSA-N 0.000 description 1
• SWJZWKSJUDGALQ-UHFFFAOYSA-N n-[4-[(4-chloroanilino)methyl]-2,6-dimethylphenyl]-2-cyclopentylacetamide Chemical compound C=1C(C)=C(NC(=O)CC2CCCC2)C(C)=CC=1CNC1=CC=C(Cl)C=C1 SWJZWKSJUDGALQ-UHFFFAOYSA-N 0.000 description 1
• HFOBLYQFMYXPKI-UHFFFAOYSA-N n-[4-[(4-chloroanilino)methyl]-2,6-dimethylphenyl]pentanamide Chemical compound C1=C(C)C(NC(=O)CCCC)=C(C)C=C1CNC1=CC=C(Cl)C=C1 HFOBLYQFMYXPKI-UHFFFAOYSA-N 0.000 description 1
• YNWPLUKYJAPYJQ-UHFFFAOYSA-N n-[4-[(4-chloroanilino)methyl]-2-fluorophenyl]butanamide Chemical compound C1=C(F)C(NC(=O)CCC)=CC=C1CNC1=CC=C(Cl)C=C1 YNWPLUKYJAPYJQ-UHFFFAOYSA-N 0.000 description 1
• XFZWRYINWCHARH-UHFFFAOYSA-N n-[4-[(4-chloroanilino)methyl]-2-methylphenyl]butanamide Chemical compound C1=C(C)C(NC(=O)CCC)=CC=C1CNC1=CC=C(Cl)C=C1 XFZWRYINWCHARH-UHFFFAOYSA-N 0.000 description 1
• SESQTSCDOREBKJ-UHFFFAOYSA-N n-[4-[(4-chloroanilino)methyl]phenyl]butanamide Chemical compound C1=CC(NC(=O)CCC)=CC=C1CNC1=CC=C(Cl)C=C1 SESQTSCDOREBKJ-UHFFFAOYSA-N 0.000 description 1
• IMMNNWSVPCTHKC-UHFFFAOYSA-N n-[4-[(4-fluoroanilino)methyl]-2-methylphenyl]butanamide Chemical compound C1=C(C)C(NC(=O)CCC)=CC=C1CNC1=CC=C(F)C=C1 IMMNNWSVPCTHKC-UHFFFAOYSA-N 0.000 description 1
• LJRXFNXMIQEJIO-UHFFFAOYSA-N n-[4-[(4-tert-butylphenyl)methylamino]-2-methoxyphenyl]butanamide Chemical compound C1=C(OC)C(NC(=O)CCC)=CC=C1NCC1=CC=C(C(C)(C)C)C=C1 LJRXFNXMIQEJIO-UHFFFAOYSA-N 0.000 description 1
• QXLDJYKVHQGGIE-UHFFFAOYSA-N n-[4-[(5-bromothiophen-2-yl)methylamino]-2-methoxyphenyl]butanamide Chemical compound C1=C(OC)C(NC(=O)CCC)=CC=C1NCC1=CC=C(Br)S1 QXLDJYKVHQGGIE-UHFFFAOYSA-N 0.000 description 1
• PUWKCSUQTQBIRA-UHFFFAOYSA-N n-[4-[(5-chlorothiophen-2-yl)methyl-methylamino]-2-methylphenyl]-2,2-dimethylpropanamide Chemical compound C=1C=C(NC(=O)C(C)(C)C)C(C)=CC=1N(C)CC1=CC=C(Cl)S1 PUWKCSUQTQBIRA-UHFFFAOYSA-N 0.000 description 1
• BYMZSQYOOFBETO-UHFFFAOYSA-N n-[4-[(5-chlorothiophen-2-yl)methyl-methylamino]-2-methylphenyl]-2-(3-methoxyphenyl)acetamide Chemical compound COC1=CC=CC(CC(=O)NC=2C(=CC(=CC=2)N(C)CC=2SC(Cl)=CC=2)C)=C1 BYMZSQYOOFBETO-UHFFFAOYSA-N 0.000 description 1
• XFEGTPTVEMIAHI-UHFFFAOYSA-N n-[4-[(5-chlorothiophen-2-yl)methyl-methylamino]-2-methylphenyl]-2-(4-fluorophenyl)acetamide Chemical compound C=1C=C(NC(=O)CC=2C=CC(F)=CC=2)C(C)=CC=1N(C)CC1=CC=C(Cl)S1 XFEGTPTVEMIAHI-UHFFFAOYSA-N 0.000 description 1
• LVTRCLBSFHCSJM-UHFFFAOYSA-N n-[4-[(5-chlorothiophen-2-yl)methyl-methylamino]-2-methylphenyl]-2-phenylacetamide Chemical compound C=1C=C(NC(=O)CC=2C=CC=CC=2)C(C)=CC=1N(C)CC1=CC=C(Cl)S1 LVTRCLBSFHCSJM-UHFFFAOYSA-N 0.000 description 1
• FZSKMPVDJNZYPW-UHFFFAOYSA-N n-[4-[(5-chlorothiophen-2-yl)methyl-methylamino]-2-methylphenyl]-2-thiophen-2-ylacetamide Chemical compound C=1C=C(NC(=O)CC=2SC=CC=2)C(C)=CC=1N(C)CC1=CC=C(Cl)S1 FZSKMPVDJNZYPW-UHFFFAOYSA-N 0.000 description 1
• ULWXUDKJPRSZJJ-UHFFFAOYSA-N n-[4-[(5-chlorothiophen-2-yl)methyl-methylamino]-2-methylphenyl]-3,3-dimethylbutanamide Chemical compound C=1C=C(NC(=O)CC(C)(C)C)C(C)=CC=1N(C)CC1=CC=C(Cl)S1 ULWXUDKJPRSZJJ-UHFFFAOYSA-N 0.000 description 1
• PMDHTUCYTXCBRV-UHFFFAOYSA-N n-[4-[(5-chlorothiophen-2-yl)methyl-methylamino]-2-methylphenyl]-3-cyclohexylpropanamide Chemical compound C=1C=C(NC(=O)CCC2CCCCC2)C(C)=CC=1N(C)CC1=CC=C(Cl)S1 PMDHTUCYTXCBRV-UHFFFAOYSA-N 0.000 description 1
• ZANNEMGAMBXAJH-UHFFFAOYSA-N n-[4-[(5-chlorothiophen-2-yl)methyl-methylamino]-2-methylphenyl]-3-phenylpropanamide Chemical compound C=1C=C(NC(=O)CCC=2C=CC=CC=2)C(C)=CC=1N(C)CC1=CC=C(Cl)S1 ZANNEMGAMBXAJH-UHFFFAOYSA-N 0.000 description 1
• SBGPXKACAAELIX-UHFFFAOYSA-N n-[4-[(5-chlorothiophen-2-yl)methyl-methylamino]-2-methylphenyl]cyclobutanecarboxamide Chemical compound C=1C=C(NC(=O)C2CCC2)C(C)=CC=1N(C)CC1=CC=C(Cl)S1 SBGPXKACAAELIX-UHFFFAOYSA-N 0.000 description 1
• ODIRDRIAAMZLCL-UHFFFAOYSA-N n-[4-[(5-chlorothiophen-2-yl)methyl-methylamino]-2-methylphenyl]cyclopentanecarboxamide Chemical compound C=1C=C(NC(=O)C2CCCC2)C(C)=CC=1N(C)CC1=CC=C(Cl)S1 ODIRDRIAAMZLCL-UHFFFAOYSA-N 0.000 description 1
• CYGSZWQLHYXDPR-UHFFFAOYSA-N n-[4-[(5-chlorothiophen-2-yl)methyl-methylamino]-2-methylphenyl]cyclopropanecarboxamide Chemical compound C=1C=C(NC(=O)C2CC2)C(C)=CC=1N(C)CC1=CC=C(Cl)S1 CYGSZWQLHYXDPR-UHFFFAOYSA-N 0.000 description 1
• RHEJEMHTZMPVHX-UHFFFAOYSA-N n-[4-[(5-chlorothiophen-2-yl)methylamino]-2-[4-(dimethylamino)phenyl]phenyl]-2-(4-fluorophenyl)acetamide Chemical compound C1=CC(N(C)C)=CC=C1C1=CC(NCC=2SC(Cl)=CC=2)=CC=C1NC(=O)CC1=CC=C(F)C=C1 RHEJEMHTZMPVHX-UHFFFAOYSA-N 0.000 description 1
• TXYYXEJXGQEJQO-UHFFFAOYSA-N n-[4-[(5-chlorothiophen-2-yl)methylamino]-2-iodophenyl]-2-(4-fluorophenyl)acetamide Chemical compound C1=CC(F)=CC=C1CC(=O)NC(C(=C1)I)=CC=C1NCC1=CC=C(Cl)S1 TXYYXEJXGQEJQO-UHFFFAOYSA-N 0.000 description 1
• NFTGAJLMMXINJN-UHFFFAOYSA-N n-[4-[(5-chlorothiophen-2-yl)methylamino]-2-methoxyphenyl]butanamide Chemical compound C1=C(OC)C(NC(=O)CCC)=CC=C1NCC1=CC=C(Cl)S1 NFTGAJLMMXINJN-UHFFFAOYSA-N 0.000 description 1
• ZNDKCOPIFNSNSB-UHFFFAOYSA-N n-[4-[(6-chloropyridin-3-yl)methylamino]-2-methylphenyl]-2-(4-fluorophenyl)acetamide Chemical compound C=1C=C(NC(=O)CC=2C=CC(F)=CC=2)C(C)=CC=1NCC1=CC=C(Cl)N=C1 ZNDKCOPIFNSNSB-UHFFFAOYSA-N 0.000 description 1
• TWOAAVBTWULEDV-UHFFFAOYSA-N n-[4-[2-(2-chlorophenyl)morpholin-4-yl]-2,6-dimethylphenyl]-2-cyclopentylacetamide Chemical compound CC1=CC(N2CC(OCC2)C=2C(=CC=CC=2)Cl)=CC(C)=C1NC(=O)CC1CCCC1 TWOAAVBTWULEDV-UHFFFAOYSA-N 0.000 description 1
• HYHPENAHMAZITK-UHFFFAOYSA-N n-[4-[2-(2-chlorophenyl)thiomorpholin-4-yl]-2,6-dimethylphenyl]-2-cyclopentylacetamide Chemical compound CC1=CC(N2CC(SCC2)C=2C(=CC=CC=2)Cl)=CC(C)=C1NC(=O)CC1CCCC1 HYHPENAHMAZITK-UHFFFAOYSA-N 0.000 description 1
• HPSQCKGKVCFDOI-UHFFFAOYSA-N n-[4-[[(5-chloropyridin-2-yl)amino]methyl]-2,6-dimethylphenyl]-2-cyclopentylacetamide Chemical compound C=1C(C)=C(NC(=O)CC2CCCC2)C(C)=CC=1CNC1=CC=C(Cl)C=N1 HPSQCKGKVCFDOI-UHFFFAOYSA-N 0.000 description 1
• MAABUWLWOVWWDB-UHFFFAOYSA-N n-[4-[[5-(4-chlorophenoxy)-1,3-dimethylpyrazol-4-yl]methylamino]-2-methylphenyl]-2,2-dimethylpropanamide Chemical compound C=1C=C(NC(=O)C(C)(C)C)C(C)=CC=1NCC=1C(C)=NN(C)C=1OC1=CC=C(Cl)C=C1 MAABUWLWOVWWDB-UHFFFAOYSA-N 0.000 description 1
• XETNUEHTWCZNAQ-UHFFFAOYSA-N n-[4-[[6-(4-cyanophenoxy)pyridin-3-yl]methylamino]-2-methylphenyl]-2-(4-fluorophenyl)acetamide Chemical compound C=1C=C(NC(=O)CC=2C=CC(F)=CC=2)C(C)=CC=1NCC(C=N1)=CC=C1OC1=CC=C(C#N)C=C1 XETNUEHTWCZNAQ-UHFFFAOYSA-N 0.000 description 1
• GIGOQAZYYLYRQV-UHFFFAOYSA-N n-[4-chloro-1-[(5-chlorothiophen-2-yl)methyl]-2,3-dihydroindol-5-yl]-3,3-dimethylbutanamide Chemical compound C1CC2=C(Cl)C(NC(=O)CC(C)(C)C)=CC=C2N1CC1=CC=C(Cl)S1 GIGOQAZYYLYRQV-UHFFFAOYSA-N 0.000 description 1
• WMITZKMKKZVUOA-UHFFFAOYSA-N n-[6-amino-1-[(4-fluorophenyl)methyl]-2,3-dihydroindol-5-yl]-3,3-dimethylbutanamide Chemical compound C1=2C=C(N)C(NC(=O)CC(C)(C)C)=CC=2CCN1CC1=CC=C(F)C=C1 WMITZKMKKZVUOA-UHFFFAOYSA-N 0.000 description 1
• FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
• 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
• 230000008693 nausea Effects 0.000 description 1
• 208000004296 neuralgia Diseases 0.000 description 1
• 230000000926 neurological effect Effects 0.000 description 1
• 208000021722 neuropathic pain Diseases 0.000 description 1
• 125000005187 nonenyl group Chemical group C(=CCCCCCCC)* 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 125000005071 nonynyl group Chemical group C(#CCCCCCCC)* 0.000 description 1
• 238000010606 normalization Methods 0.000 description 1
• 229950010634 ocaperidone Drugs 0.000 description 1
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
• OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
• QXFHPLPMTXEJPV-UHFFFAOYSA-N octane-1-sulfonic acid;sodium Chemical compound [Na].CCCCCCCCS(O)(=O)=O QXFHPLPMTXEJPV-UHFFFAOYSA-N 0.000 description 1
• 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
• 125000005069 octynyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C#C* 0.000 description 1
• 235000019198 oils Nutrition 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 239000004006 olive oil Substances 0.000 description 1
• 235000008390 olive oil Nutrition 0.000 description 1
• 229940127240 opiate Drugs 0.000 description 1
• 238000011369 optimal treatment Methods 0.000 description 1
• 239000003960 organic solvent Substances 0.000 description 1
• 230000002018 overexpression Effects 0.000 description 1
• 229960002841 oxypertine Drugs 0.000 description 1
• 125000005489 p-toluenesulfonic acid group Chemical class 0.000 description 1
• 229960001057 paliperidone Drugs 0.000 description 1
• IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 238000005192 partition Methods 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• 235000020232 peanut Nutrition 0.000 description 1
• 239000000312 peanut oil Substances 0.000 description 1
• 239000001814 pectin Substances 0.000 description 1
• 235000010987 pectin Nutrition 0.000 description 1
• 229920001277 pectin Polymers 0.000 description 1
• 229960004505 penfluridol Drugs 0.000 description 1
• 230000018052 penile erection Effects 0.000 description 1
• 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
• 125000005981 pentynyl group Chemical group 0.000 description 1
• WEYVCQFUGFRXOM-UHFFFAOYSA-N perazine Chemical compound C1CN(C)CCN1CCCN1C2=CC=CC=C2SC2=CC=CC=C21 WEYVCQFUGFRXOM-UHFFFAOYSA-N 0.000 description 1
• 229960002195 perazine Drugs 0.000 description 1
• 230000010412 perfusion Effects 0.000 description 1
• LUALIOATIOESLM-UHFFFAOYSA-N periciazine Chemical compound C1CC(O)CCN1CCCN1C2=CC(C#N)=CC=C2SC2=CC=CC=C21 LUALIOATIOESLM-UHFFFAOYSA-N 0.000 description 1
• 229960000769 periciazine Drugs 0.000 description 1
• 229960000762 perphenazine Drugs 0.000 description 1
• 230000002688 persistence Effects 0.000 description 1
• 230000002974 pharmacogenomic effect Effects 0.000 description 1
• 230000000079 pharmacotherapeutic effect Effects 0.000 description 1
• QYNJALBPNQXKOG-UHFFFAOYSA-N phenyl n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]carbamate Chemical compound C=1C=C(NC(=O)OC=2C=CC=CC=2)C(Cl)=CC=1N(C)CC1=CC=C(Cl)S1 QYNJALBPNQXKOG-UHFFFAOYSA-N 0.000 description 1
• 229940067631 phospholipid Drugs 0.000 description 1
• 150000003904 phospholipids Chemical class 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 229960003300 pimavanserin Drugs 0.000 description 1
• RGSULKHNAKTFIZ-CEAXSRTFSA-N pimavanserin tartrate Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(OCC(C)C)=CC=C1CNC(=O)N(C1CCN(C)CC1)CC1=CC=C(F)C=C1.C1=CC(OCC(C)C)=CC=C1CNC(=O)N(C1CCN(C)CC1)CC1=CC=C(F)C=C1 RGSULKHNAKTFIZ-CEAXSRTFSA-N 0.000 description 1
• YVUQSNJEYSNKRX-UHFFFAOYSA-N pimozide Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)CCCN1CCC(N2C(NC3=CC=CC=C32)=O)CC1 YVUQSNJEYSNKRX-UHFFFAOYSA-N 0.000 description 1
• 229960003634 pimozide Drugs 0.000 description 1
• AXKPFOAXAHJUAG-UHFFFAOYSA-N pipamperone Chemical compound C1CC(C(=O)N)(N2CCCCC2)CCN1CCCC(=O)C1=CC=C(F)C=C1 AXKPFOAXAHJUAG-UHFFFAOYSA-N 0.000 description 1
• 229960002776 pipamperone Drugs 0.000 description 1
• JOMHSQGEWSNUKU-UHFFFAOYSA-N pipotiazine Chemical compound C12=CC(S(=O)(=O)N(C)C)=CC=C2SC2=CC=CC=C2N1CCCN1CCC(CCO)CC1 JOMHSQGEWSNUKU-UHFFFAOYSA-N 0.000 description 1
• 229960003252 pipotiazine Drugs 0.000 description 1
• 239000004417 polycarbonate Substances 0.000 description 1
• 229920000515 polycarbonate Polymers 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 239000004036 potassium channel stimulating agent Substances 0.000 description 1
• 229920001592 potato starch Polymers 0.000 description 1
• 229940069328 povidone Drugs 0.000 description 1
• YRVIKLBSVVNSHF-JTQLQIEISA-N pozanicline Chemical compound CC1=NC=CC=C1OC[C@H]1NCCC1 YRVIKLBSVVNSHF-JTQLQIEISA-N 0.000 description 1
• 238000004321 preservation Methods 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 102000004196 processed proteins & peptides Human genes 0.000 description 1
• 229960003111 prochlorperazine Drugs 0.000 description 1
• WIKYUJGCLQQFNW-UHFFFAOYSA-N prochlorperazine Chemical compound C1CN(C)CCN1CCCN1C2=CC(Cl)=CC=C2SC2=CC=CC=C21 WIKYUJGCLQQFNW-UHFFFAOYSA-N 0.000 description 1
• 230000003414 procognitive effect Effects 0.000 description 1
• 229940002612 prodrug Drugs 0.000 description 1
• 239000000651 prodrug Substances 0.000 description 1
• 239000000047 product Substances 0.000 description 1
• 210000001176 projection neuron Anatomy 0.000 description 1
• 229960003598 promazine Drugs 0.000 description 1
• QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
• AQMMAJZBLIFENA-UHFFFAOYSA-N propyl n-(4-bromo-2,6-dimethylphenyl)carbamate Chemical compound CCCOC(=O)NC1=C(C)C=C(Br)C=C1C AQMMAJZBLIFENA-UHFFFAOYSA-N 0.000 description 1
• YVNQJVUAEHJVSD-UHFFFAOYSA-N propyl n-[2,6-dimethyl-4-[(4-methyl-2-phenylpyrimidin-5-yl)methylamino]phenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=C(C)C=C1NCC1=CN=C(C=2C=CC=CC=2)N=C1C YVNQJVUAEHJVSD-UHFFFAOYSA-N 0.000 description 1
• SCZBYOLAIVJLAL-UHFFFAOYSA-N propyl n-[2,6-dimethyl-4-[[4-(trifluoromethyl)anilino]methyl]phenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=C(C)C=C1CNC1=CC=C(C(F)(F)F)C=C1 SCZBYOLAIVJLAL-UHFFFAOYSA-N 0.000 description 1
• JRUNPSYYKOZIFI-UHFFFAOYSA-N propyl n-[2,6-dimethyl-4-[[4-(trifluoromethyl)phenyl]methylamino]phenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=C(C)C=C1NCC1=CC=C(C(F)(F)F)C=C1 JRUNPSYYKOZIFI-UHFFFAOYSA-N 0.000 description 1
• KAMAAAVPELJCKX-UHFFFAOYSA-N propyl n-[2,6-dimethyl-4-[[6-(4-methylphenoxy)pyridin-3-yl]methylamino]phenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=C(C)C=C1NCC(C=N1)=CC=C1OC1=CC=C(C)C=C1 KAMAAAVPELJCKX-UHFFFAOYSA-N 0.000 description 1
• GUWWVMJPRYOTKR-UHFFFAOYSA-N propyl n-[2-(furan-2-yl)-4-[(4-propan-2-ylphenyl)methylamino]phenyl]carbamate Chemical compound C1=C(C=2OC=CC=2)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(C(C)C)C=C1 GUWWVMJPRYOTKR-UHFFFAOYSA-N 0.000 description 1
• SNWAFDKDRJRUCS-UHFFFAOYSA-N propyl n-[2-(trifluoromethyl)-4-[[4-(trifluoromethyl)phenyl]methylamino]phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(C(F)(F)F)C=C1 SNWAFDKDRJRUCS-UHFFFAOYSA-N 0.000 description 1
• KYYUTTNFUCOPCS-UHFFFAOYSA-N propyl n-[2-amino-4-(1-benzothiophen-2-ylmethylamino)phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OCCC)=CC=C1NCC1=CC2=CC=CC=C2S1 KYYUTTNFUCOPCS-UHFFFAOYSA-N 0.000 description 1
• QHMVGVWNQLCEIC-UHFFFAOYSA-N propyl n-[2-bromo-4-[(4-methylsulfanylphenyl)methylamino]phenyl]carbamate Chemical compound C1=C(Br)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(SC)C=C1 QHMVGVWNQLCEIC-UHFFFAOYSA-N 0.000 description 1
• XSCQBIFKOLPBQP-UHFFFAOYSA-N propyl n-[2-bromo-4-[(4-propan-2-ylphenyl)methylamino]phenyl]carbamate Chemical compound C1=C(Br)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(C(C)C)C=C1 XSCQBIFKOLPBQP-UHFFFAOYSA-N 0.000 description 1
• YLYPVBMLXLRFPR-UHFFFAOYSA-N propyl n-[2-bromo-4-[(4-tert-butylphenyl)methyl-methylamino]phenyl]carbamate Chemical compound C1=C(Br)C(NC(=O)OCCC)=CC=C1N(C)CC1=CC=C(C(C)(C)C)C=C1 YLYPVBMLXLRFPR-UHFFFAOYSA-N 0.000 description 1
• CSVKGTLKBFHNBH-UHFFFAOYSA-N propyl n-[2-bromo-4-[(4-tert-butylphenyl)methylamino]phenyl]carbamate Chemical compound C1=C(Br)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(C(C)(C)C)C=C1 CSVKGTLKBFHNBH-UHFFFAOYSA-N 0.000 description 1
• BWNNQSDXPGZXIU-UHFFFAOYSA-N propyl n-[2-bromo-4-[(5-bromothiophen-2-yl)methyl-methylamino]phenyl]carbamate Chemical compound C1=C(Br)C(NC(=O)OCCC)=CC=C1N(C)CC1=CC=C(Br)S1 BWNNQSDXPGZXIU-UHFFFAOYSA-N 0.000 description 1
• RDVVIESVSGRXJS-UHFFFAOYSA-N propyl n-[2-bromo-4-[(5-bromothiophen-2-yl)methylamino]phenyl]carbamate Chemical compound C1=C(Br)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(Br)S1 RDVVIESVSGRXJS-UHFFFAOYSA-N 0.000 description 1
• RFBPNVJIXZBIRC-UHFFFAOYSA-N propyl n-[2-bromo-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]carbamate Chemical compound C1=C(Br)C(NC(=O)OCCC)=CC=C1N(C)CC1=CC=C(Cl)S1 RFBPNVJIXZBIRC-UHFFFAOYSA-N 0.000 description 1
• UJYLUVNQOIWRHI-UHFFFAOYSA-N propyl n-[2-bromo-4-[(5-chlorothiophen-2-yl)methylamino]phenyl]carbamate Chemical compound C1=C(Br)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(Cl)S1 UJYLUVNQOIWRHI-UHFFFAOYSA-N 0.000 description 1
• ZVJQBZOVZAKHCL-UHFFFAOYSA-N propyl n-[2-bromo-4-[[4-(trifluoromethyl)phenyl]methylamino]phenyl]carbamate Chemical compound C1=C(Br)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(C(F)(F)F)C=C1 ZVJQBZOVZAKHCL-UHFFFAOYSA-N 0.000 description 1
• TXNONQHAXVVONT-UHFFFAOYSA-N propyl n-[2-bromo-4-[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]phenyl]carbamate Chemical compound C1=C(Br)C(NC(=O)OCCC)=CC=C1N(C)CC1=CC=C(C(F)(F)F)C=C1 TXNONQHAXVVONT-UHFFFAOYSA-N 0.000 description 1
• CYWFLRNPZAOFSD-UHFFFAOYSA-N propyl n-[2-chloro-4-[(4-fluorophenyl)methylamino]phenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(F)C=C1 CYWFLRNPZAOFSD-UHFFFAOYSA-N 0.000 description 1
• YJOPZVBUMWERJC-UHFFFAOYSA-N propyl n-[2-chloro-4-[(5-chlorothiophen-2-yl)methyl-methylamino]phenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCCC)=CC=C1N(C)CC1=CC=C(Cl)S1 YJOPZVBUMWERJC-UHFFFAOYSA-N 0.000 description 1
• AFEGKGPOQWHFQJ-UHFFFAOYSA-N propyl n-[2-chloro-4-[(5-chlorothiophen-2-yl)methylamino]phenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(Cl)S1 AFEGKGPOQWHFQJ-UHFFFAOYSA-N 0.000 description 1
• UGBFSKGLWGZLCW-UHFFFAOYSA-N propyl n-[2-chloro-4-[(5-methylthiophen-2-yl)methylamino]phenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(C)S1 UGBFSKGLWGZLCW-UHFFFAOYSA-N 0.000 description 1
• YEXHSLUGSAGMJM-UHFFFAOYSA-N propyl n-[2-chloro-4-[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCCC)=CC=C1N(C)CC1=CC=C(C(F)(F)F)C=C1 YEXHSLUGSAGMJM-UHFFFAOYSA-N 0.000 description 1
• HMQPLANFTAPTBN-UHFFFAOYSA-N propyl n-[2-cyano-4-[[4-(trifluoromethyl)phenyl]methylamino]phenyl]carbamate Chemical compound C1=C(C#N)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(C(F)(F)F)C=C1 HMQPLANFTAPTBN-UHFFFAOYSA-N 0.000 description 1
• CPKOTQLROKZIHS-UHFFFAOYSA-N propyl n-[2-cyano-4-[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]phenyl]carbamate Chemical compound C1=C(C#N)C(NC(=O)OCCC)=CC=C1N(C)CC1=CC=C(C(F)(F)F)C=C1 CPKOTQLROKZIHS-UHFFFAOYSA-N 0.000 description 1
• QMKMMGGJLUWMDT-UHFFFAOYSA-N propyl n-[2-iodo-4-[(4-methylsulfanylphenyl)methylamino]phenyl]carbamate Chemical compound C1=C(I)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(SC)C=C1 QMKMMGGJLUWMDT-UHFFFAOYSA-N 0.000 description 1
• BXPLVYLJBOHLAC-UHFFFAOYSA-N propyl n-[2-iodo-4-[(4-propan-2-ylphenyl)methylamino]phenyl]carbamate Chemical compound C1=C(I)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(C(C)C)C=C1 BXPLVYLJBOHLAC-UHFFFAOYSA-N 0.000 description 1
• NUIPDYRCSYMGEO-UHFFFAOYSA-N propyl n-[2-iodo-4-[[4-(trifluoromethyl)phenyl]methylamino]phenyl]carbamate Chemical compound C1=C(I)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(C(F)(F)F)C=C1 NUIPDYRCSYMGEO-UHFFFAOYSA-N 0.000 description 1
• RJBCLHKMVOWSML-UHFFFAOYSA-N propyl n-[2-methoxy-4-[methyl-[(5-methylthiophen-2-yl)methyl]amino]phenyl]carbamate Chemical compound C1=C(OC)C(NC(=O)OCCC)=CC=C1N(C)CC1=CC=C(C)S1 RJBCLHKMVOWSML-UHFFFAOYSA-N 0.000 description 1
• VACFMSSWACPZHI-UHFFFAOYSA-N propyl n-[2-methyl-4-[(4-propan-2-ylphenyl)methylamino]phenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(C(C)C)C=C1 VACFMSSWACPZHI-UHFFFAOYSA-N 0.000 description 1
• AAPHGYAVTQDBAX-UHFFFAOYSA-N propyl n-[2-methyl-4-[(5-methylthiophen-2-yl)methylamino]phenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(C)S1 AAPHGYAVTQDBAX-UHFFFAOYSA-N 0.000 description 1
• QVCSVXPJFKCBPU-UHFFFAOYSA-N propyl n-[2-methyl-4-[(5-phenylthiophen-2-yl)methylamino]phenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(C=2C=CC=CC=2)S1 QVCSVXPJFKCBPU-UHFFFAOYSA-N 0.000 description 1
• PINFNGLHVSTBBG-UHFFFAOYSA-N propyl n-[2-methyl-4-[methyl-[(4-methylsulfanylphenyl)methyl]amino]phenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=CC=C1N(C)CC1=CC=C(SC)C=C1 PINFNGLHVSTBBG-UHFFFAOYSA-N 0.000 description 1
• GOJPEGLCQDFVPT-UHFFFAOYSA-N propyl n-[2-methyl-4-[methyl-[(4-propan-2-ylphenyl)methyl]amino]phenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=CC=C1N(C)CC1=CC=C(C(C)C)C=C1 GOJPEGLCQDFVPT-UHFFFAOYSA-N 0.000 description 1
• UZUYYMCKQDLORF-UHFFFAOYSA-N propyl n-[2-phenyl-4-[(4-propan-2-ylphenyl)methylamino]phenyl]carbamate Chemical compound C1=C(C=2C=CC=CC=2)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(C(C)C)C=C1 UZUYYMCKQDLORF-UHFFFAOYSA-N 0.000 description 1
• CUZJSPJHSHZBAK-UHFFFAOYSA-N propyl n-[4-(1-benzofuran-2-ylmethylamino)-2-chlorophenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCCC)=CC=C1NCC1=CC2=CC=CC=C2O1 CUZJSPJHSHZBAK-UHFFFAOYSA-N 0.000 description 1
• NPXGSEYMDJBGGG-UHFFFAOYSA-N propyl n-[4-(1-benzofuran-2-ylmethylamino)-2-methylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=CC=C1NCC1=CC2=CC=CC=C2O1 NPXGSEYMDJBGGG-UHFFFAOYSA-N 0.000 description 1
• OKURPJNOOJFAPL-UHFFFAOYSA-N propyl n-[4-(1-benzothiophen-2-ylmethylamino)-2-chlorophenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCCC)=CC=C1NCC1=CC2=CC=CC=C2S1 OKURPJNOOJFAPL-UHFFFAOYSA-N 0.000 description 1
• HIZHMAAIAJCCJA-UHFFFAOYSA-N propyl n-[4-(1-benzothiophen-2-ylmethylamino)-2-methylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=CC=C1NCC1=CC2=CC=CC=C2S1 HIZHMAAIAJCCJA-UHFFFAOYSA-N 0.000 description 1
• UIDDHJYOJQKCBL-UHFFFAOYSA-N propyl n-[4-[(3,5-difluoroanilino)methyl]-2,6-dimethylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=C(C)C=C1CNC1=CC(F)=CC(F)=C1 UIDDHJYOJQKCBL-UHFFFAOYSA-N 0.000 description 1
• YDWHGGSSEKVEEC-UHFFFAOYSA-N propyl n-[4-[(3-fluoroanilino)methyl]-2,6-dimethylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=C(C)C=C1CNC1=CC=CC(F)=C1 YDWHGGSSEKVEEC-UHFFFAOYSA-N 0.000 description 1
• AQIFYVHPKXHKSC-UHFFFAOYSA-N propyl n-[4-[(4-chloroanilino)methyl]-2,6-dimethylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=C(C)C=C1CNC1=CC=C(Cl)C=C1 AQIFYVHPKXHKSC-UHFFFAOYSA-N 0.000 description 1
• MMKYWFRMYQWGMK-UHFFFAOYSA-N propyl n-[4-[(4-fluoroanilino)methyl]-2,6-dimethylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=C(C)C=C1CNC1=CC=C(F)C=C1 MMKYWFRMYQWGMK-UHFFFAOYSA-N 0.000 description 1
• FCHLJBHFHBTVKP-UHFFFAOYSA-N propyl n-[4-[(4-fluorophenyl)methyl-methylamino]-2-methoxyphenyl]carbamate Chemical compound C1=C(OC)C(NC(=O)OCCC)=CC=C1N(C)CC1=CC=C(F)C=C1 FCHLJBHFHBTVKP-UHFFFAOYSA-N 0.000 description 1
• SMJVYXBKVNPKMX-UHFFFAOYSA-N propyl n-[4-[(4-fluorophenyl)methylamino]-2,6-dimethylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=C(C)C=C1NCC1=CC=C(F)C=C1 SMJVYXBKVNPKMX-UHFFFAOYSA-N 0.000 description 1
• ZUMWFZLNACCXQY-UHFFFAOYSA-N propyl n-[4-[(4-fluorophenyl)methylamino]-2-methylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(F)C=C1 ZUMWFZLNACCXQY-UHFFFAOYSA-N 0.000 description 1
• LFRNMSVOMBZWHX-UHFFFAOYSA-N propyl n-[4-[(4-fluorophenyl)methylamino]-2-phenylphenyl]carbamate Chemical compound C1=C(C=2C=CC=CC=2)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(F)C=C1 LFRNMSVOMBZWHX-UHFFFAOYSA-N 0.000 description 1
• BHLLLFQNDMQXGM-UHFFFAOYSA-N propyl n-[4-[(4-methoxyanilino)methyl]-2,6-dimethylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=C(C)C=C1CNC1=CC=C(OC)C=C1 BHLLLFQNDMQXGM-UHFFFAOYSA-N 0.000 description 1
• JZWNUSQHKDGSPL-UHFFFAOYSA-N propyl n-[4-[(4-propan-2-ylphenyl)methylamino]-2-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(C(C)C)C=C1 JZWNUSQHKDGSPL-UHFFFAOYSA-N 0.000 description 1
• OAYSXZNFPMSWAG-UHFFFAOYSA-N propyl n-[4-[(4-tert-butylphenyl)methyl-methylamino]-2-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(NC(=O)OCCC)=CC=C1N(C)CC1=CC=C(C(C)(C)C)C=C1 OAYSXZNFPMSWAG-UHFFFAOYSA-N 0.000 description 1
• GNWHHFNXSDFJRR-UHFFFAOYSA-N propyl n-[4-[(4-tert-butylphenyl)methyl-methylamino]-2-cyanophenyl]carbamate Chemical compound C1=C(C#N)C(NC(=O)OCCC)=CC=C1N(C)CC1=CC=C(C(C)(C)C)C=C1 GNWHHFNXSDFJRR-UHFFFAOYSA-N 0.000 description 1
• SIEUTMUKGSAJCV-UHFFFAOYSA-N propyl n-[4-[(4-tert-butylphenyl)methylamino]-2-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(C(C)(C)C)C=C1 SIEUTMUKGSAJCV-UHFFFAOYSA-N 0.000 description 1
• HBJYCGYONGRNBT-UHFFFAOYSA-N propyl n-[4-[(4-tert-butylphenyl)methylamino]-2-iodophenyl]carbamate Chemical compound C1=C(I)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(C(C)(C)C)C=C1 HBJYCGYONGRNBT-UHFFFAOYSA-N 0.000 description 1
• UHEROFPUOURMRS-UHFFFAOYSA-N propyl n-[4-[(5-bromothiophen-2-yl)methyl-methylamino]-2-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(NC(=O)OCCC)=CC=C1N(C)CC1=CC=C(Br)S1 UHEROFPUOURMRS-UHFFFAOYSA-N 0.000 description 1
• PCQHVHNZUALPAY-UHFFFAOYSA-N propyl n-[4-[(5-bromothiophen-2-yl)methyl-methylamino]-2-chlorophenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCCC)=CC=C1N(C)CC1=CC=C(Br)S1 PCQHVHNZUALPAY-UHFFFAOYSA-N 0.000 description 1
• FWDZPVMNVYWYDE-UHFFFAOYSA-N propyl n-[4-[(5-bromothiophen-2-yl)methyl-methylamino]-2-cyanophenyl]carbamate Chemical compound C1=C(C#N)C(NC(=O)OCCC)=CC=C1N(C)CC1=CC=C(Br)S1 FWDZPVMNVYWYDE-UHFFFAOYSA-N 0.000 description 1
• YQQGBVKAOAIQCU-UHFFFAOYSA-N propyl n-[4-[(5-bromothiophen-2-yl)methyl-methylamino]-2-methoxyphenyl]carbamate Chemical compound C1=C(OC)C(NC(=O)OCCC)=CC=C1N(C)CC1=CC=C(Br)S1 YQQGBVKAOAIQCU-UHFFFAOYSA-N 0.000 description 1
• CUWJGDXDNIVHMT-UHFFFAOYSA-N propyl n-[4-[(5-bromothiophen-2-yl)methyl-methylamino]-2-methylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=CC=C1N(C)CC1=CC=C(Br)S1 CUWJGDXDNIVHMT-UHFFFAOYSA-N 0.000 description 1
• VNMZPITYDDGRFI-UHFFFAOYSA-N propyl n-[4-[(5-bromothiophen-2-yl)methylamino]-2-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(Br)S1 VNMZPITYDDGRFI-UHFFFAOYSA-N 0.000 description 1
• BYUTZEHIGCHKBV-UHFFFAOYSA-N propyl n-[4-[(5-bromothiophen-2-yl)methylamino]-2-chlorophenyl]carbamate Chemical compound C1=C(Cl)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(Br)S1 BYUTZEHIGCHKBV-UHFFFAOYSA-N 0.000 description 1
• USVUDEJACSYFMY-UHFFFAOYSA-N propyl n-[4-[(5-bromothiophen-2-yl)methylamino]-2-cyanophenyl]carbamate Chemical compound C1=C(C#N)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(Br)S1 USVUDEJACSYFMY-UHFFFAOYSA-N 0.000 description 1
• QIOHVQFTNMAWDO-UHFFFAOYSA-N propyl n-[4-[(5-bromothiophen-2-yl)methylamino]-2-methylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(Br)S1 QIOHVQFTNMAWDO-UHFFFAOYSA-N 0.000 description 1
• ROLKYIHQDWATHN-UHFFFAOYSA-N propyl n-[4-[(5-bromothiophen-2-yl)methylamino]phenyl]carbamate Chemical compound C1=CC(NC(=O)OCCC)=CC=C1NCC1=CC=C(Br)S1 ROLKYIHQDWATHN-UHFFFAOYSA-N 0.000 description 1
• LWONAZIZWSZQPC-UHFFFAOYSA-N propyl n-[4-[(5-chlorothiophen-2-yl)methyl-methylamino]-2-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(NC(=O)OCCC)=CC=C1N(C)CC1=CC=C(Cl)S1 LWONAZIZWSZQPC-UHFFFAOYSA-N 0.000 description 1
• NFJFMYAGECOXQG-UHFFFAOYSA-N propyl n-[4-[(5-chlorothiophen-2-yl)methylamino]-2,6-dimethylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=C(C)C=C1NCC1=CC=C(Cl)S1 NFJFMYAGECOXQG-UHFFFAOYSA-N 0.000 description 1
• DJUQASMTDBQSDU-UHFFFAOYSA-N propyl n-[4-[(5-chlorothiophen-2-yl)methylamino]-2-cyanophenyl]carbamate Chemical compound C1=C(C#N)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(Cl)S1 DJUQASMTDBQSDU-UHFFFAOYSA-N 0.000 description 1
• JTBGMUOYQQVBTC-UHFFFAOYSA-N propyl n-[4-[(5-chlorothiophen-2-yl)methylamino]-2-methylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(Cl)S1 JTBGMUOYQQVBTC-UHFFFAOYSA-N 0.000 description 1
• HXYZXAFZZIRHHL-UHFFFAOYSA-N propyl n-[4-[(5-chlorothiophen-2-yl)methylamino]-2-phenylphenyl]carbamate Chemical compound C1=C(C=2C=CC=CC=2)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(Cl)S1 HXYZXAFZZIRHHL-UHFFFAOYSA-N 0.000 description 1
• AANRTTWSJLIBNU-UHFFFAOYSA-N propyl n-[4-[(5-chlorothiophen-2-yl)methylamino]phenyl]carbamate Chemical compound C1=CC(NC(=O)OCCC)=CC=C1NCC1=CC=C(Cl)S1 AANRTTWSJLIBNU-UHFFFAOYSA-N 0.000 description 1
• NUTZCWRUFKZYLV-UHFFFAOYSA-N propyl n-[4-[(6-methoxy-1-benzothiophen-2-yl)methylamino]-2-methylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=CC=C1NCC1=CC2=CC=C(OC)C=C2S1 NUTZCWRUFKZYLV-UHFFFAOYSA-N 0.000 description 1
• NREXXJQDOCMIGN-UHFFFAOYSA-N propyl n-[4-[(6-methoxypyridin-3-yl)methylamino]-2,6-dimethylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=C(C)C=C1NCC1=CC=C(OC)N=C1 NREXXJQDOCMIGN-UHFFFAOYSA-N 0.000 description 1
• YGACWVPIOXYFMJ-UHFFFAOYSA-N propyl n-[4-[1-benzothiophen-2-ylmethyl(methyl)amino]-2-methoxyphenyl]carbamate Chemical compound C1=C(OC)C(NC(=O)OCCC)=CC=C1N(C)CC1=CC2=CC=CC=C2S1 YGACWVPIOXYFMJ-UHFFFAOYSA-N 0.000 description 1
• PCCQSQGHSVUCBZ-UHFFFAOYSA-N propyl n-[4-[[3-fluoro-4-(trifluoromethyl)phenyl]methyl-methylamino]-2,6-dimethylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=C(C)C=C1N(C)CC1=CC=C(C(F)(F)F)C(F)=C1 PCCQSQGHSVUCBZ-UHFFFAOYSA-N 0.000 description 1
• NEHSTGIZKPRPQM-UHFFFAOYSA-N propyl n-[4-[[3-fluoro-4-(trifluoromethyl)phenyl]methylamino]-2,6-dimethylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=C(C)C=C1NCC1=CC=C(C(F)(F)F)C(F)=C1 NEHSTGIZKPRPQM-UHFFFAOYSA-N 0.000 description 1
• PXPOVHBJPNEAIO-UHFFFAOYSA-N propyl n-[4-[[4-(4-chlorophenyl)sulfonyl-3-methylthiophen-2-yl]methylamino]-2-methylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=CC=C1NCC1=C(C)C(S(=O)(=O)C=2C=CC(Cl)=CC=2)=CS1 PXPOVHBJPNEAIO-UHFFFAOYSA-N 0.000 description 1
• QQGCEBGXHWJPAE-UHFFFAOYSA-N propyl n-[4-[[4-(dimethylamino)phenyl]methylamino]-2-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(NC(=O)OCCC)=CC=C1NCC1=CC=C(N(C)C)C=C1 QQGCEBGXHWJPAE-UHFFFAOYSA-N 0.000 description 1
• BXBONVDXYZLIRH-UHFFFAOYSA-N propyl n-[4-[[5-(dimethylamino)-3-methyl-1-benzothiophen-2-yl]methylamino]-2-methylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=CC=C1NCC1=C(C)C2=CC(N(C)C)=CC=C2S1 BXBONVDXYZLIRH-UHFFFAOYSA-N 0.000 description 1
• PKMRTAMQCXTVMS-UHFFFAOYSA-N propyl n-[4-[[7-(dimethylamino)-1-benzothiophen-2-yl]methylamino]-2-methylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=CC=C1NCC1=CC2=CC=CC(N(C)C)=C2S1 PKMRTAMQCXTVMS-UHFFFAOYSA-N 0.000 description 1
• GKFDLOMGRKRKCN-UHFFFAOYSA-N propyl n-[4-[methyl-[(4-methylsulfanylphenyl)methyl]amino]-2-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(NC(=O)OCCC)=CC=C1N(C)CC1=CC=C(SC)C=C1 GKFDLOMGRKRKCN-UHFFFAOYSA-N 0.000 description 1
• DPDDVOFOYUWVOB-UHFFFAOYSA-N propyl n-[4-[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]-2-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(NC(=O)OCCC)=CC=C1N(C)CC1=CC=C(C(F)(F)F)C=C1 DPDDVOFOYUWVOB-UHFFFAOYSA-N 0.000 description 1
• 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
• 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
• 229960003415 propylparaben Drugs 0.000 description 1
• 238000000159 protein binding assay Methods 0.000 description 1
• 229960000957 prothipendyl Drugs 0.000 description 1
• JTTAUPUMOLRVRA-UHFFFAOYSA-N prothipendyl Chemical group C1=CN=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 JTTAUPUMOLRVRA-UHFFFAOYSA-N 0.000 description 1
• 229940127250 psychostimulant medication Drugs 0.000 description 1
• 230000002685 pulmonary effect Effects 0.000 description 1
• NYCVCXMSZNOGDH-UHFFFAOYSA-N pyrrolidine-1-carboxylic acid Chemical compound OC(=O)N1CCCC1 NYCVCXMSZNOGDH-UHFFFAOYSA-N 0.000 description 1
• 230000035484 reaction time Effects 0.000 description 1
• 239000000018 receptor agonist Substances 0.000 description 1
• 229940044601 receptor agonist Drugs 0.000 description 1
• 230000002787 reinforcement Effects 0.000 description 1
• 229960003448 remoxipride Drugs 0.000 description 1
• 230000004043 responsiveness Effects 0.000 description 1
• 230000036390 resting membrane potential Effects 0.000 description 1
• 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
• QXUAYTHTYPXRJX-UHFFFAOYSA-N s-ethyl n-[2-cyclopentyloxy-4-[(4-fluorophenyl)methyl-methylamino]phenyl]carbamothioate Chemical compound CCSC(=O)NC1=CC=C(N(C)CC=2C=CC(F)=CC=2)C=C1OC1CCCC1 QXUAYTHTYPXRJX-UHFFFAOYSA-N 0.000 description 1
• UVTVKEZLGLETEN-UHFFFAOYSA-N s-ethyl n-[4-[(4-fluorophenyl)methyl-methylamino]-2-phenylmethoxyphenyl]carbamothioate Chemical compound CCSC(=O)NC1=CC=C(N(C)CC=2C=CC(F)=CC=2)C=C1OCC1=CC=CC=C1 UVTVKEZLGLETEN-UHFFFAOYSA-N 0.000 description 1
• 229950000425 sabcomeline Drugs 0.000 description 1
• IQWCBYSUUOFOMF-QTLFRQQHSA-N sabcomeline Chemical compound C1CC2[C@@H](C(/C#N)=N/OC)CN1CC2 IQWCBYSUUOFOMF-QTLFRQQHSA-N 0.000 description 1
• HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
• DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
• 230000018448 secretion by cell Effects 0.000 description 1
• 239000000932 sedative agent Substances 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 230000000862 serotonergic effect Effects 0.000 description 1
• 230000000697 serotonin reuptake Effects 0.000 description 1
• 230000009329 sexual behaviour Effects 0.000 description 1
• 230000006403 short-term memory Effects 0.000 description 1
• 230000011664 signaling Effects 0.000 description 1
• 238000009097 single-agent therapy Methods 0.000 description 1
• 210000003625 skull Anatomy 0.000 description 1
• 239000001509 sodium citrate Substances 0.000 description 1
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
• AEQFSUDEHCCHBT-UHFFFAOYSA-M sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 description 1
• 239000007909 solid dosage form Substances 0.000 description 1
• 238000013222 sprague-dawley male rat Methods 0.000 description 1
• 239000007921 spray Substances 0.000 description 1
• 235000000891 standard diet Nutrition 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 239000007858 starting material Substances 0.000 description 1
• 239000008117 stearic acid Substances 0.000 description 1
• 239000008223 sterile water Substances 0.000 description 1
• 230000001954 sterilising effect Effects 0.000 description 1
• 201000006152 substance dependence Diseases 0.000 description 1
• 210000003523 substantia nigra Anatomy 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• RAHZWNYVWXNFOC-UHFFFAOYSA-N sulfur dioxide Inorganic materials O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 1
• 229960004940 sulpiride Drugs 0.000 description 1
• 229960004724 sultopride Drugs 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 230000008093 supporting effect Effects 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 238000013268 sustained release Methods 0.000 description 1
• 239000012730 sustained-release form Substances 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• 230000002195 synergetic effect Effects 0.000 description 1
• 230000006794 tachycardia Effects 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• 235000012222 talc Nutrition 0.000 description 1
• 229950011332 talnetant Drugs 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• 150000003892 tartrate salts Chemical class 0.000 description 1
• QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical class C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
• 229960000278 theophylline Drugs 0.000 description 1
• 229960004728 thiopropazate Drugs 0.000 description 1
• AIUHRQHVWSUTGJ-UHFFFAOYSA-N thiopropazate Chemical compound C1CN(CCOC(=O)C)CCN1CCCN1C2=CC(Cl)=CC=C2SC2=CC=CC=C21 AIUHRQHVWSUTGJ-UHFFFAOYSA-N 0.000 description 1
• 229960003397 thioproperazine Drugs 0.000 description 1
• VZYCZNZBPPHOFY-UHFFFAOYSA-N thioproperazine Chemical compound C12=CC(S(=O)(=O)N(C)C)=CC=C2SC2=CC=CC=C2N1CCCN1CCN(C)CC1 VZYCZNZBPPHOFY-UHFFFAOYSA-N 0.000 description 1
• 229960002784 thioridazine Drugs 0.000 description 1
• 229960005344 tiapride Drugs 0.000 description 1
• 208000016686 tic disease Diseases 0.000 description 1
• 229960005013 tiotixene Drugs 0.000 description 1
• KJAMZCVTJDTESW-UHFFFAOYSA-N tiracizine Chemical compound C1CC2=CC=CC=C2N(C(=O)CN(C)C)C2=CC(NC(=O)OCC)=CC=C21 KJAMZCVTJDTESW-UHFFFAOYSA-N 0.000 description 1
• 210000001519 tissue Anatomy 0.000 description 1
• 125000003944 tolyl group Chemical group 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 238000011830 transgenic mouse model Methods 0.000 description 1
• 239000003029 tricyclic antidepressant agent Substances 0.000 description 1
• 229960002324 trifluoperazine Drugs 0.000 description 1
• ZEWQUBUPAILYHI-UHFFFAOYSA-N trifluoperazine Chemical compound C1CN(C)CCN1CCCN1C2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C21 ZEWQUBUPAILYHI-UHFFFAOYSA-N 0.000 description 1
• 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
• GPMXUUPHFNMNDH-UHFFFAOYSA-N trifluperidol Chemical compound C1CC(O)(C=2C=C(C=CC=2)C(F)(F)F)CCN1CCCC(=O)C1=CC=C(F)C=C1 GPMXUUPHFNMNDH-UHFFFAOYSA-N 0.000 description 1
• 229960002341 trifluperidol Drugs 0.000 description 1
• 229960003904 triflupromazine Drugs 0.000 description 1
• XSCGXQMFQXDFCW-UHFFFAOYSA-N triflupromazine Chemical compound C1=C(C(F)(F)F)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 XSCGXQMFQXDFCW-UHFFFAOYSA-N 0.000 description 1
• 210000004496 type 1 vestibular hair cell Anatomy 0.000 description 1
• NPTIPEQJIDTVKR-STQMWFEESA-N vabicaserin Chemical compound C1CNCC2=CC=CC3=C2N1C[C@@H]1CCC[C@@H]13 NPTIPEQJIDTVKR-STQMWFEESA-N 0.000 description 1
• 229950009968 vabicaserin Drugs 0.000 description 1
• 229940102566 valproate Drugs 0.000 description 1
• 229960001968 veralipride Drugs 0.000 description 1
• RYJXBGGBZJGVQF-UHFFFAOYSA-N veralipride Chemical compound COC1=CC(S(N)(=O)=O)=CC(C(=O)NCC2N(CCC2)CC=C)=C1OC RYJXBGGBZJGVQF-UHFFFAOYSA-N 0.000 description 1
• 238000012795 verification Methods 0.000 description 1
• 230000001720 vestibular Effects 0.000 description 1
• 235000019165 vitamin E Nutrition 0.000 description 1
• 229940046009 vitamin E Drugs 0.000 description 1
• 239000011709 vitamin E Substances 0.000 description 1
• 230000001755 vocal effect Effects 0.000 description 1
• 230000002747 voluntary effect Effects 0.000 description 1
• 230000004584 weight gain Effects 0.000 description 1
• 235000019786 weight gain Nutrition 0.000 description 1
• 229960000607 ziprasidone Drugs 0.000 description 1
• MVWVFYHBGMAFLY-UHFFFAOYSA-N ziprasidone Chemical compound C1=CC=C2C(N3CCN(CC3)CCC3=CC=4CC(=O)NC=4C=C3Cl)=NSC2=C1 MVWVFYHBGMAFLY-UHFFFAOYSA-N 0.000 description 1
• HDOZVRUNCMBHFH-UHFFFAOYSA-N zotepine Chemical compound CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12 HDOZVRUNCMBHFH-UHFFFAOYSA-N 0.000 description 1
• 229960004496 zotepine Drugs 0.000 description 1
• 229960004141 zuclopenthixol Drugs 0.000 description 1